Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.1.3.2 - acid phosphatase and Organism(s) Homo sapiens and UniProt Accession P13686

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abortion, Spontaneous
Phosphotyrosine-protein-phosphatases and human reproduction: an association between low molecular weight acid phosphatase (ACP1) and spontaneous abortion.
Abscess
[2 cases of hairy cell leukemia]
Achondroplasia
FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossification.
acid phosphatase deficiency
Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.
Isolation and characterization of acid phosphatase mutants in Schizosaccharomycespombe.
Liver-specific lysosomal acid phosphatase deficiency (Apl) on mouse chromosome 17.
Lysosomal Acid Phosphatase Deficiency: Liver Specific Variant in the Mouse.
Lysosomal tartrate sensitive acid phosphatase deficiency in cells which contain lysosomal "high uptake forms".
Spatial and Temporal Expression of Lysosomal Acid Phosphatase 2 (ACP2) Reveals Dynamic Patterning of the Mouse Cerebellar Cortex.
Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature.
Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus.
Treatment of acid phosphatase deficiency disorders.
Acidosis
Automated determination of blood metabolic acidosis, total acid phosphatase, angiotensin converting enzyme, fructosamine and urinary oxalate and citrate on the ABX Pentra 400.
Renal tubular acidosis, hypokalemia, and acid phosphatase.
Acidosis, Renal Tubular
Renal tubular acidosis, hypokalemia, and acid phosphatase.
Acne Vulgaris
Purification and partial characterization of an acid phosphatase (EC 3.1.3.2) produced by Propionibacterium acnes.
Acquired Immunodeficiency Syndrome
Identification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans.
[In vivo neutralization of physiological cervicovaginal acidity by sperm nitrogen bases]
Acute Kidney Injury
[The dynamics of postmortem cellular changes. Ultrastructural-histochemical research]
Adenocarcinoma
'Endometrial' adenocarcinoma of the prostatic urethra arising in a villous polyp. A light microscopic and immunoperoxidase study.
A case report of a high serum acid phosphatase level in metastatic prostatic adenocarcinoma.
Absence of serum prostate-specific antigen and loss of tissue immunoreactive prostatic markers in advanced prostatic adenocarcinoma after hormonal therapy: a report of two cases.
Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.
Atypical ductal adenocarcinoma of the prostate with endometrioid immunohistological features.
Biochemical parameters as prognostic factors in prostatic adenocarcinoma.
Carcinoembryonic antigen and carbohydrate antigen 19-9-producing adenocarcinoma of the prostate: report of an autopsy case.
Carcinosarcoma of the prostate in combination with adenocarcinoma of the prostate and adenocarcinoma of the seminal vesicles. A case report with immunocytochemical analysis and review of the literature.
Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy.
Characterization of residual tumor cells following radical radiation therapy for prostatic adenocarcinoma; immunohistochemical expression of prostate-specific antigen, prostatic acid phosphatase, and cytokeratin 8.
Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison.
Clear cell adenocarcinoma of the female urethra showing positive staining with antibodies to prostate-specific antigen and prostatic acid phosphatase.
Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
Correlation of Peripheral Vein Tumour Marker Levels, Internal Iliac Vein Tumour Marker Levels and Radical Prostatectomy Specimens in Patients with Prostate Cancer and Borderline High Prostate-Specific Antigen: A Pilot Study.
Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation.
Discordance between concentrations of prostate-specific antigen and acid phosphatase in serum of patients with adenocarcinoma of the prostate.
Distant Cutaneous Metastases of Prostate Cancer: A Report of 2 Cases.
Distribution pattern of basal cells detected by cytokeratin 34 beta E12 in primary prostatic duct adenocarcinoma.
DNA and protein content as cellular biochemical parameters. A discussion with two examples: acid phosphatase and cathepsin D in rat liver and hepatoma and acid phosphatase in human breast normal tissue and adenocarcinoma.
Effect of hormone therapy on immune response in patients with prostatic cancer.
Effect of hormone treatment on prostatic acid phosphatase in a serially transplantable human prostatic adenocarcinoma (PC-82).
Elevated prostatic acid phosphatase: a prognostic factor for stage C adenocarcinoma of the prostate.
Elevation of prostate-specific markers after cardiopulmonary resuscitation.
Enzyme activity and distribution in rat prostatic adenocarcinoma.
Enzyme tests in diseases of the prostate.
Enzymorphology of adenocarcinoma of the endometrium; beta-glucuronidase, acid phosphatase, reduced diphosphopyridine nucleotide (DPNH) diaphorase, and alpha-naphthyl esterase.
Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.
Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypertrophy or prostate cancer.
Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase.
Florid hyperplasia of mesonephric remnants involving prostate and periprostatic tissue. Possible confusion with adenocarcinoma.
Histology, histochemistry, and acid phosphatase of Noble (Nb) rat prostate adenocarcinomas and treatment of an androgen-dependent Nb rat prostate adenocarcinoma.
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Identification of the phosphatidic acid phosphatase type 2a isozyme as an androgen-regulated gene in the human prostatic adenocarcinoma cell line LNCaP.
Immunocytochemical demonstration of prostatic acid phosphatase: different secretion kinetics between normal, hyperplastic and neoplastic prostates.
Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma.
Immunoperoxidase staining of acid phosphatase in human prostatic tissue.
Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores.
Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
Intraoperative and early complications of staging pelvic lymph node dissection in prostatic adenocarcinoma.
Lack of usefulness of bone marrow enzymes and calcium in staging patients with prostatic cancer.
Lymphangitic pulmonary metastases in castrate-resistant prostate adenocarcinoma.
Metastasis of prostatic adenocarcinoma to the sphenoid sinus.
Metastatic Adenocarcinoma of the Prostate to the Brain Initially Suspected as Meningioma by Magnetic Resonance Imaging.
Metastatic prostatic carcinoma to testis: histological features mimicking lymphoma.
Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity.
MULTIMODAL IMAGING AND HISTOLOGIC CORRELATION OF ISOLATED METASTASIS OF PROSTATE ADENOCARCINOMA TO THE CHOROID.
Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases.
New diagnostic use of bone marrow acid and alkaline phosphatase.
NKX3.1 as a marker of prostatic origin in metastatic tumors.
Orbital metastasis as presenting symptom from a prostatic adenocarcinoma.
Pleomorphic giant cell carcinoma of the prostate.
Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostatic specific antigen by immunohistochemistry.
Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study.
Primary adenocarcinoma of the seminal vesicles. A review of the literature.
Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
Prostate adenocarcinoma using Gleason scores correlates with prostate-specific antigen and prostate acid phosphatase measurements.
Prostate carcinoma with squamous differentiation: an analysis of 33 cases.
Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry.
Prostate specific antigen and prostate specific acid phosphatase in adenocarcinoma of Skene's paraurethral glands and ducts.
Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder.
Prostate-specific acid phosphatase: re-evaluation of radioimmunoassay in diagnosing prostatic disease.
Prostate-specific antigen as a marker of adenocarcinoma of prostate.
Prostate-specific antigen in the follow-up of prostatic adenocarcinoma treated with external beam radiation.
Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with nonprostate adenocarcinoma.
Prostatic acid phosphatase as measured with two radioimmunoassay kits in the detection of prostatic adenocarcinoma.
Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
Prostatic acid phosphatase in carcinoid tumors. Immunohistochemical and immunoblot studies.
Prostatic adenocarcinoma metastatic to the breasts: report of a case with diagnosis by fine needle aspiration biopsy.
Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase.
Prostatic ductal adenocarcinoma showing Bcl-2 expression.
Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
R3327 prostate adenocarcinoma clonogenic cells: epithelial properties and hormone response.
Radioimmunoassay of bone marrow prostatic acid phosphatase.
Radioimmunoassay of creatine kinase B-isoenzymes in serum of patients with azotemia, obstructive uropathy, or carcinoma of the prostate or bladder.
Radioimmunological imaging of metastatic prostatic cancer with 111indium-labeled monoclonal antibody PAY 276.
Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience.
Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases.
Secondary prostatic adenocarcinoma: a cytopathological study of 50 cases.
Seminal vesicle volume as a sonographic predictor of prostate cancer stage.
Serum PSA and PAP measurements discriminating patients with prostate carcinoma from patients with nodular hyperplasia.
Signet-ring-cell carcinoma of the prostate. Electron-microscopic and immunohistochemical studies of eight cases.
Sister Mary Joseph's nodule as a presenting sign of internal malignancy.
Splenic metastasis in hairy cell leukemia.
The appropriate uses of prostatic acid phosphatase determination in the diagnosis of adenocarcinoma of the prostate.
The diagnostic significance of serum creatine kinase-BB isoenzyme in adenocarcinoma of prostate.
The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study.
The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma.
The laboratory diagnosis of prostatic adenocarcinoma.
The Nb rat prostatic adenocarcinoma model system.
The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localized human prostatic adenocarcinoma.
The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate.
The role of serum prostatic acid phosphatase as a tumor marker in men with advanced adenocarcinoma of the prostate.
The role of serum prostatic acid phosphatase in the management of adenocarcinoma of the prostate with radiotherapy.
The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma.
Transmembrane prostatic acid phosphatase (TMPAP) delays cells in G1 phase of the cell cycle.
Transmembrane Prostatic Acid Phosphatase (TMPAP) Interacts with Snapin and Deficient Mice Develop Prostate Adenocarcinoma.
Unusual metastatic patterns of prostate adenocarcinoma.
Urothelial-type adenocarcinoma of the prostate mimicking metastatic colorectal adenocarcinoma.
[A case of clear cell adenocarcinoma of the female urethra]
[A case of small cell carcinoma of the prostate]
[A primary adenocarcinoma of the seminal vesicles. Case report of a rare malignancy]
[An immunohistological study of metastatic adenocarcinoma of the lymph node: is it useful in diagnosing a primary tumor?]
[Clinical analysis and treatment of carcinoma of the prostate with bone metastasis]
[Cytochemical studies for determining the histogenesis of anaplastic and poorly differentiated lung tumors]
[Diagnostic, clinical and therapeutic aspects of primary transitional cell carcinoma of the prostate]
[Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)]
[Relation of serum levels of acid phosphatase in the femoral vein and the inferior vena cava in adenocarcinoma of the prostate]
[Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate]
[Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases]
[Skin metastasis as first manifestation of prostatic adenocarcinoma]
Adenocarcinoma of Lung
Lipin-1 determines lung cancer cell survival and chemotherapy sensitivity by regulation of endoplasmic reticulum homeostasis and autophagy.
Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma.
Adenocarcinoma, Bronchiolo-Alveolar
[Enzyme cytochemistry and morphometric study of the effects of macrophages on A549 pulmonary alveolar cell carcinoma cell line]
Adenocarcinoma, Clear Cell
Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison.
Clear cell adenocarcinoma of the female urethra showing positive staining with antibodies to prostate-specific antigen and prostatic acid phosphatase.
Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases.
[A case of clear cell adenocarcinoma of the female urethra]
Adenocarcinoma, Mucinous
Ultrastructural cytochemistry of human gastric cancer: electron microscopic observations of five organellae marker enzymes.
[A case of mucinous adenocarcinoma of the prostate]
[Two cases of mucinous adenocarcinoma of the prostate]
Adenocarcinoma, Papillary
Papillary adenocarcinomas of the prostate. An immunohistochemical study.
Adenoma
Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies.
Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison.
Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Enzyme activities in biopsy specimens from large-bowel mucosa in colorectal adenomas and carcinomas.
Incidence of serum acid phosphatase elevation after transurethral prostatectomy.
Nephrogenic adenomas of the urethra involving the prostate gland: a report of two cases of a lesion that may be confused with prostatic adenocarcinoma.
[Citrate and acid phosphatase in the ejaculate in prostatic carcinoma and adenoma]
[Diagnostic value of prostatic specific antigen (PSA) in comparison to prostatic acid phosphatase (PAP) in prostatic cancer and adenoma]
[Enzymatic activity of adenosine triphosphatase and acid phosphatase in adenoma of the tongue]
[Immunochemical properties of acid phosphatase of the human prostate gland and its adenoma]
[Immunochemical tests in the diagnosis of diseases of the male reproductive system]
[The significance of acid phosphatase activity in the cytologic diagnosis of thyroid malignancy (author's transl)]
[Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase]
Adenoma, Islet Cell
Prostate-specific acid phosphatase in carcinoid tumors.
Prostatic acid phosphatase in carcinoid and islet cell tumors.
Adenoma, Pleomorphic
Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation.
Adenomatoid Tumor
Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.
Adrenal Insufficiency
Effect of thyroidectomy and adrenalectomy on the physiochemical status of rat testes.
Adrenocortical Adenoma
Enzyme histo-cytochemical studies in human adrenocortical adenomas. [II] Cushing's syndrome.
Enzyme histocytochemical studies in human adrenocortical adenomas. [I]. Primary aldosteronism.
African Swine Fever
Evidence for an acid phosphatase in African swine fever virus.
Agranulocytosis
Chronic lymphocytic leukaemia of T cell origin. Clinical variation possibly due to involvement of different T lymphocyte subpopulations.
Alveolar Bone Loss
Effectiveness of the diode laser in the treatment of ligature-induced periodontitis in rats: a histopathological, histometric, and immunohistochemical study.
Effects of Histamine Receptor Antagonist Cetirizine on Orthodontic Tooth Movement.
Novel antioxidative nanotherapeutics in a rat periodontitis model: Reactive oxygen species scavenging by redox injectable gel suppresses alveolar bone resorption.
Osteopenic effects of high-fat diet-induced obesity on mechanically induced alveolar bone remodeling.
Periodontal ligament-associated protein-1 gets involved in experimental periodontitis.
Protective effect of hinokitiol against periodontal bone loss in ligature-induced experimental periodontitis in mice.
Alzheimer Disease
Alterations of low molecular weight acid phosphatase protein level in Alzheimer's disease.
Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia.
Genetic aspects of Alzheimer disease.
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
Amebiasis
Structure-Function Relationship Study of a Secretory Amoebic Phosphatase: A Computational-Experimental Approach.
Ameloblastoma
Identification of RANKL in osteolytic lesions of the facial skeleton.
Amelogenesis Imperfecta
Defects in the acid phosphatase ACPT cause recessive hypoplastic amelogenesis imperfecta.
Recessive Mutations in ACPT, Encoding Testicular Acid Phosphatase, Cause Hypoplastic Amelogenesis Imperfecta.
Amyloidosis
Parallel intraylysosomal amyloid fibrils, a possible result of phagocytosis.
The effect of beta aminoproprionitrile (BAPN) on experimental amyloidosis.
Anaphylaxis
Morphochemical investigations of the liver and biochemical studies of the blood of guinea pigs in anaphylactic shock.
Anemia
Advanced cancer of the prostate combined with hypercalcaemia.
Biological characterization of avian osteopetrosis.
Effects of androgen therapy on prostatic markers in hemodialyzed patients.
Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis.
Prognostic factors in patients with advanced stage prostate cancer.
The activity of certain hydrolases of rat erythrocytes in experimental magnesium deficiency.
[Activity of selected neutrophil enzymes of patients maintained on hemodialysis and treated with erythropoietin (rHu EPO)]
[Leucocyte tartrate-resistant acid phosphatase as marker for the transition of monocyte to macrophage]
Anemia, Hemolytic
Development of the embryonic chick phagocytic system: intraembryonic erythrophagocytosis induced by phenylhydrazine.
Anemia, Pernicious
Cytochemical detection of erythroblastic enzymes in acquired dyserythropoiesis.
Anemia, Sickle Cell
Predictors of osteoclast activity in patients with sickle cell disease.
Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
Tissue damage in sickle cell disease as assessed by serum acid phosphatase.
Angina, Unstable
[Activation of the antibacterial properties and neutrophil myeloperoxidase and acid phosphatase in patients with unstable angina pectoris]
Ankylosis
Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling.
Appendicitis
Experimental model of acute appendicitis in the rabbit with determination of leucine amino peptidase (LAP) and acid phosphatase (acid-P) activities in portal blood samples.
Arteritis
Polymyalgia rheumatica and giant cell arteritis--rational diagnosis and treatment predicated and disordered prostaglandin metabolism.
Arthritis
Adenosine A2A Receptor Mediates Inhibition of Synovitis and Osteoclastogenesis after Electroacupuncture in Rats with Collagen-Induced Arthritis.
Cherubism mice also deficient in c-Fos exhibit inflammatory bone destruction executed by macrophages that express MMP14 despite the absence of TRAP+ osteoclasts.
Dextran sulphate induced arthritis in rabbits.
Histochemical investigation of adjuvant-induced arthritis.
Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis.
Induction of autoimmune arthritis after direct injection of bone marrow cells from arthritis-prone SKG/Jcl mice into bone cavity of normal mice.
Interleukin-27 suppresses osteoclastogenesis via induction of interferon-?
Metabolomics analysis of the therapeutic effects of Qiwei Tongbi oral liquid on rheumatoid arthritis in rats.
Osseous tissue reaction around hydroxyapatite block implanted into proximal metaphysis of tibia of rat with collagen-induced arthritis.
Prevention of progressive joint destruction in adjuvant induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR217840.
Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/?-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats.
Synovial fluid acid phosphatase in seropositive and seronegative arthritides.
Tartrate-resistant acid phosphatase as a diagnostic factor for arthritis.
The use of aqueous propolis extract against radiation-induced damage.
[Identification of mesenchymal stem cells derived from rheumatoid arthritis synovial fluid and their regulatory effect on osteoblast formation.]
Arthritis, Experimental
Abundant expression of tetraspanin CD9 in activated osteoclasts in ovariectomy-induced osteoporosis and in bone erosions of collagen-induced arthritis.
Adiponectin aggravates bone erosion by promoting osteopontin production in synovial tissue of rheumatoid arthritis.
Changes in location and number of tartrate-resistant acid phosphatase (TRAP)-positive cells during the development of type II collagen-induced arthritis in DBA/1J mice.
Evaluation of protective efficacy of Spirulina platensis against collagen-induced arthritis in rats.
IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
Synergistic Effects of Erzhi Pill Combined With Methotrexate on Osteoblasts Mediated via the Wnt1/LRP5/?-Catenin Signaling Pathway in Collagen-Induced Arthritis Rats.
[Behavior of serum acid phosphatase in adjuvant arthritis of the rat]
[Hydrolytic enzymes of rat tissues with adjuvant arthritis]
Arthritis, Gouty
[Relation of serum Dickkopf-1 with bone destruction in patients with gouty arthritis].
Arthritis, Psoriatic
In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes.
Arthritis, Rheumatoid
Appearance of specific acid phosphatase isozymes in the synovial fluid of patients with rheumatoid arthritis.
Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients.
Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
Disease-specific expression of tartrate-resistant acid phosphatase isoforms.
Electrophoretic study of tartrate-resistant acid phosphatase isoforms in endstage renal disease and rheumatoid arthritis.
In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes.
Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio.
KLF2 (kruppel like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
Lymphocyte subpopulations in rheumatoid arthritis. An immunological, enzyme histochemical and morphological study.
Predictive value of synovial fluid analysis in rheumatoid arthritis. A 7.5-year follow-up study.
Prognostic significance of synovial fluid analysis in rheumatoid arthritis.
Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells.
Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.
Significance of serum TRACP in rheumatoid arthritis.
Synovial fluid acid phosphatase in rheumatoid arthritis.
Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage.
Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
[Biomarker of bone and cartilage destruction in rheumatoid arthritis].
[Morphologic analysis of synovial effusion in rheumatoid arthritis. I. Light microscopy--cytology, histochemistry and semi-thin sections]
[Relation between serum enzymes and articular radionuclide tests in the diagnosis of osteoarthrosis and rheumatoid arthritis]
[Study of lysosomal enzymes in human synovial membrane and fluid from rheumatoid and non-rheumatoid patients]
[Technetium[(99)Tc] methylenediphosphonate inhibits osteoclast formation from PBMCs in patients with rheumatoid arthritis.]
[The chronobiological aspects of lysosomal enzyme activity in the synovial fluid and of remission in rheumatoid inflammation]
[The cytochemical characteristics of neutrophilic leukocytes in the peripheral blood and synovial fluid of patients with rheumatoid arthritis in the course of treatment]
[The diagnostic information value of determining the cytochemical properties of the neutrophils from the blood and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis deformans]
[The effect of intra-articular treatment with corticosteroids, polyvinylpyrrolidone and dimethyl sulfoxide on the composition of the synovial fluid in patients with rheumatoid arthritis]
[The mechanism of TRACP 5b maturation]
Ascorbic Acid Deficiency
Dietary vitamin C deficiency depressed the gill physical barriers and immune barriers referring to Nrf2, apoptosis, MLCK, NF-?B and TOR signaling in grass carp (Ctenopharyngodon idella) under infection of Flavobacterium columnare.
Dietary vitamin C deficiency depresses the growth, head kidney and spleen immunity and structural integrity by regulating NF-?B, TOR, Nrf2, apoptosis and MLCK signaling in young grass carp (Ctenopharyngodon idella).
Increase in tartrate-resistant acid phosphatase of bone at the early stage of ascorbic acid deficiency in the ascorbate-requiring Osteogenic Disorder Shionogi (ODS) rat.
Aspermia
Prostatic acid phosphatase, aspermia, and alcoholism in rape cases.
Asthenozoospermia
Adnexal gland secretion markers in unexplained asthenozoospermia.
Asthma
Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate.
Genetic polymorphism and TH1/TH2 orientation.
Immunobiochemical evaluation of bronchoalveolar lavage (BAL) in atopic bronchial asthma, chronic bronchitis and bronchiectasis.
[Effect of non-specific sensitization with bacterial vaccine on acid phosphatase release from peripheral blood leukocytes in bronchial asthma]
[Effect of specific desensitization on acid phosphatase release from peripheral blood leukocytes in allergic (atopic) bronchial asthma]
[Immunoglobulin level and the activity of the lysosomal acid phosphatase in infectious-allergic bronchial asthma]
[In vitro Intal effect on the activity of beta-glucuronidase and acid phosphatase of leukocytes in patients with asthma]
[The influence of climatic treatment on the levels of complement and some lysosomal enzymes in serum of patients with asthma bronchiale (author's transl)]
Astrocytoma
An acid phosphatase in the plasma membranes of human astrocytoma showing marked specificity toward phosphotyrosine protein.
Increased activity of lysosomal glycohydrolases in glioma tissue and surrounding areas from human brain.
Ataxia
Cerebellar Expression of the Neurotrophin Receptor p75 in Naked-Ataxia Mutant Mouse.
Atherosclerosis
ACP1 Genetic Polymorphism and Coronary Artery Disease: An Association Study.
Early atherogenesis in the White Carneau pigeon. III. Lipid accumulation in nascent foam cells.
Long Noncoding RNA-H19 Contributes to Atherosclerosis and Induces Ischemic Stroke via the Upregulation of Acid Phosphatase 5.
[Subpopulations of lymphocytes and monocytes/macrophages at the early stages of human aorta atherosclerosis]
Autoimmune Diseases
Applications and performance of monoclonal antibodies to human tartrate resistant acid phosphatase.
Avitaminosis
[Study of enzymatic activity in avitaminosis B1 in the pigeon. II. Acid phosphatase.]
Azoospermia
[Immunologic sperm detection]
[Semen characteristics and fertility (author's transl)]
[Zinc in the seminal plasma in infertile men]
Bacterial Infections
Fishmeal replacement by rice protein concentrate with xylooligosaccharides supplement benefits the growth performance, antioxidant capability and immune responses against Aeromonas hydrophila in blunt snout bream (Megalobrama amblycephala).
The role of Langerhans cells in Pseudomonas aeruginosa infection.
YAP in epithelium senses gut barrier loss to deploy defenses against pathogens.
beta-Thalassemia
Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.
Bladder Exstrophy
Prostate-specific antigen in men born with bladder exstrophy.
Blast Crisis
Cytochemical studies in the blastic transformation of chronic granulocytic leukaemia.
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia.
Ultrastructural study of chronic myeloid leukemia in blast crisis using myeloperoxidase and acid phosphatase reactions.
Blister
Acid hydrolases in blister fluid. I. Characterization and quantification of acid phosphatase.
Acid phosphatase localization in neurons of Bulla gouldiana (Gastropoda: Opisthobranchia.
Neurotoxic action of permethrin in Rhipicephalus sanguineus (Latreille, 1806) (Acari: Ixodidae) female ticks. Morphological and cytochemical evaluation of the central nervous system.
Programmed cell death in the larval salivary glands of Apis mellifera (Hymenoptera, Apidae).
Bone Cysts
Acid and alkaline phosphatase activity in bone-cyst fluid.
The role of lysosomes in the pathogenesis of unicameral bone cysts.
Bone Diseases
Alkaline and acid phosphatase determinations in bone disease.
Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis.
Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease.
Diagnostic Significance of Serum Alkaline and Acid Phosphatase Values in Relation to Bone Disease.
Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.
Evaluation of Dexamethasone-Induced Osteoporosis In Vivo Using Zebrafish Scales.
Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase.
Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study.
Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
[The influence and clinical significance of proteasome inhibitor on serum bone metabolite markers in patients with myeloma bone disease].
Bone Diseases, Developmental
Exceptional thermal stability of therapeutical enzymes entrapped in alumina sol-gel matrices.
Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature.
Bone Diseases, Metabolic
A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts.
Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
Assessing the Effectiveness of Panchatikta Ghrita, a Classical Ayurvedic Formulation as Add-on Therapy to Vitamin D3 and Calcium Supplements in Patients with Osteopenia: A Randomized, Open-Labeled, Comparative, Controlled Clinical Study.
Bone mineral density in pediatric patients with idiopathic hypercalciuria.
Clinical usefulness of serum tartrate-resistant fluoride-sensitive acid phosphatase activity in evaluating bone turnover.
Condylar Degradation from Decreased Occlusal Loading following Masticatory Muscle Atrophy.
Correlation between alkaline and acid phosphatase activities and age-related osteopenia in murine vertebrae.
Disease-specific expression of tartrate-resistant acid phosphatase isoforms.
Limited utility of tartrate-resistant acid phosphatase isoform 5b in assessing response to therapy in osteoporosis.
Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Tartrate-resistant acid phosphatase 5b (TRAP 5b) as a marker of osteoclast activity in the early phase after cementless total hip replacement.
[Application of analyses of acid phosphatase 5b bone isoenzyme in patients with osteopenia and osteoporosis (pilot study)]
[Epidemiologic, clinical, biological and therapeutic aspects of Gaucher disease]
[Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia]
Bone Neoplasms
[Malignant fibrous histiocytoma of the bone]
Bone Resorption
"iNOS-Derived Nitric Oxide Stimulates Osteoclast Activity and Alveolar Bone Loss in Ligature-Induced Periodontitis in Rats"
(-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice.
1,25-Dihydroxy vitamin D3 treatment attenuates osteopenia, and improves bone muscle quality in Goto-Kakizaki type 2 diabetes model rats.
16 T high static magnetic field inhibits receptor activator of nuclear factor kappa-? ligand-induced osteoclast differentiation by regulating iron metabolism in Raw264.7 cells.
17 beta-estradiol suppresses gene expression of tartrate-resistant acid phosphatase and carbonic anhydrase II in ovariectomized rats.
2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.
4-Acetylantroquinonol B Inhibits Osteoclastogenesis by Inhibiting the Autophagy Pathway in a Simulated Microgravity Model.
A 300??m Organotypic Bone Slice Culture Model for Temporal Investigation of Endochondral Osteogenesis.
A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro.
A dried blood spot-based method to measure levels of tartrate-resistant acid phosphatase 5b (TRACP-5b), a marker of bone resorption.
A High-Fat Diet Decreases Bone Mass in Growing Mice with Systemic Chronic Inflammation Induced by Low-Dose, Slow-Release Lipopolysaccharide Pellets.
A new cytokine-dependent monoblastic cell line with t(9;11)(p22;q23) differentiates to macrophages with macrophage colony-stimulating factor (M-CSF) and to osteoclast-like cells with M-CSF and interleukin-4.
A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
A Novel Sandwich ELISA for Tartrate-Resistant Acid Phosphatase 5a and 5b Protein Reveals that Both Isoforms are Secreted by Differentiating Osteoclasts and Correlate to the Type I Collagen Degradation Marker CTX-I In Vivo and In Vitro.
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma.
A serum metabolomics-based profile in low bone mineral density postmenopausal women.
Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and ?-arrestin recruitment than teriparatide.
Abeliophyllum distichum Nakai alleviates postmenopausal osteoporosis in ovariectomized rats and prevents RANKL-induced osteoclastogenesis in vitro.
Abnormal bone architecture in mice expressing MyD88 in cells of the osteoclast lineage.
Abnormal bone mineral density and bone turnover marker expression profiles in patients with primary spontaneous pneumothorax.
Acid phosphatases.
ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
ACP5: its structure, distribution, regulation and novel functions.
Activin A Expressed in Rheumatoid Synovial Cells Downregulates TNF?-Induced CXCL10 Expression and Osteoclastogenesis.
Acute effects of bisphosphonates on new and traditional markers of bone resorption.
Adenosine A(2A) receptor ligation inhibits osteoclast formation.
Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function.
Aesculetin Inhibits Osteoclastic Bone Resorption through Blocking Ruffled Border Formation and Lysosomal Trafficking.
Age-related changes in biochemical bone profile in thalassemic children.
Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.
Alterations in osteoclast morphology following long-term 17beta-estradiol administration in the mouse.
Altered serum levels of the osteoclast-specific TRACP 5b isoform in Chinese children undergoing orthodontic treatment.
Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-?B and mitogen-activated protein kinase activity in receptor activator of nuclear factor-?B-induced RAW264.7 cells.
Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model.
Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis.
Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo.
Antiosteoporotic activity and constituents of Podocarpium podocarpum.
Antiosteoporotic effects and proteomic characterization of the target and mechanism of an Er-Xian Decoction on osteoblastic UMR-106 and osteoclasts induced from RAW264.7.
Appliance-induced osteopenia of dentoalveolar bone in the rat: effect of reduced bone strains on serum bone markers and the multifunctional hormone leptin.
Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells.
Asiatic Acid Attenuates Bone Loss by Regulating Osteoclastic Differentiation.
Assignment of the mouse tartrate-resistant acid phosphatase gene (Acp5) to chromosome 9.
Association between indoxyl sulfate and skeletal resistance in hemodialysis patients.
Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation.
Atorvastatin promotes bone formation in aged apoE-/- mice through the Sirt1-Runx2 axis.
AZD8835 inhibits osteoclastogenesis and periodontitis-induced alveolar bone loss in rats.
BADGE, a synthetic antagonist for PPAR?, prevents steroid-related osteonecrosis in a rabbit model.
Beneficial effects of hyperoside on bone metabolism in ovariectomized mice.
Biochemical assessment of bone loss in patients on long-term thyroid hormone treatment.
Biochemical bone markers in patients with multiple myeloma.
Biochemical markers of bone metabolism and prediction of fracture in elderly women.
Biochemical markers of bone metabolism in breast cancer.
Biochemical markers of bone metabolism in multiple myeloma.
Biochemical markers of bone metabolism.
Biochemical markers of bone metabolism: an overview.
Biochemical markers of bone turnover are influenced by recently sustained fracture.
Biochemical markers of bone turnover for the clinical investigation of osteoporosis.
Biochemical markers of bone turnover in girls during puberty.
Biochemical markers of bone turnover.
Biochemical measurements of bone turnover in children and adolescents.
Biological sources of variations of tartrate-resistant acid phosphatase 5b in a healthy Japanese population.
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Biphasic effect of calcitonin on tartrate-resistant acid phosphatase activity in isolated rat osteoclasts.
Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption.
Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function.
Bone composition and metabolism after hyperbaric oxygenation in rats with 1-hydroxyethylidene-1,1-bisphosphonate-induced rickets.
Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome.
Bone formation and resorption markers as diagnostic tools for bone metastases evaluation.
Bone formation by marrow osteogenic cells (MBA-15) is not accompanied by osteoclastogenesis and generation of hematopoietic supportive microenvironment.
Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy.
Bone mass protective potential mediated by bovine milk basic protein requires normal calcium homeostasis in mice.
Bone metabolism after cinacalcet administration in patients with secondary hyperparathyroidism.
Bone metabolism and daily physical activity in women undergoing hemodialysis.
Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate.
Bone Metabolism in the Healing Process of Lumbar Interbody Fusion-Temporal changes of bone turnover markers.
Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.
Bone remodelling markers in rheumatoid arthritis.
Bone resorption associated with uncoupling of osteoclastic and osteoblastic activities in adult T cell leukemia with hypercalcemia: case report.
Bone resorption in chronic otitis media. A light-microscopical and histochemical investigation of acid phosphatase activity.
Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
Briarane-type diterpenoids suppress osteoclastogenisis by regulation of Nrf2 and MAPK/NF-kB signaling pathway.
BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions.
Cadmium induces the differentiation of duck embryonic bone marrow cells into osteoclasts in vitro.
Calcitonin inhibits the increase in bone acid phosphatase activity by high dose of zinc in rats.
CaMKII(?) regulates osteoclastogenesis through ERK, JNK, and p38 MAPKs and CREB signalling pathway.
Cannabinoid receptor 2 agonist prevents local and systemic inflammatory bone destruction in rheumatoid arthritis.
Changes in bone mass and bone turnover following ankle fracture.
Changes in bone mass and bone turnover following distal forearm fracture.
Changes in enzyme expression related to differentiation and regulatory factors: the acid phosphatase of osteoclasts and other macrophages.
Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study.
Changes in the markers of bone metabolism following skeletal unloading.
Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption.
Characterization of monoclonal antibodies specific to human tartrate-resistant acid phosphatase.
Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay.
Chitooligosaccharides prevent osteopenia by promoting bone formation and suppressing bone resorption in ovariectomised rats: possible involvement of COX-2.
Chloroquine ameliorates bone loss induced by d-galactose in male rats via inhibition of ERK associated osteoclastogenesis and antioxidant effect.
Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children.
Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus.
Circulating sclerostin is not suppressed following a single bout of exercise in young men.
Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment.
Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase.
Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
Cloning and characterization of the 5'-flanking region of the mouse tartrate-resistant acid phosphatase gene.
Cloning, sequence, and developmental expression of a type 5, tartrate-resistant, acid phosphatase of rat bone.
Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.
Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
Comparison of the efficacy of denosumab and bisphosphonates for treating secondary osteoporosis in patients with rheumatoid arthritis.
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis.
Constitutive c-fos expression in osteoblastic MC3T3-E1 cells stimulates osteoclast maturation and osteoclastic bone resorption.
Consumption of Vitamin D-and Calcium-Fortified Soft White Cheese Lowers the Biochemical Marker of Bone Resorption TRAP 5b in Postmenopausal Women at Moderate Risk of Osteoporosis Fracture.
Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis.
Could biomarkers of bone, cartilage or synovium turnover be used for relapse prediction in rheumatoid arthritis patients?
Coumarin Ameliorates Impaired Bone Turnover by Inhibiting the Formation of Advanced Glycation End Products in Diabetic Osteoblasts and Osteoclasts.
Crocin attenuates metabolic syndrome-induced osteoporosis in rats.
Crocin attenuates methylglyoxal-induced osteoclast dysfunction by regulating glyoxalase, oxidative stress, and mitochondrial function.
Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone.
Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL-induced osteoclastogenesis.
Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease.
Decitabine Inhibits Bone Resorption in Periodontitis by Upregulating Anti-Inflammatory Cytokines and Suppressing Osteoclastogenesis.
Decreased bone mineralization in children with phenylketonuria under treatment.
Decreasing the Ratio of Dietary Linoleic to ?-Linolenic Acid from 10 to 4 by Changing Only the Former Does Not Prevent Adiposity or Bone Deterioration in Obese Mice.
Defective circadian control in mesenchymal cells reduces adult bone mass in mice by promoting osteoclast function.
Detection of alkaline and acid phosphatases around titanium implants: a light microscopical and histochemical study in rabbits.
Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b), a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP), a Bone Formation Marker, in Lieu of Whole Body Skeletal Scintigraphy with Technetium99m MDP.
Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.
Development of a synthetic peptide-based tartrate-resistant acid phosphatase radioimmunoassay for the measurement of bone resorption in rat serum.
Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
Development of an in vitro culture method for stepwise differentiation of mouse embryonic stem cells and induced pluripotent stem cells into mature osteoclasts.
Development of immunoassays for type-5 tartrate-resistant acid phosphatase in human serum.
Development, validation and characterization of a novel mouse model of Adynamic Bone Disease (ABD).
Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
Diamagnetic Levitation Promotes Osteoclast Differentiation From RAW264.7 Cells.
Dietary l-carnitine supplementation improves bone mineral density by suppressing bone turnover in aged ovariectomized rats.
Dietary xylitol protects against the imbalance in bone metabolism during the early phase of collagen type II-induced arthritis in dark agouti rats.
Different levels of the neuronal nitric oxide synthase isoform modulate the rate of osteoclastic differentiation of TIB-71 and CRL-2278 RAW 264.7 murine cell clones.
Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget disease.
Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
Disappearing bone disease. A clinical and histological study.
Disruption of the Man-6-P Targeting Pathway in Mice Impairs Osteoclast Secretory Lysosome Biogenesis.
Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a "calcium receptor".
Does combined gastrectomy and ovariectomy induce greater osteopenia in young female rats than gastrectomy alone?
Does methamphetamine affect bone metabolism?
Dose-response assessment of chemically-modified curcumin in experimental periodontitis.
Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases.
Early changes of bone histology and circulating markers of bone turnover after parathyroidectomy in hemodialysis patients with severe hyperparathyroidism.
Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report.
Edgeworthia papyrifera Regulates Osteoblast and Osteoclast Differentiation In Vitro and Exhibits Anti-osteoporosis Activity in Animal Models of Osteoporosis.
Effect of age on some blood variables relating to bone metabolism in women.
Effect of Bacillus subtilis C-3102 on bone mineral density in healthy postmenopausal Japanese women: a randomized, placebo-controlled, double-blind clinical trial.
Effect of bergenin on RANKL-induced osteoclast differentiation in the presence of methylglyoxal.
Effect of escitalopram and carbidopa on bone markers in Wistar rats: a preliminary experimental study.
Effect of high-density lipoprotein on lipopolysaccharide-induced alveolar bone resorption in rats.
Effect of Korean oriental medicine extract on bone mass as compared with alendronate in ovariectomized rats.
Effect of local bone marrow stromal cell administration on ligature-induced periodontitis in mice.
Effect of Reveromycin A on experimental tooth movement in OPG-/- mice.
Effect of vitamin A on bone resorption: evidence for direct stimulation of isolated chicken osteoclasts by retinol and retinoic acid.
Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute.
Effects and interaction of icariin, curculigoside, and berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption.
Effects of aging on bone mineral content and bone biomarkers in female cynomolgus monkeys.
Effects of an Oleaginous Calcitriol on Changes in Plasma Calcitriol, Calcium and Bone Metabolic Markers in Dairy Cows.
Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
Effects of Ca2+/calmodulin?dependent protein kinase pathway inhibitor KN93 on osteoclastogenesis.
Effects of cadmium on bone microstructure and serum tartrate-resistant acid phosphatase 5b in male rats.
Effects of capsaicin-induced sensory denervation on bone metabolism in adult rats.
Effects of cortisol secreted via a 12-h infusion of adrenocorticotropic hormone on mineral homeostasis and bone metabolism in ovariectomized cows.
Effects of Lemon Beverage Containing Citric Acid with Calcium Supplementation on Bone Metabolism and Mineral Density in Postmenopausal Women: Double-Blind 11-Month Intervention Study.
Effects of magnesium coating on bone-implant interfaces with and without polyether-ether-ketone particle interference: A rabbit model based on porous Ti6Al4V implants.
Effects of Melandrium firmum Rohrbach on RANKL?induced osteoclast differentiation and OVX rats.
Effects of moderate intensity static magnetic fields on osteoclastic differentiation in mouse bone marrow cells.
Effects of nicotine on bone during orthodontic tooth movement in male rats. Histological and immunohistochemical study.
Effects of paprika carotenoid supplementation on bone turnover in postmenopausal women: a randomized, double-blind, placebo-controlled, parallel-group comparison study.
Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
Effects of pulsed electromagnetic fields on the mRNA expression of RANK and CAII in ovariectomized rat osteoclast-like cell.
Effects of short-term dry immersion on bone remodeling markers, insulin and adipokines.
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
Effects of Suppression of Follicle Stimulating Hormone Secretion on Bone Resorption Markers in Postmenopausal Women.
Effects of the (1-34) fragment of synthetic parathyroid hormone-related protein on tartrate-resistant acid phosphatase and alkaline phosphatase and alkaline phosphatase activities, and on osteocalcin synthesis, in cultured fetal rat calvaria.
Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-?1/Smads pathway in GIOP rats.
Efficacy of vitamin D plus calcium with/without alendronate on bone metabolism in immunologic thrombocytopenic purpura patients with steroid treatment: Nine-month results of a randomized, double-blinded, controlled trial.
Elevated HbA1c Is Associated with Altered Cortical and Trabecular Microarchitecture in Girls with Type 1 Diabetes.
Endocytosis of tartrate-resistant Acid phosphatase by osteoblast-like cells is followed by inactivation of the enzyme.
Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption.
Enzyme histochemical characteristics of osteoblasts and mononucleated osteoclasts in a teleost fish with acellular bone (Oreochromis niloticus, Cichlidae)
Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo.
Estrogen directly attenuates human osteoclastogenesis, but has no effect on resorption by mature osteoclasts.
Estrogen inhibits osteoclasts formation and bone resorption via microRNA-27a targeting PPAR? and APC.
Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel.
Evaluation of bone loss and the serum markers of bone metabolism in patients with hyperparathyroidism.
Evaluation of bone turnover markers and serum minerals variations for predicting fracture healing versus non-union processes in adult sheep as a model for orthopedic research.
Evaluation of Dexamethasone-Induced Osteoporosis In Vivo Using Zebrafish Scales.
Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases.
Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
Evaluation of the usefulness of serum phosphatases and osteocalcin as serum markers in a calcium depletion-repletion rat model.
Exosomes from TNF-?-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss.
Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506.
Expression of osteoclastogenic and anti-osteoclastogenic cytokines differs in mouse gingiva injected with lipopolysaccharide, peptidoglycan, or both.
Extracellular matrix-mediated tissue remodeling following axial movement of teeth.
Facilitation of bone resorption activities in synovial lavage fluid patients with mandibular condyle fractures.
Febuxostat Attenuates the Progression of Periodontitis in Rats.
Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss.
Ferryl Hemoglobin Inhibits Osteoclastic Differentiation of Macrophages in Hemorrhaged Atherosclerotic Plaques.
Fetal Bone Formation Is Decreased from Middle Pregnancy to Birth.
FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study.
FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function.
Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice.
Gender differences in serum markers of bone resorption in healthy subjects and patients with disorders affecting bone.
Generation and characterization of putative monoclonal and polyclonal antibodies against tartrate-resistant acid phosphatase.
Ginsenoside Rg3 Attenuates Aluminum-Induced Osteoporosis Through Regulation of Oxidative Stress and Bone Metabolism in Rats.
Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-?B and Akt pathways.
Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption.
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment.
High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: relevance as a marker of bone resorption in jaundiced patients.
High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway.
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
High vitamin D3 diet administered during active colitis negatively affects bone metabolism in an adoptive T cell transfer model.
HIV-1 replicates in human osteoclasts and enhances their differentiation in vitro.
Hormonal regulation of acid phosphatase release by osteoclasts disaggregated from neonatal rat bone.
Hormone replacement therapy and osteoporosis: bone enzymes and nutrient imbalances.
Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis.
Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells.
Ibandronate Prevents Bone Loss and Reduces Vertebral Fracture Risk in Male Cardiac Transplant Patients: A Randomised Double-Blind, Placebo Controlled Trial.
Icariin ameliorates dexamethasone?induced bone deterioration in an experimental mouse model via activation of microRNA?186 inhibition of cathepsin K.
Identification of a non-purple tartrate-resistant acid phosphatase: an evolutionary link to Ser/Thr protein phosphatases?
Identification of rat osteoclasts in bone smears with quantification of acid phosphatase activity in vitamin D deficiency.
IL-12 Inhibits Lipopolysaccharide Stimulated Osteoclastogenesis in Mice.
IL-37 inhibits lipopolysaccharide-induced osteoclast formation and bone resorption in vivo.
IL-4 inhibits TNF-?-mediated osteoclast formation by inhibition of RANKL expression in TNF-?-activated stromal cells and direct inhibition of TNF-?-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis.
Imbalance of osteoprotegerin/receptor activator of nuclear factor-?B ligand and oxidative stress in patients with obstructive sleep apnea-hypopnea syndrome.
In vitro bone resorption is dependent on physiological concentrations of zinc.
In vivo randomized trial of three marketed milk preparations enriched with calcium and vitamins (D and K) on bone mass and bone turnover markers from biological fluids in premenopausal Caucasian women.
Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss.
Increase in osteoclastogenesis in an obese Otsuka Long-Evans Tokushima fatty rat model.
Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.
Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection.
Increased expression of the receptor for activation of NF-kappaB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocin-induced diabetes.
Increased osteoclastic differentiation by PMMA particle-associated macrophages. Inhibitory effect by interleukin 4 and leukemia inhibitory factor.
Increased Serum 25(OH)D3 Levels in Post-Menopausal Japanese Women with Osteoporosis after 3-Year Bisphosphonate Treatment.
Induction of human osteoclast-like cells by treatment of blood monocytes with anti-fusion regulatory protein-1/CD98 monoclonal antibodies.
Induction of osteopenia during experimental tooth movement in the rat: alveolar bone remodelling and the mechanostat theory.
Influence of oestrogen deficiency and excessive mechanical stress on condylar head of mandible.
Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro.
Influence of weight reduction on muscle performance and bone mass, structure and metabolism in obese premenopausal women.
Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.
Inhibition of osteoclastic acid phosphatase abolishes bone resorption.
Inhibition of osteoclastogenesis by RNA interference targeting RANK.
Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis.
Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation.
Inhibitory effect of (-)-saucerneol on osteoclast differentiation and bone pit formation.
Inhibitory effects of ChondroT and its constituent herbs on RANKL-induced osteoclastogenesis.
Intensive weight gain therapy in patients with anorexia nervosa results in improved serum tartrate-resistant acid phosphatase (TRAP) 5a and 5b isoform protein levels.
Interferon ? protects against avascular osteonecrosis through interleukin 6 inhibition and silent information regulator transcript-1 upregulation.
Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide.
Interleukin-35 Inhibits TNF-?-Induced Osteoclastogenesis and Promotes Apoptosis via Shifting the Activation From TNF Receptor-Associated Death Domain (TRADD)-TRAF2 to TRADD-Fas-Associated Death Domain by JAK1/STAT1.
Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase.
Intracellular machinery for matrix degradation in bone-resorbing osteoclasts.
Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.
Intramuscular bone induction by the simultaneous administration of recombinant human bone morphogenetic protein 2 and bisphosphonate for autobone graft.
Intravenous 1alpha, 25[OH]2 vitamin D3 (calcitriol) pulse therapy for bone lesions in a murine model of chronic cadmium toxicosis.
Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients.
Involvement of the mitogen?activated protein kinase signaling pathway in osteoprotegerin?induced inhibition of osteoclast differentiation and maturation.
Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation.
Ipriflavone modulates IGF-I but is unable to restore bone in rats.
Irp2 Knockout Causes Osteoporosis by Inhibition of Bone Remodeling.
Ischemic stroke in rats enhances bone resorption in vitro.
Isolation of antiosteoporotic compounds from seeds of Sophora japonica.
Isorhamnetin 3-O-neohesperidoside promotes the resorption of crown-covered bone during tooth eruption by osteoclastogenesis.
Joint fluid from patients with failed total hip arthroplasty stimulates pit formation by mouse osteoclasts on dentin slices.
Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis.
Knockout of TRPV6 Causes Osteopenia in Mice by Increasing Osteoclastic Differentiation and Activity.
Kudzu (Pueraria lobata) vine ethanol extracts improve ovariectomy-induced bone loss in female mice.
Lactobacillus Fermentum ZS40 prevents secondary osteoporosis in Wistar Rat.
Lanthanum Chloride Attenuates Osteoclast Formation and Function Via the Downregulation of Rankl-Induced Nf-?b and Nfatc1 Activities.
LDC000067 suppresses RANKL-induced osteoclastogenesis in vitro and prevents LPS-induced osteolysis in vivo.
Leptin corrects increased gene expression of renal 25-hydroxyvitamin D3-1 alpha-hydroxylase and -24-hydroxylase in leptin-deficient, ob/ob mice.
Limited utility of tartrate-resistant acid phosphatase isoform 5b in assessing response to therapy in osteoporosis.
LncRNA AK077216 promotes RANKL-induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45.
Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice.
Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans.
Low-1 level mechanical vibration improves bone microstructure, tissue mechanical properties and porous titanium implant osseointegration by promoting anabolic response in type 1 diabetic rabbits.
Low?molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats.
Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL-induced NFAT activation and calcium signaling.
Lysosomal cysteine and aspartic proteinases, acid phosphatase, and an endogenous cysteine proteinase inhibitor, cystatin-beta, in rat osteoclasts.
M-CSF mediates TNF-induced inflammatory osteolysis.
Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
Malignant osteopetrosis: a disease of abnormal osteoclast proliferation.
Markers of bone metabolism in multiple myeloma patients switched from zoledronic acid to denosumab.
Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.
Markers of bone turnover: biochemical and clinical perspectives.
Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.
MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation.
MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
Mesoporous bioactive glasses equipped with stimuli-responsive molecular gates for the controlled delivery of levofloxacin against bacteria.
Metabolic and bone effects of high-fat diet in adult zebrafish.
Metacarpal cortical thickness by computed radiography in osteoporosis.
Metformin repositioning in rheumatoid arthritis.
MicroRNA MiR-130b promotes wear particle-induced osteolysis via down regulating frizzled-related protein (FRZB).
MicroRNA-130b Promotes Wear Particle-Induced Osteolysis via Downregulating Frizzled-Related Protein (FRZB).
MiR-1-3p regulates the differentiation of mesenchymal stem cells to prevent osteoporosis by targeting secreted frizzled-related protein 1.
miR-346-3p promotes osteoclastogenesis via inhibiting TRAF3 gene.
miR-506-3p alleviates uncontrolled osteoclastogenesis via repression of RANKL/NFATc1 signaling pathway.
Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers.
Morphological changes in periodontal mechanoreceptors of mouse maxillary incisors after the experimental induction of anterior crossbite: a light and electron microscopic observation using immunohistochemistry for PGP 9.5.
Multivalent Presentation of Peptide Targeting Groups Alters Polymer Biodistribution to Target Tissues.
Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.
Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines.
N-Acetyl Cysteine Treatment Restores Early Phase Fracture Healing in Ethanol-Fed Rats.
N-Acetylcysteine Attenuates Lipopolysaccharide-Induced Osteolysis by Restoring Bone Remodeling Balance via Reduction of Reactive Oxygen Species Formation During Osteoclastogenesis.
N-terminal telopeptides of type I collagen and bone mineral density for early diagnosis of nonunion: An experimental study in rabbits.
Nasal inverted papilloma expresses the muscle segment homeobox gene Msx2: possible prognostic implications.
Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
Neoplastic infiltration of laryngeal cartilages: histocytochemical study.
New evidence that serum beta(2)-microglobulin behaves as a biological marker of bone remodelling in women.
Nirogacestat suppresses RANKL-Induced osteoclast formation in vitro and attenuates LPS-Induced bone resorption in vivo.
Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation.
Noncanonical G-protein-dependent modulation of osteoclast differentiation and bone resorption mediated by Pasteurella multocida toxin.
Noninvasive parameters of bone metabolism.
Normal bone particles are preferentially resorbed in the presence of osteocalcin-deficient bone particles in vivo.
Notopterol Attenuates Estrogen Deficiency-Induced Osteoporosis via Repressing RANKL Signaling and Reactive Oxygen Species.
Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats.
Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function.
OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell.
Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.
Osseous and intestinal compartments in the humoral hypercalcemia of malignancy associated to Walker 256 tumor in rats.
Osteoblast-mediated effects of zinc on isolated rat osteoclasts: inhibition of bone resorption and enhancement of osteoclast number.
Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Osteoclastic differentiation by mononuclear phagocytes containing biomaterial particles.
Osteogenic activity of yellow flag iris (Iris pseudacorus) extract modulating differentiation of osteoblasts and osteoclasts.
Osteogenic capacity of transgenic flax scaffolds.
Osteogenic effect of Drynariae rhizoma extracts and Naringin on MC3T3-E1 cells and an induced rat alveolar bone resorption model.
Osteoprotective Activity and Metabolite Fingerprint via UPLC/MS and GC/MS of Lepidium sativum in Ovariectomized Rats.
Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
Ostericum koreanum Reduces LPS-Induced Bone Loss Through Inhibition of Osteoclastogenesis.
Oxidative stress induced by chromium (VI) in bone of suckling rats.
p53 positively regulates osteoprotegerin-mediated inhibition of osteoclastogenesis by downregulating TSC2-induced autophagy in vitro.
Paeoniflorin Inhibits Receptor Activator for Nuclear Factor ?B (RANK) Ligand-Induced Osteoclast Differentiation In Vitro and Particle-Induced Osteolysis In Vivo.
Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA.
Pamidronate and biochemical markers of bone turnover.
Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.
Paradoxical elevation of serum TRACP5b levels despite increase in lumbar spine bone mineral density during anti-TNF? therapy in patients with inflammatory rheumatic disease: a 2-year prospective assessment of bone mass, bone metabolism, and the trabecular bone score.
Parathyroid hormone related peptide (1-34) and 1,25-dihydroxyvitamin D, have no additive effects on bone tartrate resistant acid phosphatase activity in fetal rat calvaria cultures.
Peptidoglycan and lipopolysaccharide synergistically enhance bone resorption and osteoclastogenesis.
Periodontal ligament cells in adolescents and adults: Genetic level responses to orthodontic forces.
Peroxidase enzymes inhibit osteoclast differentiation and bone resorption.
Phenotypic research on senile osteoporosis caused by SIRT6 deficiency.
Phorbol myristate acetate stimulates osteoclast formation in 1 alpha,25-dihydroxyvitamin D3-primed mouse embryonic calvarial cells by a prostaglandin-dependent mechanism.
Pit Assay to Measure the Bone Resorptive Activity of Bone Marrow-derived Osteoclasts.
Plasma fluctuation in estradiol-17? and bone resorption markers around parturition in dairy cows.
Plasma tartrate resistant acid phosphatase: a marker for osteoclastic bone resorption.
Plectin stabilizes microtubules during osteoclastic bone resorption by acting as a scaffold for Src and Pyk2.
Polyethylene and methyl methacrylate particle-stimulated inflammatory tissue and macrophages up-regulate bone resorption in a murine neonatal calvaria in vitro organ system.
Polyphosphate-mediated inhibition of tartrate-resistant acid phosphatase and suppression of bone resorption of osteoclasts.
Poria cocos polysaccharide attenuates RANKL-induced osteoclastogenesis by suppressing NFATc1 activity and phosphorylation of ERK and STAT3.
Positive Effect of Gushukang on Type-H Vessel and Bone Formation.
Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.
Potential function for the ROS-generating activity of TRACP.
Potential of electrical impedance spectroscopy to differentiate between healthy and osteopenic bone.
PP121 suppresses RANKL-Induced osteoclast formation in vitro and LPS-Induced bone resorption in vivo.
Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid.
Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL.
Preventive Effects of Chrysanthemum coronarium L. Extract on Bone Metabolism In Vitro and In Vivo.
PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice.
Production and Functional Characterization of Murine Osteoclasts Differentiated from ER-Hoxb8-Immortalized Myeloid Progenitor Cells.
Prognostic significance of ACP5 expression in patients with lung adenocarcinoma.
Programmed core-shell electrospun nanofibers to sequentially regulate osteogenesis-osteoclastogenesis balance for promoting immediate implant osseointegration.
Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells.
Protective action of aqueous black tea (Camellia sinensis) extract (BTE) against ovariectomy-induced oxidative stress of mononuclear cells and its associated progression of bone loss.
Protective Effect of Acteoside on Ovariectomy-Induced Bone Loss in Mice.
Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats.
Protocatechuic acid attenuates anterior cruciate ligament transection-induced osteoarthritis by suppressing osteoclastogenesis.
Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts.
Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions.
Pulsed electromagnetic fields (PEMF) attenuate changes in vertebral bone mass, architecture and strength in ovariectomized mice.
Pulsed electromagnetic fields partially preserve bone mass, microarchitecture, and strength by promoting bone formation in hindlimb-suspended rats.
Pulsed electromagnetic fields stimulation affects osteoclast formation by modulation of osteoprotegerin, RANK ligand and macrophage colony-stimulating factor.
Purified Pasteurella multocida protein toxin reduces acid phosphatase-positive osteoclasts in the ventral nasal concha of gnotobiotic pigs.
Purple acid phosphatase of the human macrophage and osteoclast. Characterization, molecular properties, and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells.
Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females.
Quantification of osteoclastic resorption of the bovine otic capsule in vitro by an enzyme-linked immunosorbent assay.
Quantification of tartrate resistant acid phosphatase distribution in mouse tibiae using image analysis.
Quercitrin Nanocoated Implant Surfaces Reduce Osteoclast Activity In Vitro and In Vivo.
Radio-opaque agents in bone cement increase bone resorption.
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
RANKL/Osteoprotegerin System and Bone Turnover in Hashimoto Thyroiditis.
Rapid and robust response of biochemical markers of bone formation to teriparatide therapy.
Rapid new bone tissue remodeling during distraction osteogenesis is associated with apoptosis.
Recombinant VSV G proteins reveal a novel raft-dependent endocytic pathway in resorbing osteoclasts.
Recommendations for dietary level of micro-minerals and vitamin D3 to Atlantic salmon (Salmo salar) parr and post-smolt when fed low fish meal diets.
Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry.
Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.
Relationship between sex hormone fluctuations and biomarkers of bone resorption in bovine plasma during the oestrous cycle.
Relationship between tartrate-resistant acid phosphatase 5b and stress fractures in female athletes.
Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
Relevance of Caspase-1 and Nlrp3 Inflammasome on Inflammatory Bone Resorption in A Murine Model of Periodontitis.
Relevance of parathyroid hormone (PTH), vitamin 25(OH)D3, calcitonin (CT), bone metabolic markers, and bone mass density (BMD) in 860 female cases.
Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.
Restoration of Parathyroid Function After Change of Phosphate Binder From Calcium Carbonate to Lanthanum Carbonate in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone.
Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK.
Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
Ribosome inactivating protein B-chain induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
Role of food fortification with vitamin D and calcium in the bone remodeling process in postmenopausal women: a systematic review of randomized controlled trials.
Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS).
Running exercise for short duration increases bone mineral density of loaded long bones in young growing rats.
Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report.
Schistosoma japonicum cystatin suppresses osteoclastogenesis via manipulating the NF??B signaling pathway.
Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-?B and MAPK signaling pathway.
Secretion of tartrate-resistant acid phosphatase by osteoclasts correlates with resorptive behavior.
Segregated localization of immunocompetent cells and osteoclasts in the periodontal ligament of the rat molar.
Serum Bone Resorption Markers after Parathyroidectomy for Renal Hyperparathyroidism: Correlation Analyses for the Cross-Linked N-telopeptide of Collagen I and Tartrate-Resistant Acid Phosphatase.
Serum calcium concentration is maintained when bone resorption is suppressed by osteoprotegerin in young growing male rats.
Serum dipeptidyl peptidase-4 is associated with multiple vertebral fractures in type 2 diabetes mellitus.
Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.
Serum N-terminal telopeptide of type I collagen as an early marker of fracture nonunion in rabbits.
Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption.
Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.
Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure.
Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-?B and MAPK Signaling Pathways.
Severe nutritional iron-deficiency anaemia has a negative effect on some bone turnover biomarkers in rats.
Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation.
siRNA Knock-Down of RANK Signaling to Control Osteoclast-Mediated Bone Resorption.
Smoking cessation increases levels of osteocalcin and uncarboxylated osteocalcin in human sera.
Species specificity of monoclonal antibodies to human tartrate-resistant acid phosphatase.
Specificity and clinical performance of two commercial TRACP 5b immunoassays.
Stauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression.
Stimulation of a Gs-like G protein in the osteoclast inhibits bone resorption but enhances tartrate-resistant acid phosphatase secretion.
Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.
Strontium ranelate decreases receptor activator of nuclear factor-?B ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptor.
Structure of Acid phosphatases.
Suppression of alveolar bone resorption by salubrinal in a mouse model of periodontal disease.
Suppressive effect of syndecan ectodomains and N-desulfated heparins on osteoclastogenesis via direct binding to macrophage-colony stimulating factor.
Suppressive effects of an apoptotic mimicry prepared from jumbo-flying squid-skin phospholipids on the osteoclastogenesis in receptor activator of nuclear factor kappa B ligand/macrophage colony-stimulating factor-induced RAW 264.7 cells.
Survival markers related to bone metastases in prostate cancer.
Synovial fibroblasts infected with Salmonella enterica serovar Typhimurium mediate osteoclast differentiation and activation.
Systemic administration of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)-Ig abrogates alveolar bone resorption in induced periodontitis through inhibition of osteoclast differentiation and activation: An experimental investigation.
Tartrate resistant acid phosphatase activity in rat cultured osteoclasts is inhibited by a carboxyl terminal peptide (osteostatin) from parathyroid hormone-related protein.
Tartrate Resistant Acid Phosphatase Assisted Degradation of Single-Wall Carbon Nanotubes (SWCNTs).
Tartrate-resistant acid phosphatase (TRACP 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the BoneTRAP kit assay.
Tartrate-resistant acid phosphatase (TRAP) activity in serum: potential use in assessing bone resorption in patients with multiple myeloma.
Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Tartrate-resistant Acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear ?B ligand.
Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
Tartrate-resistant acid phosphatase activity and glutathione levels are modulated during hFOB 1.19 osteoblastic differentiation.
Tartrate-resistant acid phosphatase as a marker of bone resorption.
Tartrate-resistant acid phosphatase as a serum marker of bone resorption.
Tartrate-resistant acid phosphatase in mononuclear and multinuclear cells during the bone resorption of tooth eruption.
Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
Tartrate-resistant acid phosphate activity as osteoclastic marker: sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry.
Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis.
TGF?1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression.
The Antiosteoporosis Effects of Zhuanggu Guanjie Pill In Vitro and In Vivo.
The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone.
The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite - 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease.
The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men.
The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B.
The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2-Year Follow-Up Study.
The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial.
The effect of macrophage-colony stimulating factor and other humoral factors (interleukin-1, -3, -6, and -11, tumor necrosis factor-alpha, and granulocyte macrophage-colony stimulating factor) on human osteoclast formation from circulating cells.
The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture.
The effect of particle size and electrical charge on macrophage-osteoclast differentiation and bone resorption.
The Effects of Bazedoxifene on Bone, Glucose, and Lipid Metabolism in Postmenopausal Women With Type 2 Diabetes: An Exploratory Pilot Study.
The emerging role of IMD 0354 on bone homeostasis by suppressing osteoclastogenesis and bone resorption, but without affecting bone formation.
The function of the calcium channel Orai1 in osteoclast development.
The importance of the prenyl group in the activities of osthole in enhancing bone formation and inhibiting bone resorption in vitro.
The in vivo effects of a fraction from Dioscorea spongiosa on glucocorticoid-induced osteoporosis.
The influence of adrenergic blockade in rats with apical periodontitis under chronic stress conditions.
The influence of masseter activity on rat mandibular growth.
The influence of nitric oxide synthase inhibitor L-NAME on bones of male rats with streptozotocin-induced diabetes.
The influence of thyroid hormones on periodontitis-related bone loss and tooth-supporting alveolar bone: a histological study in rats.
The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro.
The preventive effects of pulsed electromagnetic fields on diabetic bone loss in streptozotocin-treated rats.
The role of TGF? receptor 1-smad3 signaling in regulating the osteoclastic mode affected by fluoride.
The safety and effectiveness profile of daily teriparatide in a prospective observational study in Japanese patients with osteoporosis at high risk for fracture: interim report.
The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.
Three Scrophularia Species (Scrophularia buergeriana, S. koraiensis, and S. takesimensis) Inhibit RANKL-Induced Osteoclast Differentiation in Bone Marrow-Derived Macrophages.
Thyroid-stimulating hormone maintains bone mass and strength by suppressing osteoclast differentiation.
TLR4 mediates alveolar bone resorption in experimental peri-implantitis through regulation of CD45+ cell infiltration, RANKL/OPG ratio, and inflammatory cytokine production.
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
Tomographic, Histological, and Immunohistochemical Evidences on the Use of N-Butyl-2-Cyanoacrilate for Onlay Graft Fixation in Rabbits.
Tooth hard tissue stimulates bone remodeling as a potential motive force during tooth eruption.
Total and regional bone mass and biochemical markers of bone remodeling in metastatic prostate cancer.
TRAF-6 dependent signaling pathway is essential for TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation.
TRAF6/ERK/p38 pathway is involved in interleukin-17-mediated autophagy to promote osteoclast precursor cell differentiation.
Transient Effect of 17?-estradiol on Osteoporosis in Ovariectomized Rats Accompanied with Unilateral Disuse in the Early Phase.
Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation.
Tumor necrosis factor ? augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression.
Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis.
Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies.
U.S. Montmorency Tart Cherry Juice Decreases Bone Resorption in Women Aged 65-80 Years.
Ultrastructural localization of a tartrate-resistant acid ATPase in bone.
Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma.
Upregulation of mmu_circ_0001066 attenuates the inhibitory effect of bisphosphonates on osteoclastogenesis.
Usefulness of biochemical markers of bone turnover in rats after clodronate administration.
Usefulness of bone resorption markers in hemodialysis patients.
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
Value of TRAcP 5b as a diagnostic marker for detection of bone metastases in patients with breast cancer.
Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis.
Voluntary running of defined distances alters bone microstructure in C57BL/6 mice fed a high-fat diet.
Water extract of tendril of Cucurbita Moschata Duch. suppresses RANKL-induced osteoclastogenesis by down-regulating p38 and ERK signaling.
Yi Shen Juan Bi Pill Ameliorates Bone Loss and Destruction Induced by Arthritis Through Modulating the Balance of Cytokines Released by Different Subpopulations of T Cells.
Yougui pills exert osteoprotective effects on rabbit steroid-related osteonecrosis of the femoral head by activating ?-catenin.
[Advances of clinical diagnosis of osteodystrophy complicated by chronic renal failure]
[Age related changes of serum sex hormone levels and tartrate-resistant acid phosphatase activity in healthy women]
[Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice]
[Biological markers of bone metabolism]
[Biological profile of tartrate-resistant acid phosphatase as a marker of bone resorption]
[Bone and bone related biochemical examinations. Bone and collagen related metabolites. Tartrate-resistant acid phosphatase (TRACP)]
[Bone resorption markers]
[Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies]
[Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum]
[Early, noninvasive diagnostic of osteoporosis in men]
[Effect of recombinant human osteoprotegerin on osteoclasts stimulated by polyethylene particles]
[Effect of resveratrol on peak bone mass in growing rats].
[EFFECT OF STAPHYLO CO CCAL PEPTID O GLYCAN ON OSTEO CL AST DIFFERENTIATION].
[Effect of staphylococcal lipoteichoic acid on differentiation of RAW264.7 cells into osteoclasts].
[Experimental study on inhibitory effect of zoledronic acid on the action style of the osteoclast].
[Histochemical and immunohistochemical double staining for osteolytic related factors in keratocystic odontogenic tumor]
[Mechanisms and therapeutics of glucocorticoid-induced osteoporosis].
[Potential mechanism of transcription factor peroxisome proliferator-activated receptor-gamma coactivator-1 beta on promoting osteoclastogenesis].
[Research progress of Rehmanniae Radix in prevention and treatment of osteoporosis].
[Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker]
[Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis]
[The mechanism of TRACP 5b maturation]
[The parathyroid function in patients with hyperthyroidism]
[The risk for osteoporosis in persons treated with thyroid hormones]
[The usefulness of biochemical markers of bone remodelling in the diagnosis and follow-up of Paget's disease of bone, primary hyperparathyroidism, tumoral hypercalcemia and postmenopausal osteoporosis. I. The markers of bone formation]
[Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers]
Brain Diseases
Lipin1 Is Involved in the Pathogenesis of Diabetic Encephalopathy through the PKD/Limk/Cofilin Signaling Pathway.
Lysosomal acid phosphatase decrease in nutritional encephalopathy in chicks.
Brain Edema
[Activity of lysosomal enzymes in rabbit brain during the development of edema]
Brain Injuries
[Special aspects of fracture healing in cranio-cerebral injuries]
Brain Ischemia
Intracerebroventricular injection of human prostatic acid phosphatase has potent neuroprotective effects against transient focal cerebral ischemia in rats.
Brain Neoplasms
Adenocarcinoma of the prostate presenting initially as an intracerebral tumor.
Characterization of the cervical mucus plug in mares.
[Acid phosphatase activity in cultures of glial tumors]
[Histochemical study of acid phosphatase strongly activated by zinc acetate and its behavior in the early phases of brain tumor development induced in rats by N-ethyl-N-nitrosourea]
[Stage D1 prostatic cancer benefited by a single regimen of Estracyt]
Branchioma
The lining of branchial cysts studied by electron microscopy and enzyme histochemistry.
Breast Cyst
Prostatic acid phosphatase in breast cyst fluid.
Breast Diseases
[Studies into carcino-embryonic antigen (CEA) and enzyme activities of alkaline and acid phosphatase in patients with fibrocystic breast disease (author's transl)]
Breast Neoplasms
A prostatic-like acid phosphatase is present in human lactating milk.
Abnormal serum alkaline and acid phosphatase isoenzymes in female breast cancer patients.
Acid phosphatase in human breast cancer tissue.
Artemisinin inhibits breast cancer-induced osteolysis by inhibiting osteoclast formation and breast cancer cell proliferation.
Biochemical markers of bone metabolism in breast cancer.
Biogenesis of tartrate-resistant acid phosphatase isoforms 5a and 5b in stably transfected MDA-MB-231 breast cancer epithelial cells.
Biologic markers in cancer diagnosis and treatment.
Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway.
Breast metastasis from prostate cancer and interpretation of immunoreactivity to prostate-specific antigen.
Calcium, inorganic phosphates, alkaline and acid phosphatase activities in breast cancer patients in Calabar, Nigeria.
Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
Cathepsin K regulates localization and secretion of Tartrate-Resistant Acid Phosphatase (TRAP) in TRAP-overexpressing MDA-MB-231 breast cancer cells.
Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b), a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP), a Bone Formation Marker, in Lieu of Whole Body Skeletal Scintigraphy with Technetium99m MDP.
Diagnostic and prognostic use of bone turnover markers.
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids.
Evaluation of bone metabolic markers in breast cancer with bone metastasis.
Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
Expression of prostate specific antigen in male breast cancer.
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Histochemical studies of human breast tumors: Activity of alkaline phosphatase, acid phosphatase and glucose-6-phosphate dehydrogenase.
Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase (TRAP).
Lysosomal enzymes of neutrophils in women with breast cancer.
MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis.
Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines.
Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts.
Postoperative expressions of TRACP5b and CA125 in patients with breast cancer and their values for monitoring bone metastasis.
Role of betulinic acid derivative SH-479 in triple negative breast cancer and bone microenvironment.
Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.
Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer.
Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGF?2/T?R and CD44 in MDA-MB-231 breast cancer cells.
Tartrate-resistant Acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.
Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer.
The effect of treatment with 4-hydroxyandrostenedione or medroxyprogesterone acetate on human breast tumour regression.
The salubrious effect of tamoxifen [correction of Tamaxifen] on serum marker enzymes, glycoproteins, and lysosomal enzymes level in breast cancer woman.
The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
Value of TRAcP 5b as a diagnostic marker for detection of bone metastases in patients with breast cancer.
[Acid phosphatase activity in breast dysplasias and in carcinomas of the breast]
[Plasma granulocyte-macrophage colony stimulating factor (GM-CSF) and activity of enzymes in granulocytes of breast cancer patients]
[Prostatic acid phosphatase, beta-choriogonadotropin and alpha fetoprotein in the serum of patients with breast cancer]
[The significance of acid phosphatase activity in the cytologic diagnosis of thyroid malignancy (author's transl)]
Breast Neoplasms, Male
Immunodiagnosis by prostatic acid phosphatase to differentiate primary male breast cancer from metastatic prostate cancer.
Bronchial Spasm
Characterization of serum lysosomal enzymatic activities. III. Effect of infectious influenza in Egyptian equines.
Bronchitis
[Characteristics of the course of bronchitis in allergy]
[Cytologic and certain cytoenzymologic characteristics of sputum in chronic nonspecific lung diseases]
[Elastase and acid phosphatase activity in bronchoalveolar lavage fluid during chronic bronchitis]
Bronchitis, Chronic
[Morphological investigations of bronchial biopsy material in chronic bronchitis and asthma bronchiale (author's transl)]
Burkitt Lymphoma
Multienzymatic analyses of human malignant lymphomas. Correlation of enzymatic data with pathologic and ultrastructural findings in Burkitt's and lymphoblastic lymphomas.
carboxypeptidase taq deficiency
Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma.
Carcinogenesis
Acid phosphatase and deoxyribonucleic acid studies in D.M.B.A. induced experimental oral carcinogenesis in hamster cheek pouch.
Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.
Change in acid phosphatase during azo-dye carcinogenesis.
The phosphatidic acid phosphatase lipin-1 facilitates inflammation-driven colon carcinogenesis.
[Enzymatic and immunologic activity of lymphocytes during chemical carcinogenesis]
Carcinoid Tumor
Elevated serum acid phosphatase levels with rectal carcinoid tumor.
Evidence of hybrid cell of thyroid follicular cell and carcinoid cell in strumal carcinoid.
Grossly elevated serum prostatic acid phosphatase in a patient with carcinoid.
Identification of a novel alpha-amylase by expression of a newly cloned human amy3 cDNA in yeast.
Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen.
Primary renal carcinoid. Case report and literature review.
Prostate-specific acid phosphatase in carcinoid tumors.
Prostatic acid phosphatase activity in carcinoid tumors.
Prostatic acid phosphatase in carcinoid and islet cell tumors.
Prostatic acid phosphatase in carcinoid tumors. Immunohistochemical and immunoblot studies.
Prostatic acid phosphatase in strumal carcinoids of the ovary. An immunohistochemical study.
Serum prostatic acid phosphatase: an increase associated with a metastatic carcinoid tumor.
Strumal carcinoids of the ovary. An immunohistologic and ultrastructural study.
Carcinoma
"Endometrial" adenocarcinoma of the prostate: a distinctive tumor of probable prostatic duct origin.
A clinical assay for prostatic acid phosphatase using choline phosphate as a substrate: comparison with thymolphthalein phosphate.
A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines.
A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.
A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
A cytochemical study of acid phosphatase in carcinoma of the cervix uteri.
A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
A prostatic-like acid phosphatase is present in human lactating milk.
A radioimmune assay for human prostatic acid phosphatase-levels in prostatic disease.
A simple immunohistochemical method for the detection of prostatic acid phosphatase.
ACID AND ALKALINE PHOSPHATASE ACTIVITY IN TRANSPLANTABLE GU'ERIN EPITHELIOMA IN RATS. I. ACID PHOSPHATASE.
Acid phosphatase after examination of the prostate.
Acid phosphatase and prostatic carcinoma.
Acid phosphatase as marker for carcinoma of prostate.
Acid phosphatase content of prostatic exprimate from patients with advanced prostatic carcinoma: a potential prognostic and therapeutic index.
Acid phosphatase elevation following prostatic examination in the earlier diagnosis of prostatic carcinoma.
Acid phosphatase for monitoring prostatic carcinoma. Comparison of radioimmunoassay and enzymatic techniques.
ACID PHOSPHATASE IN CARCINOMA OF THE PROSTATE IN MAN.
Acid phosphatase in human breast cancer tissue.
Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma.
Acid phosphatase in squamous cell carcinoma.
Acid phosphatase isoenzymes in Gaucher's disease.
Acid phosphatase levels in bone marrow: value in detecting early bone metastasis from carcinoma of the prostate.
Acid phosphatase localization in prostatic carcinoma. A comparison of monoclonal antibody to heteroantisera.
Acid phosphatase.
Acid phosphatase: its influence on the management of carcinoma of the prostate.
Acid phosphatase: new developments.
Acid phosphatases in the human testis after prolonged estrogen treatment.
Adenoid cystic carcinoma of the prostate. A case report with immunoperoxidase staining for prostate-specific acid phosphatase and prostate-specific antigen.
Adverse implications of acid phosphatase levels in the upper range of normal.
An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate.
An objective look at acid phosphatase determinations: a comparison of biochemical and immunological methods.
An unusual alkaline phosphatase isoenzyme in a patient with concomitant marked elevation of acid phosphatase without clinical evidence of prostatic carcinoma.
Analysis of prostatic fluid in prostatic disease.
Androgen metabolism in the human prostatic cancer cell line LNCaP.
Antitumor activity and DNA-binding investigations of isoeuxanthone and its piperidinyl derivative.
Artifactual changes mimicking signet ring cell carcinoma in transurethral prostatectomy specimens.
Assessment of serum radioimmune and enzymatic prostatic acid phosphatase and radioimmune creatine kinase BB for monitoring response to therapy in metastatic prostatic carcinoma.
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review.
Avian prostatic acid phosphatase: estrogen regulation in the oviduct and epithelial cell-derived ovarian carcinomas.
Basaloid carcinoma of the prostate gland. An unusual finding.
Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies.
Beta-microseminoprotein immunoreactivity as a new prognostic indicator of prostatic carcinoma.
Bilateral orbital metastases from prostate carcinoma: case presentation and CT findings.
Biochemical and immunological relationships of prostatic and leukocytic acid phosphatases and their subcellular localization.
Biological markers in urologic cancer.
Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus.
Bone marrow acid phosphatase by radioimmunoassay.
Bone marrow acid phosphatase concentrations in individuals with prostatic carcinoma or other disorders.
Bone marrow acid phosphatase in staging of prostatic cancer: how reliable is it?
Bone marrow acid phosphatase in staging prostatic carcinoma.
Bone scintigraphy, radiographic survey and prostatic acid phosphatase in patients with prostatic carcinoma. A comparison of sensitivity.
CA125-producing adenocarcinoma of the seminal vesicle.
Calcium inactivation of acid phosphatase in the normal human prostate and in carcinoma of the prostate.
CALCIUM INACTIVATION OF ACID PHOSPHATASE IN THE NORMAL HUMAN PROSTATE AND IN CARCINOMA OF THE PROSTATE.
Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
Carcinoma of the prostate presenting as interstitial lung disease.
Carcinoma of the prostate presenting with massive pleural effusion and elevated pleural acid phosphatase.
Carcinoma of the prostate. II. Serum activity of acid phosphatase, prostatic acid phosphatase, LDH and its isoenzymes.
Carcinoma of the prostate; determination of the acid phosphatase of the blood serum as an aid in diagnosis.
Cationic liposome-mediated incorporation of prostatic acid phosphatase protein into human prostate carcinoma cells.
Cellular and hormonal mechanisms associated with malignant bone resorption.
Change of total and prostatic serum acid phosphatase levels following hyperglycemic treatment in patients with prostatic carcinoma.
Changes of enzyme activities recognized in lymphocytes from patients with carcinoma of the gastrointestinal tract.
Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
Characterization of Rab27a and JFC1 as constituents of the secretory machinery of prostate-specific antigen in prostate carcinoma cells.
Characterization of the metabolism of perinecrotic cells in solid tumors by enzyme histochemistry.
Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.
Clinical evaluation of immunological methods for detection for serum prostatic acid phosphatase.
Clinical experience with intra lymphatic administration of 111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma.
Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma.
Clinical significance of serum and bone marrow acid phosphatase.
Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase.
Clinical study on estramustine binding protein (EMBP) in human prostate.
Clinical utility of serum prostatic acid phosphatase measurements for detection (screening), diagnosis, and therapeutic monitoring of prostatic carcinoma; assessment of monoclonal and polyclonal enzymes and radioimmunoassays.
Clinical value of different methods for determination of acid phosphatase in prostatic cancer.
Comparative clinical features of stage A1 and stage A2 prostate cancers. Is the concept of stage A changing from the current status?
Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice.
Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma.
Comparison of prostatic acid phosphatase assays.
Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelioma, and seborrheic keratosis.
Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma.
Confirmation of metastatic prostatic carcinoma to lung by immunohistochemistry.
Correlation between serum values of prostatic acid phosphatase and morphometric analysis in the cytologic diagnosis of prostatic carcinoma.
Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
Correlation of survival with quantitative tissue staining of prostate specific acid phosphatase in patients with prostate carcinoma by using microscopic image analysis: a preliminary report of correlative studies on RTOG protocols 75-06, 77-06, and 83-07.
Creatine kinase isoenzyme (CK-BB) by RIA as a follow-up marker in stage D cancer of the prostate: comparison with PAP RIA.
Cytologic features of prostatic adenocarcinoma in urine: a clinicopathologic and immunocytochemical study.
Cytotoxic activity and DNA-binding properties of isoeuxanthone derivatives.
Definitive radiotherapy in resectable (stage A2 and B) carcinoma of the prostate--results of a nationwide overview.
Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phosphatase and prostate specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma.
Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques.
Determination of serum acid and alkaline phosphatase using 4-methylumbelliferyl phosphate.
Diagnosis of carcinoid-like metastatic prostatic carcinoma by an immunoperoxidase method.
Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
Diagnostic utility of P504S/p63 cocktail, prostate-specific antigen, and prostatic acid phosphatase in verifying prostatic carcinoma involvement in seminal vesicles: a study of 57 cases of radical prostatectomy specimens of pathologic stage pT3b.
Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
Differentiation of macrophages from Lewis lung carcinoma tumour cells in tissue sections by their alpha-naphthyl butyrate esterase activity.
Discriminative value of serum phosphatases in patients with prostatic carcinoma.
Distribution and some properties of acid phosphatase in the 7,12-dimethylbenz(alpha) anthracene-induced rat-mammary carcinoma.
DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma.
Effectiveness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy in prostatic carcinoma.
Electron-microscopic studies on the activity of the reactions of acid phosphatase in rats with transplantable Guérin epithelioma.
Electrophoretic separation of serum acid phosphatase isoenzymes in Gaucher's disease, prostatic carcinoma and multiple myeloma.
Elevated prostate markers in metastatic small cell carcinoma of unknown primary.
Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis.
Elevation of serum acid phosphatase in cancers with bone metastasis.
Elevation of serum prostatic acid phosphatase levels after prostatic massage.
Endogenous protein substrates for prostatic acid phosphatase in human prostate.
Enzyme immunoassay for the prostate-specific acid phosphatase (E. C. 3.1.3.2).
Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids.
Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Estimation of serum acid phosphatase in the diagnosis of metastasizing carcinoma of the prostate.
Estrogens in carcinoma of the prostate. Effects on enzymes and polypeptide hormones.
Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
Evaluation of commercial immunoperoxidase kits in diagnosis of prostate carcinoma.
Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disorders.
Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells.
Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines.
Expression of human prostatic acid phosphatase in a pancreatic islet cell carcinoma.
Extraocular muscle metastasis 16 years following primary prostate carcinoma.
Extremely high serum acid phosphatase level in carcinoma of prostate.
FACS quantitation of leucine aminopeptidase and acid phosphatase on tumor-associated macrophages from metastatic and nonmetastatic mouse mammary tumors.
Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
Ghost cell odontogenic carcinoma of the mandible: A case report demonstrating expression of tartrate-resistant acid phosphatase (TRAP) and vitronectin receptor.
Giant cystosarcoma phyllodes of the prostate associated with adenocarcinoma.
Heterogeneity and prognostic significance of macrophages in human colonic carcinomas.
HISTOCHEMICAL DIFFERENTIATION OF CARCINOMA OF THE PROSTATE GLAND FROM OTHER TUMORS BY A MODIFIED ACID PHOSPHATASE REACTION.
Histochemical studies of the activities and locations of -glucuronidase and acid phosphatase in the Guerin T8 epithelioma.
Histoenzymological features of epithelial cells in lesions of oral mucosa in cysts and ameloblastomas of jaws.
Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.
Human prostatic acid phosphatases: purification of a minor enzyme and comparisons of the enzymes.
Immunofluorescence for prostatic acid phosphatase: clinical applications.
Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
Immunohistochemical diagnosis of prostatic cancer with metastasis.
Immunohistochemical diagnosis of the metastasizing prostatic carcinoma.
Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma.
Immunohistochemistry in diagnostic surgical pathology of the prostate.
Immunohistologic diagnosis of 2 cases of metastatic prostate cancer to breast.
Immunological and colorimetric determination of prostatic acid phosphatase--technical and clinical reappraisal in symptomatic patients.
Immunoperoxidase demonstration of prostatic acid phosphatase in aspiration biopsy cytology (ABC).
Immunoperoxidase localization of prostatic acid phosphatase in prostatic carcinoma with sarcomatoid changes.
Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites.
Immunoperoxidase staining of acid phosphatase in human prostatic tissue.
Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients.
Immunoultrastructural demonstration of prostatic acid phosphatase isoenzyme 2 in prostatic carcinoma.
Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer.
Increased prostate-type acid phosphatase activity in serum and typical bone lesions simulating the presence of prostatic carcinoma.
Influence of luteinizing hormone-releasing hormone analogues on serum levels of prostatic acid phosphatase and prostatic specific antigen in patients with metastatic carcinoma of the prostate.
Influence of tumor grade on survival and on serum acid phosphatase levels in metastatic carcinoma of the prostate.
Inhibition of human prostatic tumour acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustards.
Laboratory studies for the detection of carcinoma of the prostate.
Limitations of prostatic acid phosphatase determination in carcinoma of phostate.
Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.
Lymph node metastases of prostatic adenocarcinoma in the mesorectum in patients with adenocarcinoma or villous tumor of the rectum with collision phenomenon in a single lymph node: report of five cases.
Lymphocyte lysosomal acid phosphatase in patients with carcinoma of the larynx.
Lymphoepithelioma-like carcinoma of the prostate.
Macro-prostatic acid phosphatase in a patient's serum.
Massive hepatomegaly and an elevated serum acid phosphatase associated with a retrovesical carcinoma.
Metastatic prostatic adenocarcinoma of male breast.
Metastatic prostatic carcinoma to supradiaphragmatic lymph nodes. A clinicopathologic and immunohistochemical study.
Metastatic, sarcomatoid, and PSA- and PAP-negative prostatic carcinoma: diagnosis by fine-needle aspiration.
Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma.
Monitoring and treatment of minimal residual cancer of the prostate.
Monitoring of prostatic cancer by an enzyme-linked immunosorbent assay of serum prostatic acid phosphatase.
Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma.
Mucinous adenocarcinoma of the prostate gland.
New agents for prostatic cancer activated specifically by prostatic acid phosphatase.
On reference values for tumor markers in prostatic carcinoma.
Origin of carcinomas causing bladder neck obstruction demonstrated by immunoperoxidase localisation of specific antigens.
PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: relation to hormone sensitivity and to cytological grading.
Papillary adenocarcinomas of the prostate. An immunohistochemical study.
Parotid saliva acid phosphatase in health and disease.
Phosphatase isoenzymes as bone metastasis markers in prostatic carcinoma.
Planning and evaluation of diagnostic tests: failure of S-prostatic acid phosphatase in screening for early-stage prostatic carcinoma.
Plasma Acid Phosphatase in Carcinoma of Prostate: Effect of Stilboestrol.
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma.
Possible significance of the prostatic secretion acid phosphatase as a diagnostic and prognostic index in carcinoma of the prostate.
Pre-treatment testosterone levels: significance in androgen deprivation therapy.
Primary signet ring cell carcinoma of the prostate.
Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma.
Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate.
Prognostic usefulness of serum acid phosphatase levels in carcinoma of the prostate.
Prognostic value of bone marrow acid phosphatase in prostatic carcinoma.
Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
Prostacyclin in prostatic cancer: a better marker than bone scan or serum acid phosphatase?
Prostate adenocarcinoma using Gleason scores correlates with prostate-specific antigen and prostate acid phosphatase measurements.
Prostate cancer induction in autoimmune rats and modulation of T cell apoptosis.
Prostate cancer screening using fine-needle aspiration cytology prior to open prostatectomy.
Prostate irradiation does not affect the serum prostatic acid phosphatase level.
Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.
Prostate specific antigen and prostatic acid phosphatase immunoreactivity as prognostic indicators of advanced prostatic carcinoma.
Prostate-specific acid phosphatase in Nigerian patients with prostate carcinoma.
Prostate-specific antigen (protein and mRNA) analysis in the differential diagnosis and staging of prostate cancer.
Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.
Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma.
Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
Prostate-specific antigen. Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor marker.
Prostatic acid phosphatase by radioimmunoassay tumor marker in bone marrow.
Prostatic acid phosphatase by radioimmunoassay. Sensitivity compared with enzymatic assay.
Prostatic acid phosphatase in cloacogenic carcinoma.
Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma.
Prostatic acid phosphatase levels (enzymatic method) from completely sectioned, clinically benign, whole prostates.
Prostatic acid phosphatase: clinical utility in detection, assessment, and monitoring carcinoma of the prostate.
Prostatic carcinoma and acid phosphatase.
Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
Prostatic carcinoma: a multivariate analysis of prognostic factors.
Prostatic origin of tumors. An immunohistochemical study.
Prostatic serum acid phosphatase as an aid in the diagnosis of prostatic carcinoma; preliminary report.
Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Protection of prostatic acid phosphatase activity in human serum samples by plasmin inhibitors.
Quantitation of prostate-specific acid phosphatase in prostate cancer: reproducibility and correlation with subjective grade.
Radioimaging of lymph node involvement in prostatic carcinoma.
Radioimaging of the prostate and metastases of prostatic carcinoma with 99mTc-labelled prostatic acid phosphatase-specific antibodies and their Fab fragments.
Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
Radioimmunoassay for prostatic acid phosphatase in early prostatic carcinoma.
Radioimmunoassay of creatine kinase B-isoenzymes in serum of patients with azotemia, obstructive uropathy, or carcinoma of the prostate or bladder.
Radioimmunoassay of prostatic acid phosphatase in carcinoma of the prostate.
Radioimmunoassay of serum prostatic acid phosphatase in prostatic carcinoma. A comparative study with an enzymatic assay.
Radioimmunodetection of prostate cancer by 111In-labeled monoclonal antibody against prostatic acid phosphatase.
Rapid radioimmunoassay for prostate-specific acid phosphatase in human serum.
Rapid rise of serum acid phosphatase after irradiation of metastatic carcinoma of prostate.
Rapid, fully automated radioimmunoassay of prostatic acid phosphatase in serum.
Ratio of serum tartrate-inhibitable acid phosphatase to total serum protein in benign prostatic hypertrophy and prostatic carcinoma.
Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells.
Regulation of the expression of prostatic acid phosphatase in LNCaP human prostate carcinoma cells.
Reliability of bone marrow acid phosphatase as a parameter of metastatic prostatic cancer.
Retroperitoneal metastatic disease due to carcinoma of the prostate: value of serum prostatic acid phosphatase in identifying retroperitoneal metastasis originating from carcinoma of prostate.
Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared.
Separation and characterization of epithelial cells from prostates and prostatic carcinomas: a review.
Separation of cells with histochemically demonstrable acid phosphatase activity from suspensions of cells from human prostatic carcinomas in an isokinetic gradient of Ficoll in tissue culture medium.
Separation of tissue and serum acid phosphatase isoenzymes by ion-exchange column chromatography.
Serial bone scanning in the evaluation of stage and clinical course in carcinoma of the prostate.
Serial lectin affinity chromatography with concavalin A and wheat germ agglutinin demonstrates altered asparagine-linked sugar-chain structures of prostatic acid phosphatase in human prostate carcinoma.
Serum acid phosphatase and screening for carcinoma of the prostate.
Serum acid phosphatase in the diagnosis of carcinoma of the prostate.
Serum acid phosphatase levels in untreated carcinoma patients.
Serum activities of lysosomal enzymes in patients with liver cell carcinoma.
Serum and seminal markers in the diagnosis of disorders of the genital tract of the dog: a mini-review.
Serum levels of prostatic acid phosphatase (PAP), tissue polypeptide antigen (TPA), CA-50, neopterine and of osteocalcin in patients with prostatic carcinoma.
Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
Serum markers as a predictor of response duration and patient survival after hormonal therapy for metastatic carcinoma of the prostate.
Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram: comparison with serum PSA/PAP measurements.
Serum prostate-specific acid phosphatase: development and validation of a specific radioimmunoassay.
Serum prostatic acid phosphatase levels in patients with carcinoma of the prostate.
Signet-ring cell carcinoma of the prostate.
Signet-ring-cell carcinoma of the prostate. Electron-microscopic and immunohistochemical studies of eight cases.
Significance of PSA and PAP in patients with or without prostatic cancer.
Skin metastasis, an uncommon course of prostate carcinoma: a report of two cases.
Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases.
Squamous metaplasia of the prostate. An immunohistochemical study.
Steroid hormone regulation of prostatic acid phosphatase expression in cultured human prostatic carcinoma cells.
Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line.
Studies on prostatic carcinoma cell lines. Their acid phosphatase productivity and various sex hormone effects on the cells.
The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells.
The changes in the binding capacity of testosterone-oestradiol binding globulin (TeBG) following castration and DES-D administration in patients with prostatic carcinoma.
The concentration and distribution of acid phosphatase in the human stomach, with particular reference to gastric carcinoma.
The development of the acid phosphatase test for prostatic carcinoma: the Sixth Ferdinand C. Valentine Memorial Lecture.
The distribution of S-100 protein in hyperplastic and neoplastic prostatic epithelium.
The effect of cancer chemotherapy on lysosomal enzymic activities (acid phosphatase) of Ehrlich ascites carcinoma cells.
The efficacy of serum prostate specific antigen as a tumour marker in prostatic carcinoma: a comparison with serum acid phosphatase.
The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells.
The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry.
The Nb rat prostatic adenocarcinoma model system.
The prognostic significance of an elevated serum acid phosphatase level in advanced prostatic carcinoma.
The prognostic significance of histological grading and pathological staging in carcinoma of the prostate.
The prognostic value of acid phosphatase and beta-glucuronidase activity in biopsy specimens from patients with reactivated prostatic cancer.
The results of some cytochemical reactions in metastatic malignant tumor cells in pleural and peritoneal effusions.
The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
The significance of bone marrow acid phosphatase in patients with prostatic carcinoma.
The use of immunohistochemistry in metastatic prostatic adenocarcinoma to the breast.
The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice.
The usefulness of serum acid phosphatase in monitoring patients with advanced prostate carcinoma.
The value of clinical laboratory tests. IV. The estimation of serum acid phosphatase in the diagnosis of carcinoma of the prostate.
The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
The value of serum carboxyterminal propeptide of type 1 procollagen in predicting bone metastases in prostate cancer.
Three predominant prostatic proteins.
Total protein and acid phosphatase concentrations in prostatic fluid from patients with BPH compared to carcinoma.
Transient high serum prostate-specific acid phosphatase measured by radioimmunoassay in prostatic infarction.
Transitional cell carcinoma of the prostate.
Transitional cell carcinoma of the urinary bladder with osteoclast-type giant cells: a report of two cases and review of the literature.
Tumor markers in chronic renal failure and hemodialysis patients.
Tumor markers in human prostatic carcinoma. An optimation of reference values.
Tumor markers in patients with chronic renal failure.
Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase.
Two-dimensional electrophoretic analysis of human prostatic fluid proteins.
Tyrosyl kinase activity is inversely related to prostatic acid phosphatase activity in two human prostate carcinoma cell lines.
Ultrastructural localization of acid phosphatase in human laryngeal carcinoma.
Unusual radiologic features of metastatic prostatic carcinoma confirmed by immunohistochemical study.
Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
Usefulness of bone marrow serum acid phosphatase in staging carcinoma of the prostate.
Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
Value of acid phosphatase in screening for carcinoma in patients with prostatism in Nigeria.
Waterhammer pulse associated with metastatic carcinoma from the prostate and extreme elevation of blood acid phosphatase.
[A case of effective urgent irradiation therapy for metastatic spine tumor]
[A case of small cell carcinoma of the prostate]
[A comparism between lysosomal enzyme activity in normal ectocervical squamous epithelium and squamous carcinoma of the ectocervix]
[A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma]
[Acid phosphatase in blood (substrate: alpha-naphthylphosphate): reference values and diagnostic significance]
[Acid phosphatase in the bone marrow: diagnostic value in prostatic carcinoma]
[Acid phosphatase of the normal prostate and prostatic carcinoma. Differentiation based on the action of ionized calcium.]
[Activity of reactions for acid phosphatase in transplantable rat's epithelioma Guérin's epithelioma]
[Bladder carcinoma with osteoclast-type giant cells. A case with a rare presentation. Review of the literature]
[Bone marrow acid phosphatase determination in patients with carcinoma of the prostate (author's transl)]
[Breast metastases from extramammary malignancies in men]
[Changes in tumor markers following cryosurgery of prostate carcinoma]
[Citrate and acid phosphatase in the ejaculate in prostatic carcinoma and adenoma]
[Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)]
[Correlation of gastroscopic, pathohistologic, cytologic and cytochemical analysis of ulcer lesions and other pathologic changes in the gastric mucosa. Preliminary study]
[Cytochemical studies for determining the histogenesis of anaplastic and poorly differentiated lung tumors]
[Demonstration of acid phosphatase in the gastric juice and its importance in the diagnosis of stomach carcinoma]
[Determination of acid phosphatase in prostatic carcinoma]
[Determination of cytotoxic properties of the blood serum by the acid phosphatase reaction in the ascitic cells of Ehrlich's carcinoma]
[Diagnosis of skeletal metastases in prostatic cancer using gamma camera (author's transl)]
[Diurnal variation of the elevated acid phosphatase activity in cases of prostate carcinoma (author's transl)]
[Enzyme cytochemistry and morphometric study of the effects of macrophages on A549 pulmonary alveolar cell carcinoma cell line]
[Enzymological study of prostatic cancer VIII. Comparison of acid phosphatase by measurement of enzymatic level and radioimmunoassay in diagnosis of patients with prostatic carcinoma (author's transl)]
[Enzymological study of prostatic cancer. VI. Serum acid phosphatase level and prognosis of patients with prostatic carcinoma (author's transl)]
[Immunochemical measurement of prostatic acid phosphatase in carcinoma of the prostate]
[Immunohistochemical detection of prostate carcinoma]
[Immunohistochemical study on the therapeutic effects on prostatic carcinoma using monoclonal and polyclonal antibodies for prostatic acid phosphatase]
[Immunoperoxidase localization of prostatic acid phosphatase, prostate-specific antigen and gamma seminoprotein in primary and metastatic prostatic carcinoma]
[Importance of serum acid phosphatase for the prognosis of prostatic carcinoma]
[Initial experience with surgical uro-laparoscopy]
[Levels of prostate-specific antigen, acid phosphatase, alkaline phosphatase and pain in the prediction of bone metastases in patients with newly diagnosed prostatic carcinoma]
[Lysosomal enzymes in neoplastic pathology of the cervix uteri. Study of acid phosphatase, as a diagnostic test, in vaginal secretions of patients with pre-invasive and invasive carcinoma of the cervix]
[Multiple forms of some enzymes in tissue of rectal carcinoma after x-ray treatment]
[N-acetyl-beta-glucosaminidase, beta-glucronidase and acid phosphatase in neutrophils of patients with laryngeal carcinoma]
[Prostatic carcinoma in a young adult: a case report]
[Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen]
[Radioimmunoassays in oncology]
[Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate]
[Role of the markers PAP-PSA in the diagnosis of cancer of the prostate]
[Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results]
[Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience]
[Studies on human prostatic carcinoma cell lines: evaluation of acid phosphatase productivity and effects of sex hormones on the cells]
[The clinical significance of acid phosphatase in carcinoma of the prostate.]
[The contribution of radio-isotopes to urological investigation (author's transl)]
[The diagnostic value of the radioimmunological estimation of prostatic acid phosphatase. Comparative value of the measurement of enzyme activity (author's transl)]
[The electrophoretic pattern of acid phosphatase in the prostatic fluid in hypertrophy and in carcinoma of the prostate.]
[The importance of tumor markers in adenocarcinoma of the prostate]
[The nuclear roundness factor as a parameter in the anatomoclinical correlation of prostatic carcinoma]
[The prognostic significance of alkaline and acid phosphatase levels in the hormonal treatment of patients with prostatic carcinoma]
[The significance of free-type PSA and complex-type PSA in patients with prostatic carcinoma--the characteristics of ACS-PSA method compared with that of Delfia- and Eiken-PSA method]
[Usefulness of the prostate-specific antigen in monitoring prostatic carcinoma. Its correlation with acid phosphatase]
[Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase]
Carcinoma in Situ
Histoenzymological features of epithelial cells in lesions of oral mucosa in cysts and ameloblastomas of jaws.
Carcinoma, Acinar Cell
Metastatic, sarcomatoid, and PSA- and PAP-negative prostatic carcinoma: diagnosis by fine-needle aspiration.
Carcinoma, Adenoid Cystic
Adenoid cystic carcinoma of the prostate. A case report with immunoperoxidase staining for prostate-specific acid phosphatase and prostate-specific antigen.
Carcinoma, Basal Cell
Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelioma, and seborrheic keratosis.
Carcinoma, Ductal
Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study.
Histochemically demonstrable enzyme activities and their independence of the hormone receptor content in female breast carcinoma.
Carcinoma, Endometrioid
Endometrioid adenocarcinoma of prostatic urethra presenting with anterior urethral implantation.
Carcinoma, Hepatocellular
A cytochemical study of acid phosphatase, thiamine pyrophosphatase and horseradish peroxidase in the Golgi-GERL complex of hepatoma ascites cells.
Association of specific genotypes in metastatic suppressor HTPAP with tumor metastasis and clinical prognosis in hepatocellular carcinoma.
beta-Lapachone induced cell death in human hepatoma (HepA2) cells.
Cytochemical localization of lectin labeled vesicles in GERL region of hepatoma ascites cells.
Cytochemical studies of acid phosphatase, adenosine triphosphatase and lactic dehydrogenase activity in thioacetamide-induced hepatoma.
Deviations in isozyme patterns of acid phosphatase and esterase, and in ultrastructures of Yoshida ascites hepatomas from rat hepatocytes.
DNA and protein content as cellular biochemical parameters. A discussion with two examples: acid phosphatase and cathepsin D in rat liver and hepatoma and acid phosphatase in human breast normal tissue and adenocarcinoma.
Effect of silymarin on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
Isozymic changes of acid phosphatase and esterase in regenerating rat liver after partial hepatectomy in relation to cell differentiation.
Kockdown of ACP5 inhibits hepatocellular carcinoma progression.
Quinidine-induced decrease of intracellular esterase activity in a hepatoma cell line.
Serum activities of lysosomal enzymes in patients with liver cell carcinoma.
Serum and host liver activities of glycosidases and sialyltransferases in animals bearing transplantable tumors.
[Acid phosphatase in the liver of the normal rat and the rat with Yoshida ascites hepatoma after stimulation with phytohemagglutinins and a physiological solution]
[Acid phosphatase isoenzyme composition of the lysosomes of normal and tumor cells]
[Cytochemical study of cells of primary and disseminated ascite Yoshida tumor cells]
[Effect of radiation on the activity of lactate dehydrogenase and acid phosphatase isoenzymes of Zajdela hepatoma]
[Isoenzymes of acid phosphatase and esterase in ortho-aminoazotoluene-induced hepatomas]
[Radioimmunoassays in oncology]
[The influence of tumor growth on natural cytotoxicity and activity of some lysosomal enzymes of human effector cells and the C3HA mouse splenocytes]
Carcinoma, Islet Cell
Expression of human prostatic acid phosphatase in a pancreatic islet cell carcinoma.
Carcinoma, Lewis Lung
Differentiation of macrophages from Lewis lung carcinoma tumour cells in tissue sections by their alpha-naphthyl butyrate esterase activity.
Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis.
Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma.
Carcinoma, Medullary
Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature.
Carcinoma, Non-Small-Cell Lung
Association between TGM5, PPAP2B and PSMA4 polymorphisms and NSCLC in never-smoking Chinese population.
microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity.
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
Carcinoma, Ovarian Epithelial
CA125-producing adenocarcinoma of the seminal vesicle.
Carcinoma, Papillary
Papillary adenocarcinomas of the prostate. An immunohistochemical study.
Carcinoma, Renal Cell
Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
Enzyme immunoassay for the prostate-specific acid phosphatase (E. C. 3.1.3.2).
[Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies]
Carcinoma, Signet Ring Cell
Primary signet ring cell carcinoma of the prostate.
Carcinoma, Small Cell
Elevated prostate markers in metastatic small cell carcinoma of unknown primary.
Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases.
[A case of small cell carcinoma of the prostate]
Carcinoma, Squamous Cell
Acid phosphatase in squamous cell carcinoma.
Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelioma, and seborrheic keratosis.
Histoenzymological features of epithelial cells in epidermoid carcinomas of oral mucosa and in ameloblastomas of jaws.
Histoenzymological features of epithelial cells in lesions of oral mucosa in cysts and ameloblastomas of jaws.
Prostate carcinoma with squamous differentiation: an analysis of 33 cases.
Squamous metaplasia of the prostate. An immunohistochemical study.
Tumor markers in chronic renal failure and hemodialysis patients.
Tumor markers in patients with chronic renal failure.
[Cytochemical studies for determining the histogenesis of anaplastic and poorly differentiated lung tumors]
[Histoenzymological characteristics of epithelial cells in oral mucosal lesions and jaw cysts. Diagnostic significance]
Carcinoma, Transitional Cell
Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
Cytologic features of prostatic adenocarcinoma in urine: a clinicopathologic and immunocytochemical study.
Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Immunoperoxidase staining of acid phosphatase in human prostatic tissue.
Transitional cell carcinoma of the urinary bladder with osteoclast-type giant cells: a report of two cases and review of the literature.
Carcinosarcoma
Carcinosarcoma of the prostate.
Cardiomegaly
Differential regulation of diacylglycerol kinase isozymes in cardiac hypertrophy.
Cardiomyopathy, Dilated
[The indices of the proteinase-peroxidase and phosphatase activities of the blood polymorphonuclear leukocytes in the differential diagnosis of dilated cardiomyopathy and idiopathic myocarditis]
Cardiovascular Diseases
Acid phosphatase, genetic polymorphism and cardiovascular risk factors in a pediatric population.
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
Serum tartrate-resistant acid phosphatase isoform 5a (TRACP5a) as a potential risk marker in cardiovascular disease.
Cataract
Acid phosphatase and lipid peroxidation in human cataractous lens epithelium.
Acid phosphatase II. Cytochemical localization in lenses of normal and galactose-fed rats.
Cataracts in the aging rat lens. Morphology and acid phosphatase histochemistry of incipient forms.
Lens epithelium and radiation cataract. V. Observations on acid phosphatase and meridional row nuclear fragmentation.
Lysosomal enzyme activities in conjunctival tissues of patients with keratoconus.
Lysosomal enzymes in tear fluids from patients with Terrien's marginal corneal degeneration.
Ultrastructural and acid phosphatase histochemical analysis of developmental lens abnormalities in rats with X-ray-induced cataract mutation.
Cerebrovascular Disorders
Lysosomal enzymes in cerebral atrophy.
Chagas Disease
The Role of DmCatD, a Cathepsin D-Like Peptidase, and Acid Phosphatase in the Process of Follicular Atresia in Dipetalogaster maxima (Hemiptera: Reduviidae), a Vector of Chagas' Disease.
Trypanosoma cruzi: experimental Chagas' disease in rhesus monkeys. II. Ultrastructural and cytochemical studies of peroxidase and acid phosphatase activities.
Chediak-Higashi Syndrome
Primary and secondary lysosomes in megakaryocytes and platelets from cattle with the Chediak-Higashi syndrome.
Cherubism
Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.
RANKL-independent osteoclastogenesis in the SH3BP2 cherubism mice.
Cholecystitis
Gallbladder epithelial acid hydrolases in human cholecystitis.
Cholera
Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.
Retrograde and transganglionic transport of horseradish peroxidase-conjugated cholera toxin B subunit, wheatgerm agglutinin and isolectin B4 from Griffonia simplicifolia I in primary afferent neurons innervating the rat urinary bladder.
[Culturing of normal and tumor cells of the human prostate]
Cholestasis
Metabolic changes in rat brain histaminergic neurons during subhepatic cholestasis.
Quantitative changes in acid phosphatase, alkaline phosphatase and 5'-nucleotidase activity in rat liver after experimentally induced cholestasis.
[Metabolic changes in rat brain histaminergic neurons in dynamics of subhepatic cholestasis]
Cholesteatoma
Clinical and biochemical studies of bone destruction in cholesteatoma.
Choline Deficiency
Dietary choline deficiency and excess induced intestinal inflammation and alteration of intestinal tight junction protein transcription potentially by modulating NF-?B, STAT and p38 MAPK signaling molecules in juvenile Jian carp.
Chondroblastoma
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Chondrocalcinosis
Mediation of spontaneous knee osteoarthritis by progressive chondrocyte ATP depletion in Hartley guinea pigs.
Chondroma
Enzyme histochemical study on bone tumors.
Chondrosarcoma
Enzyme histochemical study on bone tumors.
Spatholobus suberectus inhibits osteoclastogenesis and stimulates chondrogenesis.
[The comparative biochemical and morphological characteristics of chondrosarcoma and giant-cell tumor of the bone]
Chorioamnionitis
Phagocytosis of chorion laeve trophoblasts in patients with chorioamnionitis-associated preterm delivery: ultrastructural and enzyme-histochemical observations.
Choriocarcinoma
Phosphorylated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway.
Chronic Kidney Disease-Mineral and Bone Disorder
Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis.
Dihydrotachysterol treatment in renal osteodystrophy; the effect on alkaline and acid phosphatase.
Evaluation of different bone markers in hemodialyzed patients.
Nature of mononuclear cells positive for acid phosphatase activity in bone marrow of patients with renal osteodystrophy.
New Biochemical Serum Markers of Boneturnover in Renal Osteodystrophy.
News on biomarkers in CKD-MBD.
Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
[Biochemical markers of bone turnover. New aspect. Dialysis and bone metabolic marker]
[Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis]
Chronic Periodontitis
Activated macrophages in human periodontitis.
Alkaline phosphatase and acid phosphatase levels in saliva and serum of patients with healthy periodontium, gingivitis, and periodontitis before and after scaling with root planing: A clinico-biochemical study.
Classical Swine Fever
[Activation of proteinases and acid phosphatase in swine leukocytes infected with the swine classical plague virus]
Cleft Palate
Differentiation of cyclophosphamide-treated hamster secondary palate: ultrastructural and biochemical observations.
Genesis of hadacidin-induced cleft palate in hamster: morphogenesis, electron microscopy, and determination of DNA synthesis, cAMP, and enzyme acid phosphatase.
Coccidiosis
[Histochemistry of acid phosphatase in small intestine mucosa in experimental coccidiosis in suckling piglets]
Coinfection
Combined effects of Chinese medicine feed and ginger extract bath on co-infection of Ichthyophthirius multifiliis and Dactylogyrus ctenopharyngodonid in grass carp.
Colitis
High vitamin D3 diet administered during active colitis negatively affects bone metabolism in an adoptive T cell transfer model.
Induction and cellular expression of tartrate resistant acid phosphatase during dextran sodium sulphate induced colitis in rats.
Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs.
Colitis, Ulcerative
Increased serum acid phosphatase in ulcerative colitis.
Collagen Diseases
Bone turnover markers and the factors associated with atypical femur fractures among Japanese patients.
Colonic Neoplasms
Biologic markers in cancer diagnosis and treatment.
Macrophage expression of tartrate-resistant acid phosphatase as a prognostic indicator in colon cancer.
Colorectal Neoplasms
Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
Time-course microarray analysis for identifying candidate genes involved in obesity-associated pathological changes in the mouse colon.
[Serum levels of acid phosphatase, beta-choriongonadotropin and alpha fetoprotein in patients with colorectal cancer]
Coma
Evaluation of hypoxic brain injury with spinal fluid enzymes, lactate, and pyruvate.
Communicable Diseases
[Histochemical studies on alkaline and acid phosphatase of neutrophile leucocytes in infectious disease]
Cone Dystrophy
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Congenital Abnormalities
Erythrocyte acid phosphatase polymorphism: relationship with birth weight, duration of gestation, and congenital abnormalities.
Increased dietary phosphorous prevents vertebral deformities in triploid Atlantic salmon (Salmo salar L.)
Tartrate-resistant acid phosphatase knockout mice.
[Epidemiologic, clinical, biological and therapeutic aspects of Gaucher disease]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Acquired storage pool deficiency with increased platelet-associated IgG. Report of five cases.
Connective Tissue Diseases
Connective tissue diseases: Apoptosis-resistant T cells in SLE: role for the regulatory B subunits of PP2A phosphatase.
Corneal Dystrophies, Hereditary
Lysosomal enzyme activities in conjunctival tissues of patients with keratoconus.
Coronary Artery Disease
ACP1 Genetic Polymorphism and Coronary Artery Disease: An Association Study.
ACP1 Genetic Polymorphism and Coronary Artery Disease: Evidence of Effects on Clinical Parameters of Cardiac Function.
Mechanosensitive PPAP2B Regulates Endothelial Responses to Atherorelevant Hemodynamic Forces.
The interaction of ACP1, ADA1, diabetes and gender in coronary artery disease.
Coronary Disease
Serum and erythrocytic acid phosphatase in norms and in coronary heart disease.
Cryptorchidism
The effect of cryptorchidism on the quantitative histology, histochemistry and hydrolytic enzyme activity of the rat testis.
Cushing Syndrome
Enzyme histo-cytochemical studies in human adrenocortical adenomas. [II] Cushing's syndrome.
Cystadenoma, Serous
[A comparison of the enzyme activities of alkaline and acid phosphatase, lactic acid dehydrogenase and leucine aminopeptidase from the wall and fluid of human ovarian follicles, cysts and serous cystadenomas (author's transl)]
Cystic Fibrosis
Diagnosis of cystic fibrosis homozygotes and heterozygotes from plasma and fibroblast cultures. A three-generation family study.
Plasma and submandibular saliva lysosomal enzymes in cystic fibrosis.
[Anomalies of the sperm, vas deferens and epididymis in cystic fibrosis]
[Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis.]
Cysticercosis
The activity of alkaline and acid phosphatase and non-specific esterase in experimental bovine cysticercosis at different stages of development.
Cysts
Bilateral follicular cysts in a water buffalo.
Biochemical analysis of thyroid cyst fluid obtained by fine-needle aspiration.
Dephosphorylation of cyst wall proteins by a secreted lysosomal acid phosphatase is essential for excystation of Giardia lamblia.
Differences and similarities of nurse cells in cysts of Trichinella spiralis and T. pseudospiralis.
Effects of mebendazole, albendazole, and praziquantel on alkaline phosphatase, acid phosphatase, and adenosine triphosphatase of Echinococcus granulosus cysts harbored in mice.
Mixed Epithelial-Stromal Tumor (MEST) of Seminal Vesicle: A Proposal for Unified Nomenclature.
Osteolytic processes in human radicular cysts: morphological and biochemical results.
Submicroscopic localization of acid phosphatase in the dental cyst epithelium.
[A comparison of the enzyme activities of alkaline and acid phosphatase, lactic acid dehydrogenase and leucine aminopeptidase from the wall and fluid of human ovarian follicles, cysts and serous cystadenomas (author's transl)]
[Cytochemical studies on Besnoitia jellisoni cysts. Distribution of acid phosphatase and polysaccharide at the ultrastructural level]
[Periapical odontogenic processes of inflammatory origin. Enzyme activity]
[Studies into carcino-embryonic antigen (CEA) and enzyme activities of alkaline and acid phosphatase in patients with fibrocystic breast disease (author's transl)]
Dehydration
Adrenocortical involvement during diverse stress in soft-shelled turtle Lissemys p. punctata Bonnoterre.
Improvements in dehydration and cement line staining for methacrylate embedded human bone biopsies.
On the involvement of the Golgi apparatus and GERL in processing of secretion products and some enzyme activities in the rat pituitary mammotroph.
[Increase in intracellular acid phosphatase activity in dehydrated Saccharomyces cerevisae yeasts]
[The effect of fixation, dehydration and polymethacrylate imbedding on the results of immuno- and enzymehistochemical studies on lymphatic tissue and bone marrow]
Dementia
Lysosomal enzymes in cerebral atrophy.
Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease.
Dengue
Characterization of serum acid phosphatase associated with dengue hemorrhagic fever.
Dental Plaque
Hydrolysis of triclosan monophosphate by dental plaque and selected species of oral micro-organisms.
Ultrastructural localization of alkaline and acid phosphatase activities in dental plaque.
[Ultrastructural cytochemistry of acid phosphatase and pyrophosphatase in human dental plaque]
Dentigerous Cyst
Identification of RANKL in osteolytic lesions of the facial skeleton.
Dermatitis
Langerhans cells in the immunopathology of contact allergic dermatitis.
Sézary syndrome. Tartrate-resistant acid phosphatase in the neoplastic cells.
[Differential diagnosis of allergic and non-allergic dermatitis by measuring the levels of acid phosphatase in neutrophils and peripheral blood lymphocytes]
Diabetes Mellitus
Acid phosphatase in peripheral blood lymphocyte lysosomes in patients with diabetes mellitus.
Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus.
Bone Turnover Markers as a New Predicting Factor for Non-union After Spinal Fusion Surgery.
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
Phosphatases in human urine with emphasis on the correlation between acid phosphatase and diabetes mellitus.
Skeletal Muscle Mass Index Is Positively Associated With Bone Mineral Density in Hemodialysis Patients.
[Acid phosphatase in lymphocytes of patients with diabetes mellitus complicated by infection]
[Acid phosphatase in the lymphocytes of patients with diabetes mellitus treated with insulin and oral antidiabetics]
Diabetes Mellitus, Experimental
Effect of streptozotocin diabetes on acid phosphatase and selected glycosidase activities of serum and various rat organs.
[Lymphopoietic function of mice with alloxan diabetes]
Diabetes Mellitus, Type 1
Genotypes of cytosolic low-molecular-weight protein-tyrosine-phosphatase correlate with age at onset of type 1 diabetes in a sex-specific manner.
Is there a role of ACP1-ADA1 genetic complex in immune reaction? Association with T1D and with past malarial morbidity.
Diabetes Mellitus, Type 2
Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus.
Low-molecular-weight acid phosphatase (ACP1), obesity, and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus.
MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.
Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms.
Diabetic Retinopathy
Lysosomal enzymes in tear fluids from patients with ocular diseases.
Digestive System Diseases
Comparative characteristics of the cytochemical status of peritoneal and alveolar macrophages in the progeny of female rats with experimental liver disease.
[OCCURRENCE OF RAISED SERUM ACID PHOSPHATASE LEVELS IN PANCREATIC CANCER AND HEPATOBILIARY DISEASES.]
Diphtheria
The effect of receptor rapid-internalization signals on diphtheria toxin endocytosis and cell sensitivity.
[INCREASE OF THE FREE, SOLUBLE AND TOTAL ACTIVITY OF ACID PHOSPHATASE IN THE KIDNEYS OF GUINEA PIGS TREATED WITH DIPHTHERIA TOXIN.]
Disseminated Intravascular Coagulation
[The effect of the lysosomal function of circulating neutrophils on hemostasis and on the morphological changes in the internal organs in the disseminated intravascular coagulation syndrome]
Diverticulum
Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Down Syndrome
Oxidative stress in Portuguese children with Down syndrome.
Parotid saliva enzymes in Down's syndrome.
[Erythrocytic acid phosphatase isoenzyme patterns in Down's syndrome (author's transl)]
Dysgerminoma
Histochemistry of hormonally active ovarian tumors.
Dyslipidemias
ACP1 genotype, glutathione reductase activity, and riboflavin uptake affect cardiovascular risk in the obese.
Ear Diseases
Histochemistry of normal middle ear mucosa.
Eczema
[Differential diagnosis of allergic and non-allergic dermatitis by measuring the levels of acid phosphatase in neutrophils and peripheral blood lymphocytes]
[The interrelationship between changes in the metabolic processes in the leukocytes and the concentration of mediators in the blood of eczema patients]
Embolism
INCREASED SERUM ACID PHOSPHATASE AFTER ARTERIAL EMBOLISM.
Encephalomyelitis, Autoimmune, Experimental
[The activity of proteolytic enzymes and acid phosphatase in nervous tissue at various states of the development of allergic encephalomyelitis]
Endometrial Neoplasms
Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.
Direct interaction of the Krüppel-like family (KLF) member, BTEB1, and PR mediates progesterone-responsive gene expression in endometrial epithelial cells.
Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway.
Precision Therapy for Aggressive Endometrial Cancer by Reactivation of Protein Phosphatase 2A.
Endometriosis
Acid phosphatase locus 1 genetic polymorphism, endometriosis, and allergy.
Cellular components in peritoneal fluid in infertile patients with and without endometriosis.
Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Increased activation of pelvic macrophages in infertile women with mild endometriosis.
Peritoneal fluid in patients with and without endometriosis: prostanoids and macrophages and their effect on the spermatozoa penetration assay.
Total and regional bone mass values and biochemical markers of bone remodeling in endometriosis.
Endotoxemia
Effect of glucocorticoid receptor (GR) blockade on endotoxemia in rats.
Enteritis
Condensed tannins decreased the growth performance and impaired intestinal immune function in on-growing grass carp (Ctenopharyngodon idella).
Dietary gossypol reduced intestinal immunity and aggravated inflammation in on-growing grass carp (Ctenopharyngodon idella).
Dietary iron deficiency impaired intestinal immune function of on-growing grass carp under the infection of Aeromonas hydrophila: Regulation of NF-?B and TOR signaling.
Dietary zinc deficiency reduced growth performance, intestinal immune and physical barrier functions related to NF-?B, TOR, Nrf2, JNK and MLCK signaling pathway of young grass carp (Ctenopharyngodon idella).
Threonine deficiency decreased intestinal immunity and aggravated inflammation associated with NF-?B and target of rapamycin signalling pathways in juvenile grass carp (Ctenopharyngodon idella) after infection with Aeromonas hydrophila.
Enzootic Bovine Leukosis
High yield synthesis of the bovine leukemia virus (BLV) p24 major internal protein in Saccharomyces cerevisiae.
Eosinophilia
Histological and histochemical examinations of myocardium of rats kept on low-magnesium diet and receiving methotrexate.
The effect of uteroferrin and recombinant GM-CSF on hematopoietic parameters in normal female pigs (Sus scrofa).
Eosinophilic Granuloma
Langerhans' cells and macrophages in eosinophilic granuloma. An enzyme-histochemical, enzyme-cytochemical, and ultrastructural study.
Primary eosinophilic granuloma of the frontal lobe.
Epilepsy
Lysosomal acid phosphatase hyperactivity in cobalt epilepsy.
Erysipelas
[Histochemical studies on the alkaline and acid phosphatase content of the synovial tissue of swine with erysipelas]
Essential Hypertension
[Effects of plasmapheresis on lymphocytic energy enzymes in hypertension]
Extranodal Extension
Adverse implications of acid phosphatase levels in the upper range of normal.
Fasciitis
Tartrate-resistant acid phosphatase containing cells in nodular fasciitis, proliferative fasciitis, and proliferative myositis.
Fatty Liver
Biochemical changes associated with the fatty liver syndrome in cows.
Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1.
Favism
Association between ACP(1) genetic polymorphism and favism.
Favism: association with erythrocyte acid phosphatase phenotype.
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Fibroadenoma
Quantitative study of the lysosomes of epithelial cells from human mammary glands and fibroadenoma during proliferative and secretory phase of the menstrual cycle.
Fibrocystic Breast Disease
[Acid phosphatase activity in breast dysplasias and in carcinomas of the breast]
[Studies into carcino-embryonic antigen (CEA) and enzyme activities of alkaline and acid phosphatase in patients with fibrocystic breast disease (author's transl)]
Fibroma
Enzyme histochemical investigations on bone and soft tissue tumours.
Enzyme histochemical study on bone tumors.
Fibromatosis, Gingival
Acid phosphatase and beta-glucuronidase activities in mast cells, macrophages, plasma cells and lymphocytes in gingival fibromatosis.
Fibrosarcoma
LncRNA TUG1 positively regulates osteoclast differentiation by targeting v-maf musculoaponeurotic fibrosarcoma oncogene homolog B.
Fluorosis, Dental
[Rapamycin activates autophagy by inhibiting mTOR pathway to alleviate early osteoporosis in rats with skeletal fluorosis].
Folic Acid Deficiency
Folic acid deficiency impairs the gill health status associated with the NF-?B, MLCK and Nrf2 signaling pathways in the gills of young grass carp (Ctenopharyngodon idella).
Immunity decreases, antioxidant system damages and tight junction changes in the intestine of grass carp (Ctenopharyngodon idella) during folic acid deficiency: Regulation of NF-?B, Nrf2 and MLCK mRNA levels.
Food Hypersensitivity
Development of a BALB/c mouse model for food allergy: comparison of allergy-related responses to peanut agglutinin, ?-lactoglobulin and potato acid phosphatase.
Foodborne Diseases
[The activity of acid phosphatase and its isoenzymes in patients with food poisonings]
Gallstones
Lysosomal enzyme activities in gallbladder mucosa of gallstone-free subjects and patients with gallstones.
Ganglion Cysts
[Protective effect of exogenous glial cell line derived neurotrophic factor on neurons after sciatic nerve injury in rats]
Gastrointestinal Neoplasms
[Electron-microscopic studies of the activity of acid phosphatase reactions in the liver of patients with gastrointestinal cancer]
Gaucher Disease
Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher's and Fabry's disease.
Acid hydrolases in serum from patients with lysosomal disorders.
Acid phosphatase in Gaucher's disease.
Acid phosphatase in spleen tissue-culture in Gaucher's disease.
Acid phosphatase isoenzymes in Gaucher's disease.
Affinity separation of an acid phosphatase from rat tissues and Gaucher spleen with immobilized Cibacron Blue.
Antibodies to porcine uteroferrin used in measurement of human tartrate-resistant acid phosphatase.
Biochemical properties of the tartrate-resistant acid phosphatase activity in Gaucher disease.
Biomarkers in Serbian patients with Gaucher disease.
Bone-marrow-serum acid phosphatase in lipid histocytosis resembling Gaucher's disease.
Changes of serum hexosaminidase for the presumptive diagnosis of type I Gaucher disease in Tay-Sachs carrier screening.
Clinical and biological aspects of acid phosphatase.
Clinical and enzyme studies in Gaucher disease.
Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis.
Correlation of surrogate markers of Gaucher disease. Implications for long-term follow up of enzyme replacement therapy.
Determination of serum acid and alkaline phosphatase using 4-methylumbelliferyl phosphate.
Determination of serum acid phosphatase in Gaucher's disease using 4-methylumbelliferyl phosphate.
Electrophoretic separation of serum acid phosphatase isoenzymes in Gaucher's disease, prostatic carcinoma and multiple myeloma.
Elevation of serum acid phosphatase in Gaucher's disease.
Evaluation of three biochemical markers in the monitoring of Gaucher disease.
Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues.
GAUCHER'S DISEASE (WITH ELEVATED SERUM ACID PHOSPHATASE LEVEL) MASQUERADING AS CIRRHOSIS OF THE LIVER.
High acid phosphatase level indicating Gaucher's disease in patient with prostatism.
Isoenzymes of human prostate acid phosphatase.
Isolation and characterization of a tartrate-sensitive splenic acid phosphatase in Gaucher's disease.
Misdiagnosis of Niemann-Pick disease type C as Gaucher disease.
Multiple forms of acid phosphatase activity in Gaucher's disease.
On the increased serum acid phosphatase in Gaucher's disease.
Pathology of the Gaucher cell.
Pseudo-Gaucher cells in the bone marrow of a patient with Hodgkin's disease.
Serum acid phosphatase in Gaucher disease before and after splenectomy.
Studies on the nature of the increased serum acid phosphatase in Gaucher's disease.
Study of acid phosphatase in sera of Gaucher's disease patients, subcellular tissue fractions and platelet extracts.
Tartrate-resistant acid phosphatase staining of monocytes in Gaucher disease.
Uteroferrin: a progesterone-induced hematopoietic growth factor of uterine origin.
[Activity of acid phosphatase in patients with Gaucher's disease]
[Epidemiologic, clinical, biological and therapeutic aspects of Gaucher disease]
Giant Cell Arteritis
Polymyalgia rheumatica and giant cell arteritis--rational diagnosis and treatment predicated and disordered prostaglandin metabolism.
Giant Cell Tumor of Bone
A study of the acid phosphatase in the cells of bone and soft parts tumors, and of other tumorous conditions.
Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report.
Giant cell tumor of bone: fine structural localization of acid phosphatase.
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Malignant giant cell tumor of bone. Fine structure and localization of acid phosphatase.
Microphotometric quantitation of enzyme activities in giant cell tumor of bone. A case study.
Serum acid phosphatase as a tumour marker in giant cell tumour of bone.
Serum acid phosphatase can be a useful tumour marker for giant cell tumour of bone.
Serum Levels of NTx and TRACP5b in Giant Cell Tumor of Bone and its Clinical Implications.
Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts.
Tartrate-Resistant Acid Phosphatase 5b is a Useful Serum Marker for Diagnosis and Recurrence Detection of Giant Cell Tumor of Bone.
The ultrastructural localization of secretory acid phosphatase in giant cell tumor of bone.
Giant Cell Tumors
A study of the acid phosphatase in the cells of bone and soft parts tumors, and of other tumorous conditions.
Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report.
Enzyme histochemical investigations on bone and soft tissue tumours.
Enzyme histochemical study on bone tumors.
Functional and biochemical characterization of osteoclast-like cells derived from giant cell tumours of bone.
Giant cell tumor of bone. Variations in patterns of appearance of different cell types.
Giant cell tumor of bone: fine structural localization of acid phosphatase.
Giant cell tumors: inquiry into immunohistochemical expression of CD117 (c-Kit), microphthalmia transcription factor, tartrate-resistant acid phosphatase, and HAM-56.
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Malignant giant cell tumor of bone. Fine structure and localization of acid phosphatase.
Microphotometric quantitation of enzyme activities in giant cell tumor of bone. A case study.
New model for bone resorption study in vitro: human osteoclast-like cells from giant cell tumors of bone.
Osteoclast origin of giant cells in giant cell tumors of bone: ultrastructural and cytochemical study of six cases.
Serum acid phosphatase as a tumour marker in giant cell tumour of bone.
Serum acid phosphatase can be a useful tumour marker for giant cell tumour of bone.
Serum Levels of NTx and TRACP5b in Giant Cell Tumor of Bone and its Clinical Implications.
Serum total acid phosphatase for monitoring the clinical course of giant cell tumors of bone--26 patients with 5 local recurrences.
Size dependent enzyme activities of multinucleated (osteoclastic) giant cells in bone tumors.
Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts.
Tartrate-Resistant Acid Phosphatase 5b is a Useful Serum Marker for Diagnosis and Recurrence Detection of Giant Cell Tumor of Bone.
The ultrastructural localization of secretory acid phosphatase in giant cell tumor of bone.
[Demonstration of osteoclastic acid phosphatase in the serum of patients with giant cell tumors. Preliminary study]
Gingivitis
Alkaline phosphatase and acid phosphatase levels in saliva and serum of patients with healthy periodontium, gingivitis, and periodontitis before and after scaling with root planing: A clinico-biochemical study.
[Acid phosphatase of the human gingiva in health and in chronic catarrhal and hypertrophic gingivitis, and in alveolar pyorrhea]
Glaucoma
[Chemiluminescence and activity of acid phosphatase in the drainage zone of the eye in glaucoma patients]
[The acid phosphatase, alkaline phosphatase, lactate dehydrogenase, and succinate dehydrogenase in the endothelium on the trabecular meshwork in primary glaucoma]
Glioblastoma
Acid and alkaline phosphatase activities in homogenates and subcellular fractions of human brain tumors.
How reliable are in vitro IC50 values? Values vary with cytotoxicity assays in human glioblastoma cells.
Increased activity of lysosomal glycohydrolases in glioma tissue and surrounding areas from human brain.
Glioma
Lysosomal isozyme patterns in ethylnitrosourea-induced brain tumors.
Modification of opioid receptor activity by acid phosphatase in neuroblastoma x glioma NG108-15 hybrid cells.
Glomerulonephritis
A case of congenital nephrotic syndrome associated with partial deficiency of lecithin cholesterol acyltransferase (LCAT) and hypothyroidism.
Changes in lysosome populations in the rat kidney cortex induced by passive Heymann glomerulonephritis.
Enzyme histochemistry in plastic-embedded sections of normal and diseased kidneys.
Histochemistry of glomerular cells in animal models of crescentic glomerulonephritis.
Intracellular routes of a lysosome marker enzyme, acid phosphatase, in proximal convoluted tubule cells of human kidney in glomerulonephritis as studied by electron cytochemistry.
Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?
glucan 1,4-alpha-glucosidase deficiency
Adult-onset acid maltase deficiency in siblings.
Episodic weakness and vacuolar myopathy in hypokalemic periodic paralysis.
glucose-6-phosphate dehydrogenase (nadp+) deficiency
Association between ACP(1) genetic polymorphism and favism.
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Glucosephosphate Dehydrogenase Deficiency
Association between ACP(1) genetic polymorphism and favism.
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Glycogen Storage Disease Type II
Adult-onset acid maltase deficiency in siblings.
Combination of acid phosphatase positivity and rimmed vacuoles as useful markers in the diagnosis of adult-onset Pompe disease lacking specific clinical and pathological features.
Episodic weakness and vacuolar myopathy in hypokalemic periodic paralysis.
Prevalence of adult Pompe disease in patients with proximal myopathic syndrome and undiagnosed muscle biopsy.
Goiter
[Acid phosphatase of leukocytes in patients with diffuse toxic goiter in evaluating the stage of the disease]
Gonorrhea
[Study of the activity of acid phosphatase in biological materials from patients with gonorrhea]
Granuloma
Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells.
Cherubism. Histo-enzymological and ultrastructural study.
Histochemical analysis of experimental granulomatous uveitis.
Increased resistance to mycobacterial infection in the absence of interleukin-10.
Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2.
Studies of heterogeneity of angiotensin-converting enzyme and acid phosphatase in granulomatous lesions of skin.
T-cell subsets in cutaneous sarcoidosis.
The anti-inflammatory activity of Enicostemma littorale and Mollugo cerviana.
The sulphokinase, arylsulphatase-B and acid phosphatase activities of carrageenin granuloma in rats of different ages.
Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guérin infection in the absence of secreted TNF and lymphotoxin-alpha.
[Histochemical study on experimental silicotic granuloma; succinic dehyrogenase and acid phosphatase.]
[Periapical odontogenic processes of inflammatory origin. Enzyme activity]
Granulomatous Disease, Chronic
Acid Phosphatase Cytochemistry of Phagocytizing Leukocytes from Patients with Chronic Granulomatous Disease.
Bone turnover markers and the factors associated with atypical femur fractures among Japanese patients.
Hearing Loss
TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction.
Heart Arrest
Evaluation of hypoxic brain injury with spinal fluid enzymes, lactate, and pyruvate.
Postmortem changes in stereological parameters of cerebral neurons.
[Characteristics of the activation of lysosomal enzymes in the rat liver after death and during resuscitation]
Heart Failure
An unusual alkaline phosphatase isoenzyme in a patient with concomitant marked elevation of acid phosphatase without clinical evidence of prostatic carcinoma.
Histochemical and ultrastructural alterations of lysosomes and acid phosphatase reaction in human chronic hypoxic myocardium.
Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure.
Hemangioma
Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK.
Hemangioma, Cavernous, Central Nervous System
A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein.
Hemochromatosis
Acid hydrolase activities and lysosomal integrity in liver biopsies from patients with iron overload.
Hemospermia
Transrectal ultrasound in early detection of clinical stage A prostate cancer.
Hepatitis
BETA-GLUCURONIDASE AND ACID PHOSPHATASE ACTIVITIES OF LYSOSOMAL PREPARATIONS FROM HUMAN LIVER TISSUE OBTAINED BY NEEDLE BIOPSY FROM SUBJECTS WITH ACUTE HEPATITIS AND CIRRHOSIS.
Lysosomal enzyme activities in normals and in patients with chronic liver diseases.
Prostatic acid phosphatase and prostate specific antigen in liver disease.
[Activity of lysosomal enzymes acid phosphatase and beta-glucuronidase in patients with viral hepatitis]
[Change in the state of liver lysosomes and lymphocytes during development of secondary immunodeficiency and in chronic toxic hepatitis]
[Effect of mellaril on the liver lysosomes of rats with acute toxic hepatitis]
[The activities of acid phosphatase (ACP) and Mg++ adenosine triphosphatase in acute hepatitis with submassive necrosis]
[The significance of E and EAC rosettes, acid phosphatase and beta-glucuronidase activity in lymphocyte rosettes, and the level of glycogen in peripheral blood leukocytes in patients with viral hepatitis]
Hepatitis B
Controlled fed-batch fermentation of recombinant Saccharomyces cerevisiae to produce hepatitis B surface antigen.
Expression of hepatitis B surface antigen gene in yeast.
Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons.
Expression of the hepatitis B surface antigen gene containing the preS2 region in Saccharomyces cerevisiae.
Hepatitis C
Host phosphatidic acid phosphatase lipin1 is rate limiting for functional hepatitis C virus replicase complex formation.
Hepatitis, Chronic
Lysosomal enzyme activities in normals and in patients with chronic liver diseases.
Prostatic acid phosphatase and prostate specific antigen in liver disease.
[The activity of alkaline and acid phosphatase in chronic hepatitis and cirrhosis of the liver]
Hepatolenticular Degeneration
Electron probe microanalysis of liver in Wilson's disease. Simultaneous assay for copper and for lead deposited by acid phosphatase activity in lysosomes.
Studies on the pathogenesis of hepatolenticular degeneration. I. Acid phosphatase activity in copper-loaded rat livers.
Hepatomegaly
Associations between polymorphic variety and disease susceptibility in two New Guinea populations.
Massive hepatomegaly and an elevated serum acid phosphatase associated with a retrovesical carcinoma.
Herpes Simplex
Expression of herpes simplex virus glycoprotein B gene in yeast.
Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. III. Cytochemical localization of lysosomal enzymes in infected cells.
Influence of 2,4,6-triamino-pyrimidyl-5-azobenzene on the activities of acid phosphatase, alkaline phosphatase and lactate dehydrogenase in cell cultures infected with herpes simplex virus type 1.
Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.
[Comparative analysis of functional activity of peripheral blood phagocytes in HIV-infected patients and in those with recurrent herpes simplex]
Herpes Zoster
Linkage assignment of eleven genes to the porcine genome.
[Effects of infrasound on activities of 3beta hydroxysteroid dehydrogenase and acid phosphatase of polygonal cells in adrenal cortex zona fasciculate in mice]
Hirschsprung Disease
Light and electronmicroscopy of the bowel in an unusual form of Hirschsprung's disease.
Histiocytic Sarcoma
Malignant histiocytosis with unusual features. Disseminated intravascular coagulation with severe hyperfibrinolysis, acute polyneuroradiculitis Guillain-Barré, and a unique chromosome abnormality.
Malignant histiocytosis: a clinical, histologic, and immunohistochemical study of 20 cases.
Histiocytoma, Malignant Fibrous
Enzyme histochemical study on bone tumors.
Primary malignant fibrous histiocytoma of skin.
[Determination of tartrate-resistant acid phosphatase in malignant fibrous histiocytomas. Studies of routine formalin-fixed and paraffin-embedded material]
[The ultrastructure and histochemical characteristics of the cells of malignant fibrous histiocytoma in rats]
Histiocytosis
Increasing values of serum acid phosphatase in a child with Mycoplasma pneumoniae-associated hemophagocytic histiocytic syndrome.
Neuromuscular manifestations of L-tryptophan-associated eosinophilia-myalgia syndrome: a histomorphologic analysis of 14 patients.
Histiocytosis, Langerhans-Cell
Histiocytosis X cells and Langerhans cells: enzyme histochemical and immunologic similarities.
HIV Infections
A Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection.
Bacterial curli protein promotes the conversion of PAP248-286 into the amyloid SEVI: cross-seeding of dissimilar amyloid sequences.
Impact of semen-derived amyloid (SEVI) on sperm viability and motility: its implication in male reproductive fitness.
Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection.
The Surprising Role of Amyloid Fibrils in HIV Infection.
Hodgkin Disease
Acid phosphatase activity in monocytes and sera of patients with Hodgkin's disease.
Activity and intracellular localization of lysosomal acid phosphatase in lymphocytes from patients with Hodgkin's disease, plasma cell myeloma and primary polycythemia.
Cytochemical, ultrastructural and immunological studies of circulating Reed-Sternberg cells.
Disordered macrophage development in Hodgkin's disease shown by quantitative cytochemistry.
Histochemistry of Hodgkin's disease.
Multienzymatic analyses of human malignant lymphomas. Correlation of enzymatic data with pathologic and ultrastructural findings in Burkitt's and lymphoblastic lymphomas.
Study of the acid phosphatase and the RNA with a view to the morphologic diagnosis of Hodgkin's disease.
[Granulocyte acid phosphatase activity in patients with Hodgkin's disease]
[The rosette test with sensitized sheep erythrocytes, acid phosphatase and alpha-naphthylacetate esterase in an acid medium: comparative immunocytochemical T-cell exhibition in Hodgkin's disease]
Huntington Disease
Acid-beta-glycerophosphatase reaction products in the central nervous system mitochondria following x-ray irradiation.
Hutchinson's Melanotic Freckle
Histochemical findings in different types of malignant melanoma: biological and clinical significance.
Hydronephrosis
Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiation.
Hyperaldosteronism
Enzyme histocytochemical studies in human adrenocortical adenomas. [I]. Primary aldosteronism.
Hypercalcemia
Malignant histiocytosis with unusual features. Disseminated intravascular coagulation with severe hyperfibrinolysis, acute polyneuroradiculitis Guillain-Barré, and a unique chromosome abnormality.
The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.
Hypercholesterolemia
Soy milk powder supplemented with phytosterol esters reduced serum cholesterol level in hypercholesterolemia independently of lipoprotein E genotype: a random clinical placebo-controlled trial.
Hyperemia
Toxicity assessment of pyriproxyfen in vertebrate model zebrafish embryos (Danio rerio): A multi biomarker study.
Hypergammaglobulinemia
[Cytochemical studies of bone marrow plasma cells in monoclonal gammapathies (author's transl)]
Hyperglycemia
Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus.
Hyperglycemia alters enzyme activity and cell number in spinal sensory ganglia.
Hyperinsulinism
Circulating levels of tartrate-resistant acid phosphatase in rat models of non-insulin-dependent diabetes mellitus.
Hyperlipidemias
[The preanalytical stage of under measuring of concentration of catalytic activity of enzymes: the characteristics and tasks of standardization].
Hyperparathyroidism
Biochemical markers of bone turnover.
Bone mass protective potential mediated by bovine milk basic protein requires normal calcium homeostasis in mice.
Immunoassay of a tartrate-resistant acid phosphatase in serum.
Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.
Serum Bone Resorption Markers after Parathyroidectomy for Renal Hyperparathyroidism: Correlation Analyses for the Cross-Linked N-telopeptide of Collagen I and Tartrate-Resistant Acid Phosphatase.
[Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia]
Hyperparathyroidism, Primary
Beta-2-microglobulin in diseases with high bone remodeling.
Osteoclast cytomorphometry in patients with femoral neck fracture.
Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.
Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis.
[Quasi-distribution-free multivariate assessment of clinico-chemical patient data using of van der Waerden's X-transformation]
Hyperparathyroidism, Secondary
Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone.
Effects of Calcitriol on Type 5b Tartrate-Resistant Acid Phosphatase and Interleukin-6 in Secondary Hyperparathyroidism.
Endosteal surfaces in hyperparathyroidism: an enzyme cytochemical study on low-temperature-processed, glycol-methacrylate-embedded bone biopsies.
News on biomarkers in CKD-MBD.
Serum Bone Resorption Markers after Parathyroidectomy for Renal Hyperparathyroidism: Correlation Analyses for the Cross-Linked N-telopeptide of Collagen I and Tartrate-Resistant Acid Phosphatase.
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
Hypersensitivity
Acid phosphatase locus 1 genetic polymorphism, endometriosis, and allergy.
BCG adjuvant immunotherapy in carcinoma of the prostate: an interim report.
Diagnosis of quinine hypersensitivity, use of platelet factor 3 and acid phosphatase availability tests.
Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade.
Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3).
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy.
Raf60, a novel component of the Rpd3 histone deacetylase complex required for Rpd3 activity in Saccharomyces cerevisiae.
RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae.
Studies of heterogeneity of angiotensin-converting enzyme and acid phosphatase in granulomatous lesions of skin.
The role of Langerhans cells in Pseudomonas aeruginosa infection.
The study of the acid phosphatase of macrophagal lysosomes in delayed-type hypersensitivity.
[Acid phosphatase determination in macrophages in delayed type hypersensitivity]
[Characteristics of the course of bronchitis in allergy]
[Permeability of cutaneous macrophage lysosomal membrane in delayed hypersensitivity to streptococcal antigens]
[Study of macrophage lysosomal acid phosphatase in hypersensitivity of the delayed type]
Hypertension
Acid phosphatase activity in the aorta of spontaneously hypertensive rats and the effect of various antihypertensive drugs.
Aromatic L-amino acid decarboxylase, dopamine beta-hydroxylase, monoamine oxidase, malondialdehyde, and acid phosphatase in rat brain capillaries and kidney glomeruli in experimental hypertension.
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
Determining the association between hypertension and bone metabolism markers in osteoporotic patients.
Healing process of autogenous bone graft in spontaneously hypertensive rats treated with losartan: an immunohistochemical and histomorphometric study.
Semiquantitative histochemical investigation of lysosomal enzyme activities in the aortic endothelial cells of rats with renal hypertension.
Skeletal Muscle Mass Index Is Positively Associated With Bone Mineral Density in Hemodialysis Patients.
[Determination of dehydrogenase and acid phosphatase activity in the lymphocytes in hypertension and vasorenal hypertension]
[The contribution of radio-isotopes to urological investigation (author's transl)]
Hypertension, Renal
Semiquantitative histochemical investigation of lysosomal enzyme activities in the aortic endothelial cells of rats with renal hypertension.
Hyperthyroidism
Beta-2-microglobulin in diseases with high bone remodeling.
Dorsolateral prostatic phosphomonoesterases and adenosine triphosphatases in hypo- and hyperthyroid rats.
Effect of thyroid hormones on activity of nonspecific phosphohydrolases in blood serum, tissues and liver mitochondrial fraction of white rat.
Energy Metabolism in the Bone is Associated with Histomorphometric Changes in Rats with Hyperthyroidism.
Hypothyroidism and hyperthyroidism change ectoenzyme activity in rat platelets.
Immunoassay of a tartrate-resistant acid phosphatase in serum.
Thyroid function and bone turnover.
Ventral prostatic phosphomonoesterases and adenosine triphosphatases in hypo- and hyperthyroid albino rats.
[A histochemical study of gastric adenosine triphosphatase, alkaline and acid phosphatase in experimental hypo- and hyperthyroidism]
[Serum levels of the tartrate-resistant isoenzyme, acid phosphatase, for the evaluation of bone remodeling in hyperthyroidism]
[The parathyroid function in patients with hyperthyroidism]
Hypocalcemia
Osteopetrorickets. The paradox of plenty. Pathophysiology and treatment.
The pathogenesis of infantile malignant osteopetrosis: bone mineral metabolism and complications in five infants.
Hypoglycemia
Protective effects of aspirin in endotoxic shock.
Hypogonadism
A critical estimation of the effect of chorionic gonadotropic hormone treatment on male hypogonadism by prostatic production of acid phosphatase.
Hypokalemia
Renal tubular acidosis, hypokalemia, and acid phosphatase.
Hypokinesia
Effects of a seven-day hypokinesia on the digestive tract of nonpregnant and pregnant rats.
Hypophosphatemia
Osteopetrorickets. The paradox of plenty. Pathophysiology and treatment.
The pathogenesis of infantile malignant osteopetrosis: bone mineral metabolism and complications in five infants.
Hypotension
Changes in plasma levels of lysosomal and non lysosomal enzymes during hemorrhagic hypotension.
Hypothyroidism
Dorsolateral prostatic phosphomonoesterases and adenosine triphosphatases in hypo- and hyperthyroid rats.
Effect of altered thyroid status on lysosomal enzymes and thymidylate synthetase activity in tumors and livers of host animals.
Hypothyroidism and hyperthyroidism change ectoenzyme activity in rat platelets.
Interleukin-6 is not essential for bone turnover in hypothyroid mice.
Specific activities of seminal vesicular phosphomonoesterases and Mg2+-,Ca2+- and Na+/K(+)-adenosine triphosphatases in hypo- and hyperthyroid albino rats.
[Blast transformation and the activity of acid phosphatase of circulating lymphocytes in experimental hypothyroidism]
[Cytochemical examination of peripheral blood neutrophils of patients with hypothyroidism]
Hypoxia-Ischemia, Brain
The cytochemistry of anoxic and anoxic-ischemic encephalopathy in rats. I. Alterations in neuronal lysosomes identified by acid phosphatase activity.
Idiopathic Pulmonary Fibrosis
Circulating levels of tartrate-resistant acid phosphatase in macrophage-activated lung disease.
Ileus
[Changes in the activity of lysosomal enzymes in experimental ileus]
Immune System Diseases
Acid phosphatase locus 1 genetic polymorphism, endometriosis, and allergy.
ACP1 Genetic Polymorphism and Coronary Artery Disease: An Association Study.
Infections
An isoenzyme marker possibly associated with the susceptibility of Biomphalaria glabrata populations to Schistosoma mansoni.
Antioxidant and immune responses of the Oriental river prawn Macrobrachium nipponense to the isopod parasite Tachaea chinensis.
Bioinformatics analysis on the differentiation of bone mesenchymal stem cells into osteoblasts and adipocytes.
Canine bone marrow cell cultures infected with canine distemper virus: an in vitro model of Paget's disease.
Change in the isoenzyme composition of acid phosphatase in murine peritoneal macrophages exposed to or infected with Trypanosoma cruzi.
Changes in blood chemical components during experimentally induced Theileria annulata infections in cattle.
Changes in lysosomal enzymes of peritoneal exudate cells in albino rats and Mastomys natalensis during Plasmodium berghei infection.
Characterization of the inflammatory cells in progressing tumor-like alveolar hydatid cyst. 2. Cell surface receptors, endocytosed immune complexes and lysosomal enzyme content.
Comparative development of Brugia pahangi and variation in acid hydrolase enzyme titers in.
Comparison of protein profiles and enzymes in non-mycorrhizal and mycorrhizal roots of Pennisetum pedicellatum.
Coxiella burnetii exhibits morphological change and delays phagolysosomal fusion after internalization by J774A.1 cells.
Decrease of acid phosphatase activity in murine peritoneal macrophages infected with Leishmania donovani.
Design and characterization of high-affinity synthetic peptides as bioreceptors for diagnosis of cutaneous leishmaniasis.
Diagnostic value of determination of acid and alkaline phosphatase levels in the seminal plasma of infertile males.
Dietary Choline-Enhanced Skin Immune Response of Juvenile Grass Carp Might Be Related to the STAT3 and NF-kB Signaling Pathway (Ctenopharyngodon idella).
Dietary iron deficiency impaired intestinal immune function of on-growing grass carp under the infection of Aeromonas hydrophila: Regulation of NF-?B and TOR signaling.
Dietary vitamin C deficiency depressed the gill physical barriers and immune barriers referring to Nrf2, apoptosis, MLCK, NF-?B and TOR signaling in grass carp (Ctenopharyngodon idella) under infection of Flavobacterium columnare.
Different secreted phosphatase activities in Leishmania amazonensis.
Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas.
Dynamics of arbuscular mycorrhizal fungi and glomalin in the rhizosphere of Artemisia ordosica Krasch. in Mu Us sandland, China
Early transcriptional response to the parasitic dinoflagellate Hematodinium in hepatopancreas of Portunus trituberculatus.
Effect of enterotoxigenic Escherichia coli heat stable toxin on intestinal lysosomal enzymes in the suckling rat.
Effect of entomopathogenic nematode of Heterorhabditis indica infection on immune and antioxidant system in lepidopteran pest Spodoptera litura (Lepidoptera: Noctuidae).
Effect of lead and ancylostomiasis on phosphatases of heart in Swiss albino mice.
Effects of hesperidin on the growth performance, antioxidant capacity, immune responses and disease resistance of red swamp crayfish (Procambarus clarkii).
Effects of Specific Electric Field Stimulation on the Release and Activity of Secreted Acid Phosphatases from Leishmania tarentolae and Implications for Therapy.
Elevated total and isoenzyme forms of acid phosphatase in falciparum malaria.
Enzymatic study of tonsil tissue alkaline and acid phosphatase in children with recurrent tonsillitis and tonsil hypertrophy.
Fate of Mycobacterium tuberculosis inside rat peritoneal macrophages in vitro.
Fibrils of Prostatic Acid Phosphatase Fragments Boost Infections by XMRV, a Human Retrovirus Associated with Prostate Cancer.
Flavin metabolism during respiratory infection in mice.
Functional changes in murine macrophages infected with cytomegalovirus relate to H-2-determined sensitivity to infection.
Heterologous expression and characterization of recombinant purple acid phosphatase from red kidney bean.
HIV-1 enhancing effect of prostatic acid phosphatase peptides is reduced in human seminal plasma.
HIV-1 replicates in human osteoclasts and enhances their differentiation in vitro.
Immunochemical identification of a new molecular form of acid phosphatase of host origin arising during infection of potato tubers by Phytophthora erythroseptica Pethybr.
In vivo and in vitro analysis of lysosomes and acid phosphatase activity in human chagasic placentas.
Infection of epithelial cells by pathogenic neisseriae reduces the levels of multiple lysosomal constituents.
Influence of Vesicular-Arbuscular Mycorrhizal Fungi on the Response of Potato to Phosphorus Deficiency.
Legionella pneumophila major acid phosphatase and its role in intracellular infection.
Leishmania mexicana: a cytochemical and quantitative study of lysosomal enzymes in infected rat bone marrow-derived macrophages.
Leishmanial protein kinase C modulates host cell infection via secreted acid phosphatase.
Liver phosphatases in mice treated with lead during murine ancylostomiasis.
Lysosomal enzyme activities in susceptible and refractory strains of Biomphalaria glabrata during the course of infection with Schistosoma mansoni.
Lysosomal enzyme in Mastomys natalensis during Dipetalonema viteae infection.
Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetii.
Mesoporous bioactive glasses equipped with stimuli-responsive molecular gates for the controlled delivery of levofloxacin against bacteria.
Modulation of lysosomal protease-esterase and lysozyme in Kupffer cells and peritoneal macrophages infected with Nocardia asteroides.
Mycobacterial growth and ultrastructure in mouse L-929 fibroblasts and bone marrow-derived macrophages: evidence that infected fibroblasts secrete mediators capable of modulating bacterial growth in macrophages.
Observations on natural and experimental interactions between Schistosoma bovis and S. curassoni from West Africa.
Permeability changes of plasma and lysosomal membranes in HeLa cells infected with rabbit poxvirus.
Proteomic Characterization and Functional Analysis of Outer Membrane Vesicles of Francisella novicida Suggests Possible Role in Virulence and Use as a Vaccine.
Qualitative and quantitative histochemical changes in the caecum and liver of turkeys infected with Histomonas meleagridis.
Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.
Reversible decrease of fluoride resistant acid phosphatase-positive neurons after herpes simplex virus infection.
SapM mutation to improve the BCG vaccine: Genomic, transcriptomic and preclinical safety characterization.
Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
Seminal plasma zinc and magnesium in infertile men.
Spleen and kidney of Atlantic salmon (Salmo salar L.) show histochemical changes early in the course of experimentally induced infectious salmon anaemia (ISA).
The Acid Phosphatase AcpA Is Secreted In Vitro and in Macrophages by Francisella spp.
The activity of alkaline and acid phosphatase and non-specific esterase in experimental bovine cysticercosis at different stages of development.
The effect of human cytomegalovirus on selected functions of peripheral blood monocytes.
The Secreted Acid Phosphatase Domain-Containing GRA44 from Toxoplasma gondii Is Required for c-Myc Induction in Infected Cells.
Trichinella spp.: differential expression of acid phosphatase and myofibrillar proteins in infected muscle cells.
Trypanosoma cruzi-secreted vesicles have acid and alkaline phosphatase activities capable of increasing parasite adhesion and infection.
[Acid phosphatase in lymphocytes of patients with diabetes mellitus complicated by infection]
[Automatic detection and clinical application of semen biochemical markers].
[Biochemical changes in the blood of geese infected with Borrelia anserina]
[Changes in the serum acid phosphatase activity of guinea pigs poisoned with C1 perfringens type A toxin and a mixture of toxin and a broth culture filtrate]
[Comparative analysis of functional activity of peripheral blood phagocytes in HIV-infected patients and in those with recurrent herpes simplex]
[Cytochemical study of granulocyte enzymes in germ-free animals with adenovirus infections]
[Cytomorphological and cytochemical studies on the multiplication of bovine reovirus type 1 in a cell culture]
[Enzyme, enzyme-histochemical and immunohistological studies in chronic erysipelas polyarthritis of swine]
[High dose of enzyme replacement therapy was successful for the pulmonary involvement in a case of type 2 Gaucher disease].
[Study of lysosomal enzymes in chick embryo fibroblasts infected with microorganisms of family Halprowiaceae (Chlamydiaceae)]
Infectious Mononucleosis
[Acid phosphatase isoenzyme, beta-glucuronidase and non-specific esterase activity in certain morphological groups of atypical mononuclear cells in circulating blood in infectious mononucleosis]
Infertility
Seminal acid phosphatase in relation to fertility.
Seminal fluid acid phosphatase in sterility.
[Clinical and experimental studies on male infertility. 2. Experimental studies. Histochemical demonstration of acid phosphatase activity in the testes of mice and their responce to the drugs for the male infertility (author's transl)]
[Role of spermatic plasma enzyme in pathogenesis of relative male sterility]
[Zinc in the seminal plasma in infertile men]
Infertility, Male
Biochemical analysis of the sperm and infertility.
Seminal plasma fructose, zinc, magnesium and acid phosphatase in cases of male infertility.
[Analyse of zinc and acid phosphatase in seminal plasma and sperm parameters of infertile male]
[Clinical and experimental studies on male infertility. 2. Experimental studies. Histochemical demonstration of acid phosphatase activity in the testes of mice and their responce to the drugs for the male infertility (author's transl)]
Influenza, Human
A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer.
Acid phosphatase 2 (ACP2) is required for membrane fusion during influenza virus entry.
Characterization of serum lysosomal enzymatic activities. III. Effect of infectious influenza in Egyptian equines.
Inhibition of neutrophil lysosome-phagosome fusion associated with influenza virus infection in vitro. Role in depressed bactericidal activity.
[Activity of blood serum and organic acid phosphatase and of nucleotidase in the mouse organs following exposure of the organism to the toxic effect of influenza virus.]
[Effect of influenza on activities of nucleotidase and acid phosphatase in mouse organs.]
Insulin Resistance
Co-administration of omega-3 fatty acids and metformin showed more desirable effects than the single therapy on indices of bone mineralisation but not gluco-regulatory and antioxidant markers in diabetic rats.
Effects of bariatric weight loss surgery on glucose metabolism, inflammatory cytokines, and serum tartrate-resistant acid phosphatase 5a in obese Chinese adults.
Effects of exercise on insulin sensitivity, inflammatory cytokines, and serum tartrate-resistant acid phosphatase 5a in obese Chinese male adolescents.
Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans.
TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1.
Zinc-?2-Glycoprotein Modulates AKT-Dependent Insulin Signaling in Human Adipocytes by Activation of the PP2A Phosphatase.
[Erythrocytic acid phosphatase genetic polymorphism and cardiovascular risk in health children and adolescents]
Intestinal Volvulus
Acid phosphatase patterns in microfilariae of Onchocerca volvulus s.l. from the Upper Orinoco Basin, Venezuela.
Histochemical enzyme-staining patterns of onchocerca volvulus microfilariae and their occurrence in different onchocerciasis areas.
The development of Onchocerca ochengi in surrogate temperate Simuliidae, with a note on the infective larva.
Iron Deficiencies
Dietary iron deficiency impaired intestinal immune function of on-growing grass carp under the infection of Aeromonas hydrophila: Regulation of NF-?B and TOR signaling.
The decreased growth performance and impaired immune function and structural integrity by dietary iron deficiency or excess are associated with TOR, NF-?B, p38MAPK, Nrf2 and MLCK signaling in head kidney, spleen and skin of grass carp (Ctenopharyngodon idella).
The impaired immune function and structural integrity by dietary iron deficiency or excess in gill of fish after infection with Flavobacterium columnare: Regulation of NF-?B, TOR, JNK, p38MAPK, Nrf2 and MLCK signalling.
Iron Overload
Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.
Studies on the rat liver following iron overload. Electron probe x-ray microanalysis of acid phosphatase and iron.
Ischemic Stroke
Long Noncoding RNA-H19 Contributes to Atherosclerosis and Induces Ischemic Stroke via the Upregulation of Acid Phosphatase 5.
Jaundice, Neonatal
Enzyme variability and neonatal jaundice. The role of adenosine deaminase and acid phosphatase.
Joint Diseases
[Clinical studies of intra-articular injections of Arteparon. Retrospective study following the treatment of 754 patients]
Keratitis
Species identification and molecular characterization of Acanthamoeba isolated from contact lens paraphernalia.
Keratoconus
Cathepsin G, acid phosphatase, and alpha 1-proteinase inhibitor messenger RNA levels in keratoconus corneas.
Involvement of Sp1 elements in the promoter activity of genes affected in keratoconus.
Kruppel-like factor 6 (KLF6) affects the promoter activity of the alpha1-proteinase inhibitor gene.
Lysosomal enzyme abnormalities in keratoconus.
Lysosomal enzyme activities in conjunctival tissues of patients with keratoconus.
Keratosis, Seborrheic
Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelioma, and seborrheic keratosis.
Ketosis
[Experimental studies on the ketogenic effect of high doses of proteins in dairy cows]
Kidney Diseases
Evaluation of serum acid phosphatase study in kidney diseases.
SERUM ACID PHOSPHATASE AS AN INDEX OF KIDNEY DISEASE.
Study of serum acid phosphatase in children with kidney diseases.
[The serum acid phosphatase in kidney diseases. Preliminary report]
[Urinary acid phosphatase and beta-glucuronidase activities in kidney diseases and following kidney transplantation]
Kidney Failure, Chronic
A distinct bone phenotype in ADPKD patients with end-stage renal disease.
Activity of some lysosomal enzymes in peritoneal macrophages of patients with end-stage renal failure treated by intermittent peritoneal dialysis.
Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Changes in activity of selected lysosomal enzymes in peritoneal macrophages of renal failure patients on peritoneal dialysis.
Circulating biochemical markers of bone remodeling in uremic patients.
Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
Disease-specific expression of tartrate-resistant acid phosphatase isoforms.
Immunoassay of a tartrate-resistant acid phosphatase in serum.
New Biochemical Serum Markers of Boneturnover in Renal Osteodystrophy.
Study of the activity of erythrocyte acid phosphatase in chronic renal failure.
Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease.
Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
Tumor markers in patients with chronic renal failure.
[Biochemical markers of bone metabolism and bone tissue losses after allotransplantation of the cadaveric kidney: a cross-sectional]
[Study of tartrate resistant acid phosphatase in patients with chronic renal failure on maintenance hemodialysis]
[Total activity of glucosaminidase and acid phosphatase and its isoenzymes in the serum and urine of children with chronic renal failure]
Kidney Neoplasms
Enzyme histochemistry in plastic-embedded sections of normal and diseased kidneys.
Laryngeal Neoplasms
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Intracellular enzymatic response of lymphocytes and neutrophils in patients with cancer of the larynx.
[Lysosomal acid phosphatase of lymphocytes in patients with cancer of the larynx (authors transl)]
Legionnaires' Disease
In vitro secretion kinetics of proteins from Legionella pneumophila in comparison to proteins from non-pneumophila species.
Leiomyoma
Is there an association between uterine leiomyomas and acid phosphatase locus 1 polymorphism?
Leiomyosarcoma
Leiomyosarcoma of the heart and its pulmonary metastasis, both with prominent osteoclast-like multinucleated giant cells expressing tartrate-resistant acid phosphatase activity.
Osteoclast-like cells in soft tissue leiomyosarcomas.
Leishmaniasis
Design and characterization of high-affinity synthetic peptides as bioreceptors for diagnosis of cutaneous leishmaniasis.
[Enzymes of the peripheral blood leukocytes from the vertebrate host in an experimental Leishmania infection. 1. Neutrophil acid phosphatase]
Leishmaniasis, Cutaneous
Effect of Prophylactic Vaccination with the Membrane-Bound Acid Phosphatase Gene of Leishmania mexicana in the Murine Model of Localized Cutaneous Leishmaniasis.
Effects of Specific Electric Field Stimulation on the Release and Activity of Secreted Acid Phosphatases from Leishmania tarentolae and Implications for Therapy.
[Enzymes of the peripheral blood leukocytes from the vertebrate host in an experimental Leishmania infection. 1. Neutrophil acid phosphatase]
Leprosy
Electron microscopy of peroxidase and acid phosphatase in leprous and uninfected armadillo macrophages: a macrophage subpopulation contains peroxisomes and lacks bacilli.
Genetic markers and leprosy in South African negroes: Part II. Erythrocyte enzyme polymorphisms.
Macrophage function in leprosy.
Phagocytosis in leprosy. I. The levels of "diaphorase", beta-glucuronidase, acid phosphatase, alkaline phosphatase and lipase in circulating leucocytes.
Semen biochemistry of leprosy patients.
Leprosy, Lepromatous
Semen biochemistry of leprosy patients.
Leprosy, Paucibacillary
Semen biochemistry of leprosy patients.
Leukemia
(-)-Epiafzelechin Protects against Ovariectomy-induced Bone Loss in Adult Mice and Modulate Osteoblastic and Osteoclastic Functions In Vitro.
A customized retroviral vector confers marker gene expression in osteoclast lineage cells.
Acid phosphatase and alpha-naphthyl acetate esterase in neoplastic and non-neoplastic lymphocytes. A statistical analysis.
Acid phosphatase in acute lymphatic leukemia (ALL).
Acid phosphatase in leukemic blasts: characterization by isoelectric focusing in polyacrylamide gel.
Acid Phosphatase Isoenzyme Profiles in Acute and Chronic Leukemias.
Acid phosphatase staining pattern as an indicator of T-cell acute leukemia.
Actinomycin D induction of acid phosphatase in synchronized L5178Y mouse leukemia cells.
Alisertib induces apoptosis and autophagy through targeting the AKT/mTOR/AMPK/p38 pathway in leukemic cells.
Alkaline and acid phosphatase in murine leukemia.
Amino acid phosphoramidate nucleosides: potential ADEPT/GDEPT substrates.
Analysis of isoenzyme patterns of acid phosphatase in acute leukemias.
Backscattered electron imaging of human leukocytes.
Clinical and biological aspects of acid phosphatase.
Cutaneous findings in hairy cell leukemia.
Cytochemical evaluation of cytostatic drugs action in chronic granulocytic and lymphatic leukemia.
Cytochemistry of tartrate-resistant acid phosphatase: 15 years' experience.
Cytogenetic studies of hairy cell leukemia.
Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
Differential characterization of the "reticulum cell" in lymphoreticular neoplasms.
Dipeptidylaminopeptidase IV activity in normal and leukemic T-cell subpopulations.
Effective treatment of a refractory hairy cell leukemia variant with splenic pre-irradiation and alemtuzumab.
Elevated serum acid phosphatase in chronic myelomonocytic leukemia.
Epitope enhancement for immunohistochemical demonstration of tartrate-resistant acid phosphatase.
Evidence that tartrate-resistant acid phosphatases from osteoclastomas and hairy cell leukemia spleen are members of a multigene family.
Exceptional thermal stability of therapeutical enzymes entrapped in alumina sol-gel matrices.
Expression of FMC7 antigen and tartrate-resistant acid phosphatase isoenzyme in cases of B-lymphoproliferative diseases.
Expression of the muscle-associated gene MYF6 in hairy cell leukemia.
Flow cytoenzymology of intracellular tartrate-resistant acid phosphatase.
Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase.
Hairy cell leukemia (leukemic reticuloendotheliosis) in serous effusions.
Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
Hairy cell leukemia with bone marrow hypoplasia.
Hepatic involvement in hairy cell leukemia: diagnosis by tartrate-resistant acid phosphatase enzyme histochemistry on formalin fixed and paraffin-embedded liver biopsy specimens.
High CFTR expression in Philadelphia chromosome-positive acute leukemia protects and maintains continuous activation of BCR-ABL and related signaling pathways in combination with PP2A.
Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles.
Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.
Increased prostate-type acid phosphatase activity in serum and typical bone lesions simulating the presence of prostatic carcinoma.
Influence of chemotherapy on some cytochemical reactions in patients with acute leukemia.
Isoelectric focusing pattern of acid phosphatase in normal splenic tissue, in the lysosomal fraction of viable splenic lymphocytes and in cases of hairy cell leukemia.
Isoenzyme studies in human leukemia. I. Acid phosphatase.
Isozymes of acid esterase and acid phosphatase in permanent human hematopoietic cell lines.
KLF2 (kruppel like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
Leukemic cell differentiation in childhood leukemias. Analysis by enzyme markers.
Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retroviruses.
Molecular cloning of the type 5, iron-containing, tartrate-resistant acid phosphatase from human placenta.
New diagnostic use of bone marrow acid and alkaline phosphatase.
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Phosphatases of leukocytes. II. Isolation and characterization of acid phosphatase of normal leukocytes and leukocytes from patients with chronic granulocytic leukemia.
Presence of "prostatic" acid phosphatase in human neutrophils.
Protein-tyrosine phosphatase activity of hairy cell tartrate-resistant acid phosphatase.
Sézary syndrome. Tartrate-resistant acid phosphatase in the neoplastic cells.
Serum and host liver activities of glycosidases and sialyltransferases in animals bearing transplantable tumors.
Significance of enzyme markers as a part of multiple marker analysis in leukemia research.
Tartrate-resistant acid phosphatase reactions not specific for hairy cell leukemia.
The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report.
The type 5, acid phosphatase from spleen of humans with hairy cell leukemia. Purification, properties, immunological characterization, and comparison with porcine uteroferrin.
The value of tartrate resistant acid phosphatase (TRAP) immunoreactivity in diagnosis of hairy cell leukemia.
Total leukocyte acid phosphatase and its isoenzymes in patients with leukemia.
Transient expression of the tartrate-resistant acid phosphatase (TRAP) gene in hamster cells: a pilot study.
Ultrastruct and tartrate-resistant acid phosphatase localization in a T-cell hairy-cell leukemia cell line.
Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
Uteroferrin: a progesterone-induced hematopoietic growth factor of uterine origin.
Visualization of the ribosome-lamella complex in plastic-embedded biopsy specimens as an aid to diagnosis of hairy-cell leukemia.
[A disc electrophoretic study on acid phosphatase in leukemia and lymphoma cells, with special reference to tartrate resistant isozymzymol]
[Acid phosphatase, ACP (EC 3.1.3.2)]
[Activity of lysosomal hydrolase and acid phosphatase in T- and B-lymphocytes of healthy people and patients with chronic lymphatic leukemia (CLL)]
[Contribution of cytochemistry and delayed hypersensitivity skin tests in the diagnosis and prognosis of chronic lymphoproliferative syndromes]
[Correlation of the cytochemical classification of acute leukemia in children with the course of their disease (author's transl)]
[Cytochemical polymorphism of acid phosphatase in hairy cell leukemia]
[Detection of tartrate-resistant isoenzyme 5 of acid phosphatase in the white blood cells by disc electrophoresis in a case of hairy cell leukemia]
[Differential diagnostic significance of cytochemical studies of acid phosphatase and beta-glucuronidase in acute leukemia]
[Existence of tartaric acid-resistant acid phosphatase in adult T cell leukemia and B-CLL and its significance (author's transl)]
[Hairy cell leukemia: diagnosis using monoclonal antibodies in flow cytometry]
[Immunological cell markers on lymphoblasts of patients with acid phosphatase positive acute leukemia (author's transl)]
[Isoenzymes of acid phosphatase in blood cells of normal subjects and patients with leukemia (author's transl)]
[Leucocyte tartrate-resistant acid phosphatase as marker for the transition of monocyte to macrophage]
[Leukemia with positive reactions to tartrate-resistance acid phosphatase]
[Leukemic infiltration of gastrointestinal system: unusual complication of hairy cell leukemia]
[Lysosomal hydrolase activity during development of experimental leukemia]
[Role of alpha-interferon in the treatment of hairy cell leukemia]
[Selective staining of T-lymphoblastic leukemia cells by glycyl-prolyl-4-methoxy-beta-naphthylamiden-peptidase (DAP IV) (author's transl)]
[Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia]
Leukemia, Erythroblastic, Acute
Cytochemical detection of erythroblastic enzymes in acquired dyserythropoiesis.
Erythroleukemia cell lines HEL and K-562: changes in isoenzyme profiles and morphology during induction of differentiation.
Isoenzyme studies in human leukemia-lymphoma cell lines--V. Induction of differentiation by T-cell derived differentiation-inducing activity.
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Leukemia, Hairy Cell
Antibodies to porcine uteroferrin used in measurement of human tartrate-resistant acid phosphatase.
Biochemical characterization of the tartrate-resistant acid phosphatase of human spleen with leukemic reticuloendotheliosis as a pyrophosphatase.
Clinical and biological aspects of acid phosphatase.
Comparison of tartrate-resistant acid phosphatase in normal mouse tissues to that in the reticulum cells of leukemic reticuloendotheliosis.
Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis.
Cutaneous findings in hairy cell leukemia.
Cytochemistry of tartrate-resistant acid phosphatase: 15 years' experience.
Cytogenetic studies of hairy cell leukemia.
Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
Differential characterization of the "reticulum cell" in lymphoreticular neoplasms.
Epitope enhancement for immunohistochemical demonstration of tartrate-resistant acid phosphatase.
Evidence that tartrate-resistant acid phosphatases from osteoclastomas and hairy cell leukemia spleen are members of a multigene family.
Expression of FMC7 antigen and tartrate-resistant acid phosphatase isoenzyme in cases of B-lymphoproliferative diseases.
Expression of the muscle-associated gene MYF6 in hairy cell leukemia.
Flow cytoenzymology of intracellular tartrate-resistant acid phosphatase.
Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase.
Hairy cell leukemia (leukemic reticuloendotheliosis) in serous effusions.
Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
Hairy cell leukemia with bone marrow hypoplasia.
Hepatic involvement in hairy cell leukemia: diagnosis by tartrate-resistant acid phosphatase enzyme histochemistry on formalin fixed and paraffin-embedded liver biopsy specimens.
Histochemical study of acid phosphatase isoenzyme in leukemic reticuloendotheliosis.
Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.
Immunological and biochemical evidence for identity of tartrate-resistant isoenzymes of acid phosphatases from human serum and tissues.
Isoelectric focusing pattern of acid phosphatase in normal splenic tissue, in the lysosomal fraction of viable splenic lymphocytes and in cases of hairy cell leukemia.
Kinetic properties of tartrate-resistant acid phosphatase isolated from human spleen with leukemic reticuloendotheliosis.
Leukemic reticuloendotheliosis. The role of tartrate-resistant acid phosphatase in diagnosis and splenectomy in treatment.
Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retroviruses.
Molecular cloning of the type 5, iron-containing, tartrate-resistant acid phosphatase from human placenta.
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Protein-tyrosine phosphatase activity of hairy cell tartrate-resistant acid phosphatase.
Reassessment of a cytochemical test for differential diagnosis of leukemic reticuloendotheliosis.
Sézary syndrome. Tartrate-resistant acid phosphatase in the neoplastic cells.
Studies of intracellular distribution of acid phosphatase 5 in the spleen cells of leukemic reticuloendotheliosis by isopycnic gradient centrifugation.
Tartrate-resistant (band 5) acid phosphatase activity measured by electrophoresis on acrylamide gel.
Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis.
Tartrate-resistant acid phosphatase reactions not specific for hairy cell leukemia.
The cytochemistry of tartrate-resistant acid phosphatase. Technical considerations.
The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report.
The type 5, acid phosphatase from spleen of humans with hairy cell leukemia. Purification, properties, immunological characterization, and comparison with porcine uteroferrin.
The value of tartrate resistant acid phosphatase (TRAP) immunoreactivity in diagnosis of hairy cell leukemia.
Transient expression of the tartrate-resistant acid phosphatase (TRAP) gene in hamster cells: a pilot study.
Ultrastructural cytochemical demonstration of tartrate-resistant acid phosphatase isoenzyme activity in "hairy cells" of leukemic reticuloendotheliosis.
Uteroferrin: a progesterone-induced hematopoietic growth factor of uterine origin.
[Acid phosphatase, ACP (EC 3.1.3.2)]
[Contribution of cytochemistry and delayed hypersensitivity skin tests in the diagnosis and prognosis of chronic lymphoproliferative syndromes]
[Cytochemical polymorphism of acid phosphatase in hairy cell leukemia]
[Detection of tartrate-resistant isoenzyme 5 of acid phosphatase in the white blood cells by disc electrophoresis in a case of hairy cell leukemia]
[Hairy cell leukemia: diagnosis using monoclonal antibodies in flow cytometry]
[Leucocyte tartrate-resistant acid phosphatase as marker for the transition of monocyte to macrophage]
[Leukemic infiltration of gastrointestinal system: unusual complication of hairy cell leukemia]
[Role of alpha-interferon in the treatment of hairy cell leukemia]
[Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia]
Leukemia, Lymphocytic, Chronic, B-Cell
Acid hydrolases as markers of maturation in B-cell chronic lymphocytic leukemia.
Acid phosphatase cytochemistry of mitrogen-transformed normal and chronic lymphocytic leukemia lymphocytes.
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
Enzymecytochemical heterogeneity of human chronic T-lymphocytic leukemia as demonstrated by reactivity to dipeptidylaminopeptidase IV (DAP IV; EC 3.4.14.4).
High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia.
Morphological and cytochemical changes of peripheral blood lymphocyte lysosomes in chronic lymphocytic leukemia.
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
Reassessment of a cytochemical test for differential diagnosis of leukemic reticuloendotheliosis.
The dynamics of morphological and cytoenzymatic changes in peripheral blood lymphocyte lysosomes in patients with chronic lymphocytic leukemia during treatment.
[Activity of lysosomal hydrolase and acid phosphatase in T- and B-lymphocytes of healthy people and patients with chronic lymphatic leukemia (CLL)]
[Chronic T-cell lymphoid leukemia with helper cell phenotype]
Leukemia, Lymphoid
12-0-Tetradecanoylphorbol 13-acetate (TPA)-induced enzymatic change of human non-T, non-B lymphoid leukemia cell lines.
Analysis of isoenzyme patterns of acid phosphatase in acute leukemias.
Existence of tartrate-resistant acid phosphatase activity in differentiated lymphoid leukemic cells.
Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells.
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
The use of leukocyte acid phosphatase in the diagnosis of malignant disease. Case report and review of literature.
Visualization of the ribosome-lamella complex in plastic-embedded biopsy specimens as an aid to diagnosis of hairy-cell leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Differences in distribution of ribonuclease isoenzymes in cytosol and granules in normal human granulocytes and in granulocytes of patients with chronic granulocytic leukemia (CGL).
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Phosphatases of leukocytes. II. Isolation and characterization of acid phosphatase of normal leukocytes and leukocytes from patients with chronic granulocytic leukemia.
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report.
Ultrastructural study of chronic myeloid leukemia in blast crisis using myeloperoxidase and acid phosphatase reactions.
[Composition of acid phosphatase in normal leukocytes and in chronic granulocytic leukemia]
Leukemia, Myeloid
Effects of retinoids on induction of differentiation of cultured mouse myeloid leukemia cells.
Occurrence of particular isoenzymes in fresh and cultured leukemia-lymphoma cells. I. Tartrate-resistant acid phosphatase isoenzyme.
Phosphatases of leukocytes. II. Isolation and characterization of acid phosphatase of normal leukocytes and leukocytes from patients with chronic granulocytic leukemia.
Presence of "prostatic" acid phosphatase in human neutrophils.
Leukemia, Myeloid, Acute
Auer rod-like inclusions in circulating lymphoma cells.
Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid Leukemia.
PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect.
Leukemia, Myelomonocytic, Chronic
Elevated serum acid phosphatase in chronic myelomonocytic leukemia.
Leukemia, Prolymphocytic
Cytochemistry of acid hydrolases in chronic B- and T-cell leukemias.
Prolymphocytic leukemia with T cell properties and tartrate resistant acid phosphatase.
Leukemia, T-Cell
Cytochemical markers of murine leukemias and lymphomas.
Expression of human T-cell leukemia virus type I envelope protein in Saccharomyces cerevisiae.
[Existence of tartaric acid-resistant acid phosphatase in adult T cell leukemia and B-CLL and its significance (author's transl)]
[Immunological cell markers on lymphoblasts of patients with acid phosphatase positive acute leukemia (author's transl)]
Leukemic Infiltration
Cutaneous findings in hairy cell leukemia.
Leukocytosis
Advanced cancer of the prostate combined with hypercalcaemia.
Early diagnostic and prognostic criteria for health disorders in chemical workers.
Silent infection in male accessory genital organs and male infertility.
Uteroferrin and recombinant bovine GM-CSF modulate the myelosuppressive effects of 5-fluorouracil in young female pigs (Sus scrofa).
[The effect of insulin on the function of the lysosomal apparatus of the neutrophilic leukocytes during the formation of a stress syndrome]
Leukodystrophy, Metachromatic
Juvenile-onset metachromatic leukodystrophy: biochemical and electrophysiologic studies.
Leukopenia
Myelosuppression in the pig (Sus scrofa): uteroferrin reduces the myelosuppressive effects of 5-fluorouracil in young pigs.
Uteroferrin and recombinant bovine GM-CSF modulate the myelosuppressive effects of 5-fluorouracil in young female pigs (Sus scrofa).
[A differential cytochemical acid phosphatase granulocytogram in the study of leukopenia]
Leukoplakia
Deficiency of beta-glucuronidase in neutrophils from patients with precancerous states of the larynx.
Lymphocytes, neutrophils and serum immunoglobulins in patients with precancerous states of the larynx.
The lymphocyte cytochemical equipment and serum immunoglobulins in patients with precancerous states of the larynx.
[Enzyme and isoenzyme activity in patients with malignant tumors of the oral mucosa]
Leukoplakia, Oral
Studies in oral leukoplakias. 9. Alkaline and acid phosphatase in normal and leukoplakic epithelium before and after vitamin A application.
Lichen Planus
[Electron microscopic and histochemical research on lysosomes and acid phosphatase of epithelial cells of the normal oral mucosa and in lichen ruber planus]
Lipidoses
Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.
[Monocytes/macrophages and lipidosis of the human aortic intima in atherosclerosis]
Lipodystrophy
Lipin1 regulation by estrogen in uterus and liver: implications for diabetes and fertility.
Liver Cirrhosis
Prostatic acid phosphatase and prostate specific antigen in liver disease.
[Acid phosphatase distribution in the liver in cirrhosis]
[Extracellular breakdown of collagen as affected by lysosomal enzymes during the involution of liver cirrhosis]
[Lysosome participation in collagen resorption by hepatocytes during regression of liver cirrhosis]
Liver Cirrhosis, Alcoholic
Genetic markers in alcoholic liver cirrhosis.
Liver Diseases
Lysosomal enzymes in sera and granulocytes of patients with chronic liver diseases.
Prostatic acid phosphatase and prostate specific antigen in liver disease.
Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
Liver Failure
Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Liver Failure, Acute
Circulating lysosomal enzymes and acute hepatic necrosis.
Liver Neoplasms
Biologic markers in cancer diagnosis and treatment.
Serum activities of lysosomal enzymes in patients with liver cell carcinoma.
long-chain-3-hydroxyacyl-coa dehydrogenase deficiency
Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.
Lung Diseases
Circulating levels of tartrate-resistant acid phosphatase in macrophage-activated lung disease.
Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Lung Diseases, Interstitial
Carcinoma of the prostate presenting as interstitial lung disease.
Lung Injury
Pollution characteristics and toxic effects of PM1.0 and PM2.5 in Harbin, China.
Lung Neoplasms
Activity of some lysosomal enzymes in peripheral blood lymphocytes of patients with lung cancer. A cytochemical study.
Association between TGM5, PPAP2B and PSMA4 polymorphisms and NSCLC in never-smoking Chinese population.
Chemotherapy agents induce tartrate-resistant acid phosphatase 5a contributing to the symptom distress in lung cancer patients.
Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
Cytochemical study of neutrophils from peripheral blood of patients with lung cancer.
LC-MS/MS-Based Quantitative Proteomics Analysis of Different Stages of Non-Small-Cell Lung Cancer.
microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity.
Prognostic Significance of Bone Markers in Patients With Lung Cancer Metastatic to the Skeleton: A Review of Published Data.
Runt-related transcription factor 1 contributes to lung cancer development by binding to tartrate-resistant acid phosphatase 5.
Serum acid phosphatase activities in patients with lung cancer: a biochemical and immunohistochemical analysis of 25 cases.
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma.
The Relationship Between Inflammatory Biomarkers and Symptom Distress in Lung Cancer Patients Undergoing Chemotherapy.
[Lysosomal enzymes and natural killer activity]
Lupus Erythematosus, Discoid
[A trial of detecting acid phosphatase by cytochemical methods for assessing the functional status of the leukocytes in discoid lupus erythematosus]
Lupus Erythematosus, Systemic
Novel association of acid phosphatase locus 1*C allele with systemic lupus erythematosus.
Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus.
Lymphadenopathy
Chronic lymphocytic leukaemia of T cell origin. Clinical variation possibly due to involvement of different T lymphocyte subpopulations.
Malignant lymphoma simulating leukemic reticuloendotheliosis: a clinicopathologic study of ten cases.
Malignant lymphomas involving the prostate. A study of 13 cases.
Lymphatic Metastasis
Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
Clinical experience with intra lymphatic administration of 111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma.
Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.
Operative staging of apparently localized adenocarcinoma of the prostate: results in fifty unselected patients. I. Experimental design and preliminary results.
Pelvic lymphadenectomy for staging prostatic carcinoma: is it always necessary?
Postoperative expressions of TRACP5b and CA125 in patients with breast cancer and their values for monitoring bone metastasis.
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Prostate-specific antigen and prostate acid phosphatase in the detection of early prostate cancer and the prediction of regional lymph node metastases.
Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases.
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Lymphocytosis
[Experience in investigating splenic red pulp lymphoma].
Lymphoma
Acid phosphatase of azurophilic granules of C3HST4 lymphoma.
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
Analysis of isoenzyme patterns of acid phosphatase in acute leukemias.
Cytochemical examination of acid phosphatase and beta-glucuronidase enzymes in low-grade B cell non-Hodgkin's lymphomas.
Cytochemical markers of murine leukemias and lymphomas.
Cytochemical reactions of normal and neoplastic lymphocytes.
Dipeptidylaminopeptidase IV activity in normal and leukemic T-cell subpopulations.
High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia.
Ileal lymphoma in swine.
Immunologic and cytochemical properties of histiocytic and mixed histiocytic-lymphocytic lymphomas.
Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells.
Multienzymatic analyses of human malignant lymphomas. Correlation of enzymatic data with pathologic and ultrastructural findings in Burkitt's and lymphoblastic lymphomas.
Peripheral T cell lymphoma in adults: morphological and phenotypical study of four cases.
Primary splenic lymphoma in a horse.
Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells.
T-cell lymphomas of the stomach: morphological and immunological studies characterizing two cases of T-cell lymphoma.
Tartrate resistant acid phosphatase positive splenic lymphoma: a relatively benign condition occurring in a time-space cluster?
Transformation of hairy cell leukemia to high-grade lymphoma: a case report and review of the literature.
Unique eosinophil granules in a case of T-cell lymphoma.
[A disc electrophoretic study on acid phosphatase in leukemia and lymphoma cells, with special reference to tartrate resistant isozymzymol]
[Classiciation of non-Hodgkin's lymphomas of childhood (author's transl)]
[Enzyme cytochemical studies of malignant cutaneous lymphomas using simple smear preparations]
[Evaluation of tartrate-resistant acid phosphatase activity in lymphoma cells of the bone marrow]
[Malignant lymphoma with "hairy" lymphocytes in the blood and splenomegaly--a new variant of lymphoproliferative diseases]
[Polar acid phosphatase as T lymphoma marker (author's transl)]
Lymphoma, B-Cell
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
Dietary protein levels regulated antibacterial activity, inflammatory response and structural integrity in the head kidney, spleen and skin of grass carp (Ctenopharyngodon idella) after challenged with Aeromonas hydrophila.
Dietary vitamin C deficiency depressed the gill physical barriers and immune barriers referring to Nrf2, apoptosis, MLCK, NF-?B and TOR signaling in grass carp (Ctenopharyngodon idella) under infection of Flavobacterium columnare.
High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia.
Prostatic acid phosphatase is a possible tumor marker for intravascular large B-cell lymphoma.
Prostatic acid phosphatase: a possible diagnostic marker of intravascular large B-cell lymphoma.
Protective effect of zinc on N-methyl-N-nitrosourea and testosterone-induced prostatic intraepithelial neoplasia in the dorsolateral prostate of Sprague Dawley rats.
[Histological processing of iliac crest biopsies based on decalcification and paraffin embedding with reference to osteolytic and hematologic diagnosis]
Lymphoma, Follicular
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia.
Lymphoma, Large B-Cell, Diffuse
Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis.
Lymphoma, Non-Hodgkin
Abnormalities of esterase and glycogen in developing macrophages in non-Hodgkin's lymphoma: a quantitative cytochemical study.
An enzyme histochemical study of non-Hodgkin's lymphoma and allied disease.
Multienzymatic analyses of human malignant lymphomas. Correlation of enzymatic data with pathologic and ultrastructural findings in Burkitt's and lymphoblastic lymphomas.
[Cytochemical analysis of acid phosphatase and beta glucuronidase in B-cell non-Hodgkin's lymphoma of low-grade malignancy]
Lymphoma, T-Cell
Cell surface antigen phenotypes and enzyme expression patterns of two murine T-cell lymphomas derived from early and/or mature thymus cells.
Enzyme histochemistry of non-Hodgkin's lymphomas.
Lymphoma, T-Cell, Cutaneous
Sézary syndrome. Tartrate-resistant acid phosphatase in the neoplastic cells.
Lymphopenia
[Lymphopoietic function of mice with alloxan diabetes]
Lymphoproliferative Disorders
Acid phosphatase and acid esterase activity in neoplastic and non-neoplastic lymphoid cells. A semiquantitative evaluation related to immunological markers in 112 cases.
Malignant lymphoma simulating leukemic reticuloendotheliosis: a clinicopathologic study of ten cases.
Sézary syndrome. Tartrate-resistant acid phosphatase in the neoplastic cells.
[Lymphocyte acid phosphatase in several lymphoproliferative disorders preliminary report (author's transl)]
[Role of alpha-interferon in the treatment of hairy cell leukemia]
Macular Degeneration
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Magnesium Deficiency
[Effect of magnesium deficiency on activity of lysosomal acid phosphatase in mice lymphocytes]
Malaria
Acid phosphatase as a marker in malaria.
Elevated total and isoenzyme forms of acid phosphatase in falciparum malaria.
Genetic analysis of two enzyme polymorphisms in a malaria vector mosquito: octanol dehydrogenase and acid phosphatase in Anopheles culicifacies Giles.
Phosphatidic acid homeostasis regulated by a type-2 phosphatidic acid phosphatase represents a novel druggable target in malaria intervention.
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Malnutrition
Effects of prenatal malnutrition on development of oral tissue in neonatal rats.
Metabolism of lysosomal enzymes in the protein-deficient weanling rat.
Manganese Poisoning
Dihydronicotinamide-adenine dinucleotide (NADH2) diaphorase, thiamine pyrophosphatase and acid phosphatase in the spinal cords of rabbits with chronic manganese poisoning.
Mastitis
The activity of milk leukocytes in response to a water-soluble fraction of Mycobacterium phlei in bovine subclinical mastitis.
Measles
[The cytochemical marking of lymphocyte subpopulations in determining the immunoreactivity status of children vaccinated with a live measles vaccine]
Melanoma
A bioinformatic approach to the identification of candidate genes for the development of new cancer diagnostics.
Activity of some respiratory and lysosomal enzymes of lymphocytes in golden hamster with induced melanoma.
Autotaxin--an LPA producing enzyme with diverse functions.
Effect of trypan blue on the activity of lysosomal enzymes, tumor growth and cell ultrastructure in B16 melanotic melanoma in mice.
Histochemical findings in different types of malignant melanoma: biological and clinical significance.
Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
In vitro and in vivo antimelanoma effect of ethyl ester cyclohexyl analog of ethylenediamine dipropanoic acid.
Increased tartrate-resistant acid phosphatase (TRAP) expression in malignant breast, ovarian and melanoma tissue: an investigational study.
Influence of quercetin on B16 melanotic melanoma growth in C57BL/6 mice and on activity of some acid hydrolases in melanoma tissue.
Isolation and characterization of a Golgi-rich fraction from the Harding-Passey mouse melanoma.
Lipid rafts couple store-operated Ca2+ entry to constitutive activation of PKB/Akt in a Ca2+/calmodulin-, Src- and PP2A-mediated pathway and promote melanoma tumor growth.
Malignant melanoma with metastasis to adenocarcinoma of the prostate.
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
Melanoma, Amelanotic
Activity of some lysosomal hydrolases in the homogenates of transplantable melanotic and amelanotic melanoma in golden hamster (Mesocricetus auratus, Waterhouse).
Melanoma, Experimental
Differences in induction of lysosomal protease activity by protease inhibitors in B16 melanoma cell lines.
Induction and inhibition of cathepsin B and hemoglobin-hydrolase activity in murine B16 melanoma by thiol protease inhibitors.
Memory Disorders
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
Meningioma
[Incidence and distribution of alkaline and acid phosphatase in meningioma.]
Meningitis
Acid phosphatase activity of cerebrospinal fluid cells in bacterial and abacterial meningitis.
Meningitis, Aseptic
Cyclic adenosine-3',5-monophosphate concentration and enzyme activities of cerebrospinal fluid in meningitis of children.
Meningitis, Bacterial
CSF lysosomal hydrolase activity as an aid in the diagnosis of bacterial meningitis.
Mercury Poisoning
The effect of experimental methyl mercury poisoning on the distribution of acid phosphatase during autolysis in cat liver.
Metabolic Syndrome
Elevated serum tartrate-resistant acid phosphatase isoform 5a levels in metabolic syndrome.
The adipokine tartrate-resistant acid phosphatase 5a in serum correlates to adipose tissue expansion in obesity.
Metrorrhagia
Endometrial lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and post-partum women.
Microphthalmos
Giant cell tumors: inquiry into immunohistochemical expression of CD117 (c-Kit), microphthalmia transcription factor, tartrate-resistant acid phosphatase, and HAM-56.
Regulation of receptor activator of NF-kappaB ligand-induced tartrate-resistant acid phosphatase gene expression by PU.1-interacting protein/interferon regulatory factor-4. Synergism with microphthalmia transcription factor.
Regulation of the murine TRACP gene promoter.
The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor.
The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate the tartrate-resistant acid phosphatase promoter.
The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.
Monoclonal Gammopathy of Undetermined Significance
Enzymecytochemistry and immunohistochemistry in monoclonal gammopathy and reactive plasmacytosis.
[Cytochemical studies of bone marrow plasma cells in monoclonal gammapathies (author's transl)]
[Cytological study of acid phosphatase activity of plasma cells in monoclonal gammopathies]
Mouth Neoplasms
[Enzyme and isoenzyme activity in patients with malignant tumors of the oral mucosa]
Mucolipidoses
Acid hydrolases in serum from patients with lysosomal disorders.
Clinical and biological aspects of acid phosphatase.
Electrophoretic analysis of glycoprotein enzymes in the sialidoses and mucolipidoses.
Immunocytochemical localization of lysosomal acid phosphatase in normal and "I-cell" fibroblasts.
Prenatal diagnosis of I-cell disease.
Tartrate-inhibitable acid phosphatase. Purification from placenta, characterization and subcellular distribution in fibroblasts.
Mucopolysaccharidoses
A light and electron microscopic study of mannosidosis.
Mutant Enzymatic and Cytological Phenotypes in Cultured Human Fibroblasts.
Mucopolysaccharidosis I
Mutant Enzymatic and Cytological Phenotypes in Cultured Human Fibroblasts.
Multiple Endocrine Neoplasia Type 2b
Seminal fructose and acid phosphatase in vasectomised men.
Multiple Myeloma
Activity and intracellular localization of lysosomal acid phosphatase in lymphocytes from patients with Hodgkin's disease, plasma cell myeloma and primary polycythemia.
Biochemical markers of bone turnover.
Electrophoretic separation of serum acid phosphatase isoenzymes in Gaucher's disease, prostatic carcinoma and multiple myeloma.
Enzymecytochemistry and immunohistochemistry in monoclonal gammopathy and reactive plasmacytosis.
Membrane translocation of Bruton kinase in multiple myeloma cells is associated with osteoclastogenic phenotype in bone metastatic lesions.
Morphological and isoenzymatic differentiation of B-chronic lymphocytic leukaemia cells induced by phorbolester.
Myeloma bone marrow acid phosphatase staining: a correlative study of 38 patients.
Plasma cell acid phosphatase and prognosis in multiple myeloma.
Plasma cell acid phosphatase as an adjunct in the differential diagnosis of monoclonal immunoglobulinemias.
Plasma cell acid phosphatase in multiple myeloma.
Plasma cell acid phosphatase score in multiple myeloma and related disorders.
Prognostic correlation of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma: a Southwest Oncology Group study.
Tartrate-resistant acid phosphatase (TRAP) activity in serum: potential use in assessing bone resorption in patients with multiple myeloma.
Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
Unusual bone metastasis as the initial symptom of gastric cancer--a report of four cases.
[Biological and clinical significance of plasma-cell acid phosphatase in multiple myeloma]
[Correlation of cytogenetic changes with VEGF and TRacp-5b levels among 60 elderly patients with multiple myeloma].
[Cytochemical studies of bone marrow plasma cells in monoclonal gammapathies (author's transl)]
[Cytological study of acid phosphatase activity of plasma cells in monoclonal gammopathies]
Multiple Sclerosis
Lysosomal hydrolases in CSF of patients with multiple sclerosis.
Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.
The cellular origin of lysosomal enzymes in the plaque in multiple sclerosis. II. A histochemical study with combined demonstration of myelin and acid phosphatase.
[Activity of various lysosomal hydrolases in peripheral blood granulocytes in patients with multiple sclerosis]
Muscular Atrophy
Lipin-1 regulates Bnip3-mediated mitophagy in glycolytic muscle.
Localization of non-specific esterase and acid phosphatase in human fibroblast from skeletal muscle atrophy.
Muscular Diseases
Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes.
Episodic weakness and vacuolar myopathy in hypokalemic periodic paralysis.
Muscular Dystrophies
Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining.
Muscular Dystrophy, Duchenne
Erythrocyte enzyme allotypes in the X-linked recessive disorders, Duchenne muscular dystrophy and haemophilia-A hemizygotes and heterozygotes.
Myalgia
Sipuleucel-T (Provenge): active cellular immunotherapy for advanced prostate cancer.
Mycoses
Acid phosphatases in the haemolymph of the desert locust, Schistocerca gregaria, infected with the entomopathogenic fungus Metarhizium anisopliae.
The hydrolytic enzymes produced by fungi strains isolated from the sand and soil of recreational areas
[The histamine-serotonin-monoamine oxidase system in patients with foot mycosis during treatment]
Myeloproliferative Disorders
Platelet lysosomal enzymes are normal in myeloproliferative disorders.
The value of the ultrastructural pattern of myeloperoxidase (MPO), platelet peroxidase (PPO) and acid phosphatase in identification of blastic cell types during acute transformation of chronic myeloproliferative disorders (cMPD).
Myocardial Infarction
Acid phosphatase in serum: increase in acute myocardial infarction.
Effect of steroids on cardiac lymph content of lysosomal enzyme acid phosphatase in experimental myocardial infarction.
Synergistic effect of nicorandil and amlodipine on lysosomal hydrolases during experimental myocardial infarction in rats.
[Histochemical studies of neutrophils in myocardial infarct patients]
[Quantitative shifts in acid phosphatase isoenzymes in the blood in myocardial infarct]
[The determination of acid phosphatase in myocardial infarct and in transient forms of the anginal coronary syndrome]
Myocardial Ischemia
Release of lysosomal enzymes during ischemic injury of canine myocardium.
Myocarditis
[Effects of strophanthin, mefenamic acid and dexamethasone on the inflammatory and reparative processes in the heart in experimental myocarditis]
[The indices of the proteinase-peroxidase and phosphatase activities of the blood polymorphonuclear leukocytes in the differential diagnosis of dilated cardiomyopathy and idiopathic myocarditis]
Myopia
Lysosomal enzymes in tear fluids from patients with ocular diseases.
Lysosomal enzymes in tear fluids from patients with Terrien's marginal corneal degeneration.
Lysosomal enzymes in the serum of patients with with Behçet's disease.
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Two different genetic markers for high and low myopia.
Myositis
Enzyme patterns in human endocytotic multinucleate giant cells--a histochemical study.
Tartrate-resistant acid phosphatase containing cells in nodular fasciitis, proliferative fasciitis, and proliferative myositis.
Myotonia
Changes of metabolism during experimentally induced myotonia of rats. II. Alterations in creatine kinase and acid phosphatase activities: a possible mechanism in the development of muscle damage.
Necrobiotic Disorders
Identification of T-cell subpopulations in granuloma annulare.
[Histopathologic and histochemical examination of rat liver after prolonged experimental application of potassium bichromate]
Neoplasm Metastasis
Acid phosphatase levels in bone marrow: value in detecting early bone metastasis from carcinoma of the prostate.
Acid phosphatase: its influence on the management of carcinoma of the prostate.
Adenosquamous carcinoma of prostate.
Advanced prostate cancer follow-up with prostate-specific antigen, prostatic acid phosphatase, osteocalcin and bone isoenzyme of alkaline phosphatase.
An evaluation of a kinetic acid phosphatase method.
Assessment of value of routine bone scans in patients with newly diagnosed prostate cancer.
Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation.
Biochemical markers and skeletal metabolism in carcinoma of the prostate. Use of decision matrix theory and ROC analysis.
Biochemical markers of bone metabolism in breast cancer.
Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer.
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Bone imaging and serum phosphatases in prostatic carcinoma.
Bone marrow acid phosphatase by radioimmunoassay: 3 years of experience.
Bone marrow acid phosphatase: another look.
Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: are they helpful in staging prostatic cancer?
Bone scintigraphy, radiographic survey and prostatic acid phosphatase in patients with prostatic carcinoma. A comparison of sensitivity.
Carcinoma of gallbladder simulating metastatic prostatic cancer.
Carcinoma of the prostate in childhood and adolescence: report of a case and review of the literature.
Carcinoma of the prostate: a critical look at staging.
Carcinosarcoma of the prostate.
Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group.
Clear cell adenocarcinoma of the urethra: evidence for origin within paraurethral ducts.
Clinical applicability of acid phosphatase isoenzyme assay.
Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-ray.
Clinical experience with intra lymphatic administration of 111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma.
Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma.
Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
Combined serum and bone marrow radioimmunoassays for prostatic acid phosphatase.
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.
Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.
Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate.
Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
Conservative management with symptomatic treatment and delayed hormonal manipulation is justified in men with locally advanced carcinoma of the prostate.
Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase in serum with Eiken PAP RIA kit.
Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b), a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP), a Bone Formation Marker, in Lieu of Whole Body Skeletal Scintigraphy with Technetium99m MDP.
Diagnosis of carcinoid-like metastatic prostatic carcinoma by an immunoperoxidase method.
Diagnostic and prognostic use of bone turnover markers.
Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
Diagnostic and therapeutic utility of monoclonal antibodies in urologic oncology.
Diagnostic efficiency of biological markers in blood serum on prostate cancer: a comparison of four different markers and 12 different methods.
Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.
Differentiation of macrophages from Lewis lung carcinoma tumour cells in tissue sections by their alpha-naphthyl butyrate esterase activity.
Distant Cutaneous Metastases of Prostate Cancer: A Report of 2 Cases.
DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study.
Early detection of prostate cancer by routine screening.
Effect of estrogen therapy on metastatic carcinoma of the prostate.
Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: a Southwest Oncology Group report.
Elevated serum acid phosphatase levels with rectal carcinoid tumor.
Elevation of serum acid phosphatase in cancers with bone metastasis.
Endometrioid adenocarcinoma of prostatic urethra presenting with anterior urethral implantation.
Enzyme patterns in cancer.
Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases.
Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase.
Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase.
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Immunohistochemical diagnosis of the metastasizing prostatic carcinoma.
Immunohistochemical evaluation of prostatic carcinoma before and after radiotherapy.
Implications of Serum Bone Turnover Markers in Prostate Cancer Patients With Bone Metastasis.
Inhibitory effects of low intensity pulsed ultrasound on osteoclastogenesis induced in vitro by breast cancer cells.
Initial chemotherapeutic trials in patients with inoperable or recurrent cancer of the prostate.
Invasive carcinoma of prostate presenting as rectal carcinoma.
Lack of usefulness of bone marrow enzymes and calcium in staging patients with prostatic cancer.
Leiomyosarcoma of the heart and its pulmonary metastasis, both with prominent osteoclast-like multinucleated giant cells expressing tartrate-resistant acid phosphatase activity.
Leuprorelin acetate depot: results of a multicentre Japanese trial. TAP-144-SR Study Group.
LH-RH analogue treatment for advanced prostate cancer.
Long-term clinical study on luteinising hormone-releasing hormone agonist depot formulation in the treatment of stage D prostatic cancer. The TAP-144-SR Study Group.
Lymphangitic pulmonary metastases in castrate-resistant prostate adenocarcinoma.
LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor ? Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.
MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis.
Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid.
Measurement of prostate-specific antigen and prostatic acid phosphatase concentrations in serum before and 1-42 days after transurethral resection of the prostate and orchidectomy.
Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase.
Modulation of acid phosphatase and lactic dehydrogenase in hexachlorocyclohexane-induced hepatocarcinogenesis in mice.
Mucinous adenocarcinoma of the prostate gland.
MULTIMODAL IMAGING AND HISTOLOGIC CORRELATION OF ISOLATED METASTASIS OF PROSTATE ADENOCARCINOMA TO THE CHOROID.
Multiple cutaneous metastases in the chest from prostatic carcinoma.
New diagnostic use of bone marrow acid and alkaline phosphatase.
Nodal involvement as a prognostic indicator in patients with prostatic carcinoma.
Pelvic lymphadenectomy for staging prostatic carcinoma: is it always necessary?
Plasma acid and alkaline phosphatase in patients with breast cancer.
Postoperative expressions of TRACP5b and CA125 in patients with breast cancer and their values for monitoring bone metastasis.
Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostatic specific antigen by immunohistochemistry.
Predicting the probability of bone metastasis through histological grading of prostate carcinoma: a retrospective correlative analysis of 81 autopsy cases with antemortem transurethral resection specimen.
Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
Primary transitional cell carcinoma of the prostate.
Prognostic factors in patients with advanced prostate cancer.
Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy.
Prognostic factors in survival free of progression after androgen deprivation therapy for treatment of prostate cancer.
Prognostic factors of advanced prostatic carcinoma.
Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate.
Prognostic Significance of Bone Markers in Patients With Lung Cancer Metastatic to the Skeleton: A Review of Published Data.
Prognostic value of bone marrow acid phosphatase in prostatic carcinoma.
Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer.
Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.
Prostate cancer: a model of cancer in the elderly.
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Prostate-specific antigen and prostate acid phosphatase in the detection of early prostate cancer and the prediction of regional lymph node metastases.
Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases.
Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.
Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.
Prostatic cancer with bone metastases: serum alkaline phosphatase (SAP) as a predictor of response and the significance of the SAP "flare".
Prostatic carcinoma: a multivariate analysis of prognostic factors.
Prostatic tumor (R3327) skeletal metastasis.
Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
Radical perineal prostatectomy for palpable, clinically localized, non-obstructive cancer: experience at the Johns Hopkins Hospital 1909-1963.
Radioimaging of lymph node involvement in prostatic carcinoma.
Radioimaging of the prostate and metastases of prostatic carcinoma with 99mTc-labelled prostatic acid phosphatase-specific antibodies and their Fab fragments.
Radioimmunoassay of bone marrow prostatic acid phosphatase.
Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
Rectal obstruction secondary to carcinoma of the prostate.
Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphatase.
Renal neuroendocrine tumour and synchronous pancreas metastasis: histopathological diagnosis using prostatic acid phosphatase.
Retroperitoneal metastatic disease due to carcinoma of the prostate: value of serum prostatic acid phosphatase in identifying retroperitoneal metastasis originating from carcinoma of prostate.
Role of lymphography in carcinoma of the prostate.
Salivary duct carcinoma secreting prostate-specific antigen.
Seeding and perineal implantation of prostatic cancer in the track of the biopsy needle: three case reports and a review of the literature.
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Serum levels of procollagen type I carboxyterminal extension peptide in cancer patients with bone metastases.
Serum osteocalcin concentration in patients with prostatic cancer.
Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram: comparison with serum PSA/PAP measurements.
Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.
Serum TPS, PSA, and PAP values in relapsing stage D2 adenocarcinoma of the prostate.
Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer.
Spongious bone density determination for staging and follow-up of patients with prostatic cancer.
Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
Survival markers related to bone metastases in prostate cancer.
Systematic association of PAP and PSA determinations to bone scintigraphy in prostatic cancer.
Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts.
Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGF?2/T?R and CD44 in MDA-MB-231 breast cancer cells.
Tartrate-resistant Acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear ?B ligand.
Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.
Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer.
Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
The assessment of disease aggressivity in stage D2 prostate cancer patients (review).
The Clinical Significance of Serum Markers of Bone Turnover in NSCLC Patients: Surveillance, Management and Prognostic Implications.
The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy.
The Nb rat prostatic adenocarcinoma model system.
The prognostic significance of histological grading and pathological staging in carcinoma of the prostate.
The risk of dying of prostate cancer in patients with clinically localized disease.
The role of bone scanning in the assessment of prostatic carcinoma.
The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
The significance of bone marrow acid phosphatase in patients with prostatic carcinoma.
The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
The small chemical enzyme inhibitor 5-phenylnicotinic acid/CD13 inhibits cell migration and invasion of tartrate-resistant acid phosphatase/ACP5-overexpressing MDA-MB-231 breast cancer cells.
The staging of M1 disease: the role of bone scan, Xray and other imaging techniques.
Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma.
Treatment of advanced prostatic cancer with anti-androgens alone and a combination of anti-androgen with anti-prolactin--a pilot study.
Treatment of advanced prostatic carcinoma with D-Trp-6-LH-RH.
Tumor markers in prostate cancer.
Tumor Necrosis Factor-? Produced by Osteoclasts Might Induce Intractable Pain in a Rat Spinal Metastasis Model of Breast Cancer.
Unusual bone metastasis as the initial symptom of gastric cancer--a report of four cases.
Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
Urine hydroxyproline excretion--a marker of bone metastases in prostatic carcinoma.
Value of TRAcP 5b as a diagnostic marker for detection of bone metastases in patients with breast cancer.
[Clinical analysis and treatment of carcinoma of the prostate with bone metastasis]
[Clinical assessments on pre-treatment prognostic factors in 138 patients with advanced prostatic carcinoma (stage D2)]
[Clinical course of bone metastases by prostatic cancer studies with conventional X-ray]
[Clinical studies on endocrine therapy for prostatic carcinoma (5): Analyses of relapse from endocrine therapy]
[Correlation of vessel invasion and bone metastasis in prostatic adenocarcinoma. A clinico-pathological and immunohistochemical study of 33 cases of total prostatectomy]
[Evaluation of two serum isoenzyme phosphatases as bone metastasis markers]
[Immunohistochemical detection of prostate carcinoma]
[Levels of prostate-specific antigen, acid phosphatase, alkaline phosphatase and pain in the prediction of bone metastases in patients with newly diagnosed prostatic carcinoma]
[Mucinous adenocarcinoma of the prostatic gland. Histochemical and immunohistochemical studies]
[Ophthalmoplegia in a patient with prostate cancer and bone metastases]
[PREVENTION OF THE BONES METASTASES OCCURRENCE IN THE PATIENTS WITH RENAL-CELL CANCER].
[Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate]
[Skin metastasis as first manifestation of prostatic adenocarcinoma]
[Studies on prognosis of prostate cancer with bone metastasis by using pretreatment bone scintigraphy]
[TARTRAT-RESISTANT ACID PHOSPHATASE AS BONE'S RESORBTION MARKER IN PATIENTS WITH BONE METASTASES].
[Tartrate-resistant acid phosphatase in the detection of bone metastasis in patients with cancer]
[The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)]
[The evaluation of chemotherapy of relapse in prostatic cancer with new response criteria]
[The mechanism of TRACP 5b maturation]
Neoplasm, Residual
Characterization of residual tumor cells following radical radiation therapy for prostatic adenocarcinoma; immunohistochemical expression of prostate-specific antigen, prostatic acid phosphatase, and cytokeratin 8.
Neoplasms
"Endometrial" adenocarcinoma of the prostate: a distinctive tumor of probable prostatic duct origin.
8,8''-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8''-biapigeninyl in ovariectomized mice.
A Case of a Malignant Cutaneous Mixed Tumor (Chondroid Syringoma) of the Scapula Treated With Staged Margin-Controlled Excision.
A case of Sister Mary Joseph's nodule from prostatic cancer.
A combined approach to data mining of textual and structured data to identify cancer-related targets.
A comparative study on lysosomal accumulation of gallium-67 and indium-111 in Morris hepatoma 7316A.
A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
A methacrylate embedding technique for combined autoradiography and acid phosphatase histochemistry.
A multivariate approach to the description of patient populations. An example of the analysis of the hormone profiles of patients with advanced prostate cancer.
A new method for estimating serum acid phosphatase of prostatic origin applied to the clinical investigation of cancer of the prostate.
A Novel Screening Method to Establish Tumor-targeting Antibodies Reliable for Drug Delivery System.
A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model.
A rat model of bone cancer pain.
A report of the workshops on the current status of the histologic grading of prostate cancer.
A single application of hydrogen sulphide induces a transient osteoclast differentiation with RANKL expression in the rat model.
A soft coral-derived compound, 11-epi-sinulariolide acetate suppresses inflammatory response and bone destruction in adjuvant-induced arthritis.
A solid phase radioimmunoassay for prostatic acid phosphatase.
A solid-phase radioimmunoassay for human prostatic acid phosphatase.
A study of the acid phosphatase in the cells of bone and soft parts tumors, and of other tumorous conditions.
Absence of serum prostate-specific antigen and loss of tissue immunoreactive prostatic markers in advanced prostatic adenocarcinoma after hormonal therapy: a report of two cases.
Acid phosphatase and non-specific alpha-naphthol acetate esterase activities of monocytes in patients with cancer of the digestive tract during surgical treatment.
Acid phosphatase in human breast cancer tissue.
Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma.
Acid phosphatase in squamous cell carcinoma.
Acid phosphatase in the blood serum of male patients with tumours of the genito-urinary tract.
Acid phosphatase isozymes in cancer of the prostate.
Acid phosphatase locus 1 genetic polymorphism and cancer grading.
Acid phosphatase of azurophilic granules of C3HST4 lymphoma.
Acid phosphatase of neutrophils in patients with malignancies.
Acid phosphatase response in murine rhabdomyosarcoma for various tumour volumes and after different doses of neutron irradiation, alone or combined with exogenous ATP.
Acid phosphatase.
Acid phosphatase: clinical utility of the first tumor marker.
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
Activity of some lysosomal enzymes in neutrophils from peripheral blood of patients with digestive tract cancer at different clinical stages of the disease. A cytochemical study.
Activity of some lysosomal hydrolases in the homogenates of transplantable melanotic and amelanotic melanoma in golden hamster (Mesocricetus auratus, Waterhouse).
Adenocarcinoma of the prostate involving 2 cell types (prostate specific antigen producing and carcinoembryonic antigen producing) with selective metastatic spread.
Adenosquamous carcinoma of prostate.
Adenosquamous carcinoma of the prostate.
Advanced cancer of the prostate combined with hypercalcaemia.
Adverse implications of acid phosphatase levels in the upper range of normal.
Alterations of glycosidases in benign, premalignant and malignant human lesions.
Alveolar soft part sarcoma: an analysis of 8 cases. Review of the literature.
An acid phosphatase assay for quantifying the growth of adherent and nonadherent cells.
An evaluation of a kinetic acid phosphatase method.
An LH-RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections.
An unusual variant of prostatic adenocarcinoma with metastasis to testis.A case report.
Analysis of prognostic factors in disseminated prostatic cancer. An update. Dutch Southeastern Urological Cooperative Group.
Ankle loading ameliorates bone loss from breast cancer-associated bone metastasis.
Anti-arthritic effect of pentosan polysulfate in rats with collagen-induced arthritis.
Anti-Leu 7 immunoreactivity with human tumours: its value in the diagnosis of prostatic adenocarcinoma.
Antigen Specific T-Cell Responses Against Tumor Antigens are Controlled by Regulatory T Cells in Patients With Prostate Cancer.
Ascorbic acid and dehydroascorbic acid in HeLa cells: their effect on the collagen-peptidase activity of glucose-deficient cultures.
Aspects on reference values for tumor markers in human prostatic carcinoma.
Assessment of radioimmunoassay of serum creatine kinase BB (CK-BB) as a tumor marker: studies in patients with various cancers and a comparison of CK-BB concentrations to prostate acid phosphatase concentrations.
Attenuation of Kupffer cell activation in cold-preserved livers after pretreatment of rats with methylprednisolone or its macromolecular prodrug.
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review.
Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate.
AXC rat prostatic adenocarcinoma: characterization of cells in culture.
B lymphocytic lymphoma (large cell) of possible splenic marginal zone origin presenting with prominent splenomegaly and unusual cordal red pulp distribution.
Benign prostatic epithelial polyp of the urethra.
Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies.
BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction.
Biochemical and electrophoretic properties of acid phosphatase isozymes and their distribution in cell functions from neoplastic prostatic tissues.
Biochemical and immunological relationships of prostatic and leukocytic acid phosphatases and their subcellular localization.
Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.
Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer.
Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex).
Biologic markers in cancer diagnosis and treatment.
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Biopsy of the prostate guided by transrectal ultrasonography: early experience in a teaching community hospital.
Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting.
Blastic transformation of hairy cell leukemia.
Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.
Bone deposition, bone resorption, and osteosarcoma.
Bone formation and resorption markers as diagnostic tools for bone metastases evaluation.
Bone turnover mediates preferential localization of prostate cancer in the skeleton.
Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model.
Breast metastases of prostatic carcinoma: immunohistochemical case study.
CA125-producing adenocarcinoma of the seminal vesicle.
Cancer serum index and prostatic acid phosphatase for detection of progressive prostatic cancer.
Cancer-associated fibroblasts promote bone invasion in oral squamous cell carcinoma.
Canine peripheral nerve sheath tumor with eosinophilic cytoplasmic globules.
Carcinoembryonic antigen and carbohydrate antigen 19-9-producing adenocarcinoma of the prostate: report of an autopsy case.
Carcinoembryonic antigen and human chorionic gonadotrophin in breast carcinoma and prostatic specific acid phosphatase in prostate carcinoma.
Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.
Carcinoma of the prostate in childhood and adolescence: report of a case and review of the literature.
Carcinoma of the prostate with atypical immunohistological features. Clinical and histologic correlates.
Carcinoma of the prostate with soft tissue or non-regional lymphatic metastases at the time of diagnosis: a review of 47 cases.
Carcinoma of the prostate, Where are we?
Carcinomas metastatic to follicular adenomas of the thyroid gland. Report of two cases.
Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.
Cathepsin K regulates localization and secretion of Tartrate-Resistant Acid Phosphatase (TRAP) in TRAP-overexpressing MDA-MB-231 breast cancer cells.
Cellular and hormonal mechanisms associated with malignant bone resorption.
Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.
Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer.
Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice.
Characterization of macrophage cell line A640-BB-2: A640-BB-2 resembles peritoneal exudate macrophages in cell morphology, tumor cell recognition, responsiveness to immunomodulator OK-432 and lysosomal enzyme activity.
Characterization of two spliced variants of human phosphatidic acid phosphatase cDNAs that are differentially expressed in normal and tumor cells.
Chemotherapy in metastatic, hormone refractory prostatic cancer using chlorambucil in combination with prednisolone versus conjugate, prednimustine (Leo 1031).
Chlorella vulgaris or Spirulina platensis mitigate lead acetate-induced testicular oxidative stress and apoptosis with regard to androgen receptor expression in rats.
Cholesterol embolism of bone marrow clinically masquerading as systemic or metastatic tumor.
Chromosomal structural variations during progression of a prostate epithelial cell line to a malignant metastatic state inactivate the NF2, NIPSNAP1, UGT2B17 and LPIN2 genes.
Circadian rhythm in prostatic acid phosphatase (PAP): a potential tumor marker rhythm in prostatic cancer (PCa).
Clear cell adenocarcinoma of the female urethra showing positive staining with antibodies to prostate-specific antigen and prostatic acid phosphatase.
Clear cell adenocarcinoma of the urethra: a clinicopathologic analysis of 19 cases.
Clear cell adenocarcinoma of the urethra: evidence for origin within paraurethral ducts.
Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach.
Clinical implication of neuroendocrine differentiation in prostatic adenocarcinomas.
Clinical laboratory procedures in cancer diagnosis; serum prostatic acid phosphatase and vaginal fluid beta-glucuronidase.
Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma.
Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase.
Clinical use of tumor markers in oncology.
Comparative analysis of fluctuation of serum tumor markers in advanced cancer of prostate.
Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice.
Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease.
Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelioma, and seborrheic keratosis.
Comparison of tartrate resistant acid phosphatase in a giant cell bone tumor and a spleen infiltrated with hairy cells.
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
Constitutive in vivo mRNA expression by osteocytes of beta-actin, osteocalcin, connexin-43, IGF-I, c-fos and c-jun, but not TNF-alpha nor tartrate-resistant acid phosphatase.
Conversion of immunosuppressive monotherapy from cyclosporin a to tacrolimus reverses bone loss in rats.
Correlation between bone scans and serum levels of osteocalcin, prostate-specific antigen, and prostatic acid phosphatase in monitoring patients with disseminated cancer of the prostate.
Correlation of Serum CCL3/MIP-1? Levels with Disease Severity in Postmenopausal Osteoporotic Females
Creatine kinase BB and other markers of prostatic carcinoma.
Creatine phosphokinase isoenzymes in human prostatic tissues: a comparison between benign hyperplasia and adenocarcinoma.
Current trends in the management of localised prostate cancer.
Cystic epithelial-stromal tumor of the seminal vesicle.
Cytochemical analysis of acid hydrolases expression during phorbol diester (TPA)-driven differentiation of B-chronic lymphocytic leukaemia cells in vitro.
Cytochemical distribution of dipeptidylaminopeptidase IV (DAP IV; EC-3.4.14.5) in T-lymphoblastic lymphoma/leukemia characterized with monoclonal antibodies.
Cytochemical study of neutrophils from peripheral blood of patients with lung cancer.
Cytoenzymology of benign and malignant tumours of the corpus uteri. II. Lysosomal enzymes in relation to Golgi apparatus.
Cytotoxic activity and DNA-binding properties of isoeuxanthone derivatives.
Daphnetin inhibits RANKL-induced osteoclastogenesis in vitro.
Deficiency of dietary niacin impaired intestinal mucosal immune function via regulating intestinal NF-?B, Nrf2 and MLCK signaling pathways in young grass carp (Ctenopharyngodon idella).
Dendritic reticulum cell sarcoma? Four cases of a lymphoma probably derived from dendritic reticulum cells of the follicular compartment.
Deoxynivalenol decreased intestinal immune function related to NF-?B and TOR signalling in juvenile grass carp (Ctenopharyngodon idella).
Deoxyribonucleic acid ploidy and the direct assay of prostatic acid phosphatase and prostate specific antigen in fine needle aspiration biopsies as diagnostic methods in prostatic carcinoma.
Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation.
Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
Development of seven new human prostate tumor xenograft models and their histopathological characterization.
Diagnostic and prognostic use of bone turnover markers.
Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma.
Diagnostic value of TRACP5b expression in patients with bone tumors.
Dietary alpha-linolenic acid/linoleic acid ratios modulate immune response, physical barrier and related signaling molecules mRNA expression in the gills of juvenile grass carp (Ctenopharyngodon idella).
Dietary alpha-linolenic acid/linoleic acid ratios modulate intestinal immunity, tight junctions, anti-oxidant status and mRNA levels of NF-?B p65, MLCK and Nrf2 in juvenile grass carp (Ctenopharyngodon idella).
Dietary biotin deficiency decreased growth performance and impaired the immune function of the head kidney, spleen and skin in on-growing grass carp (Ctenopharyngodon idella).
Dietary choline deficiency and excess induced intestinal inflammation and alteration of intestinal tight junction protein transcription potentially by modulating NF-?B, STAT and p38 MAPK signaling molecules in juvenile Jian carp.
Dietary gossypol reduced intestinal immunity and aggravated inflammation in on-growing grass carp (Ctenopharyngodon idella).
Dietary pyridoxine deficiency reduced growth performance and impaired intestinal immune function associated with TOR and NF-?B signalling of young grass carp (Ctenopharyngodon idella).
Dietary vitamin C deficiency depresses the growth, head kidney and spleen immunity and structural integrity by regulating NF-?B, TOR, Nrf2, apoptosis and MLCK signaling in young grass carp (Ctenopharyngodon idella).
Differential characterization of the "reticulum cell" in lymphoreticular neoplasms.
Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.
Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma.
Differentiation of macrophages from Lewis lung carcinoma tumour cells in tissue sections by their alpha-naphthyl butyrate esterase activity.
DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer.
Does the pleomorphic xanthoastrocytoma exist? Problems in the application of immunological techniques to the classification of brain tumors.
Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases.
Ductal adenocarcinoma of the prostate: current opinion and controversies.
Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study.
Early detection of prostate cancer.
Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report.
Effect of administering cyclophosphamide and vitamin E on the levels of tumor-marker enzymes in rats with experimentally induced fibrosarcoma.
Effect of chemical modification at C1 of the glucosamine backbone of lipid A-subunit analog GLA-27 on manifestation of immunopharmacological activity.
Effect of constituents from samaras of Austroplenckia populnea (Celastraceae) on human cancer cells.
Effect of dietary astaxanthin administration on the growth performance and innate immunity of juvenile crucian carp (Carassius auratus).
Effect of hormone treatment on prostatic acid phosphatase in a serially transplantable human prostatic adenocarcinoma (PC-82).
Effect of Magnesium Supplementation on Circulating Biomarkers of Cardiovascular Disease.
Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
Effect of photoperiod on growth performance and quality characteristics of tibia and femur in layer ducks during the pullet phase.
Effect of Propionibacterium acnes or BCG on enzyme activities in spleen lymphocytes of Donryu strain rats.
Effect of unlabelled monoclonal antibody (MoAb) on biodistribution of 111indium labelled (MoAb).
Effective treatment of hormonally-unresponsive metastatic carcinoma of the prostate with adriamycin and cyclophosphamide: methods of documenting tumor response and progression.
Effects of alkaloids from Sophora flavescens on osteoblasts infected with Staphylococcus aureus and osteoclasts.
Effects of the cathepsin K inhibitor with mineral trioxide aggregate cements on osteoclastic activity.
Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats.
Effects of tumour cell culture supernatants on some biochemical activities of macrophages.
Effects of tumour mass and circulating antigen on the biodistribution of 111In-labelled F(ab')2 fragments of human prostatic acid phosphatase monoclonal antibody in nude mice bearing PC-82 human prostatic tumour xenografts.
Elevated serum acid phosphatase levels with rectal carcinoid tumor.
Elevation of lysosomal enzymes in primary Lewis lung tumor correlated with the initiation of metastasis.
Elevation of serum acid phosphatase in cancers with bone metastasis.
Enhanced therapeutic benefit of quercetin-loaded phytosome nanoparticles in ovariectomized rats.
Enhancement of osteogenesis post-splenectomy does not attenuate bone loss in ovariectomized rats.
Enzymatic activation of autotaxin by divalent cations without EF-hand loop region involvement.
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Enzyme activity profiles in mouse teratocarcinomas. A quantitative ultramicroscale analysis.
Enzyme histochemical investigations on bone and soft tissue tumours.
Enzyme histochemical studies on transplantable pancreatic adenocarcinomas in Syrian golden hamsters.
Enzyme histochemical study on bone tumors.
Enzyme histochemistry and thyroid neoplasia.
Enzyme histochemistry is useful to assess viability of tumor tissue after microwave coagulation therapy (MCT): metastatic adenocarcinoma treated by lateral segmentectomy after MCT.
Enzymes in peripheral and bone marrow serum in patients with cancer.
Epithelioid angiosarcoma: A neoplasm with potential diagnostic challenges.
Erythrocyte polyamine levels in human prostatic carcinoma.
Establishment and characterization of transplantable tumor derived from a spontaneous malignant fibrous histiocytoma in the mouse.
Establishment of a new prostatic carcinoma cell line (TSU-Pr1).
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells.
Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
Evaluation the effect of thiamin deficiency on intestinal immunity of young grass carp (Ctenopharyngodon idella).
Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties.
Exogenous phospholipids supplementation improves growth and modulates immune response and physical barrier referring to NF-?B, TOR, MLCK and Nrf2 signaling factors in the intestine of juvenile grass carp (Ctenopharyngodon idella).
Experience with an animal model for the study of prostatic carcinoma.
Experience with prostate-specific antigen in prostatic carcinoma.
Expression of E-cadherin in primary prostate cancer: correlation with clinical features.
Expression of FMC7 antigen and tartrate-resistant acid phosphatase isoenzyme in cases of B-lymphoproliferative diseases.
Expression of human prostatic acid phosphatase in a pancreatic islet cell carcinoma.
Expression of prostate specific antigen in male breast cancer.
Expression of prostatic acid phosphatase (PSAP) in transurethral resection specimens of the prostate is predictive of histopathologic tumor stage in subsequent radical prostatectomies.
Expression of the muscle-associated gene MYF6 in hairy cell leukemia.
Expression, regulation and function of autotaxin in thyroid carcinomas.
Extraocular muscle metastasis 16 years following primary prostate carcinoma.
Extraskeletal osteoclastomas responsive to dexamethasone treatment in Paget bone disease.
FACS quantitation of leucine aminopeptidase and acid phosphatase on tumor-associated macrophages from metastatic and nonmetastatic mouse mammary tumors.
False positive values of PAP and PSA in complicated and non-complicated benign prostatic hypertrophy.
Fertaric Acid Protects from Octylphenol-Related Hepatotoxicity in Rats: Biochemical, Molecular, and Histopathological Studies.
Fine structural localisation of acid phosphatase in neural tumours induced by N-ethyl-N-nitrosourea in rats.
Fine-needle aspiration of metastatic prostatic neuroendocrine carcinomas: cytomorphologic and immunophenotypic features.
Functional and biochemical characterization of osteoclast-like cells derived from giant cell tumours of bone.
Gene Expression in Osteolysis: Review on the Identification of Altered Molecular Pathways in Preclinical and Clinical Studies.
Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis.
Genistein prevents bone loss in type 2 diabetic rats induced by streptozotocin.
Giant cell tumor of bone. Variations in patterns of appearance of different cell types.
Giant cell tumor of bone: fine structural localization of acid phosphatase.
Giant Cell Tumor of Bonelike Lesion in a Trp53 Mutant Mouse.
Giant cell tumors: inquiry into immunohistochemical expression of CD117 (c-Kit), microphthalmia transcription factor, tartrate-resistant acid phosphatase, and HAM-56.
Giant cells in anaplastic mammary carcinoma of the dog and cat.
Giant dumbbell-shaped prostatic cystadenoma presenting as pelvic and scrotal mass.
Greatwall promotes cell transformation by hyperactivating AKT in human malignancies.
Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase.
Hepatocellular carcinoma with osteoclast-like giant cells: possibility of osteoclastogenesis by hepatocyte-derived cells.
Heterogeneity and prognostic significance of macrophages in human colonic carcinomas.
Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis.
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.
High-dose medroxyprogesterone acetate versus prednisolone in hormone-resistant prostatic cancer. A pilot study.
Histochemical and electron-microscopic aspects of bone tumor diagnosis.
Histochemical and immunohistochemical characterization of cells constituting the giant cell tumor of bone.
HISTOCHEMICAL DIFFERENTIATION OF CARCINOMA OF THE PROSTATE GLAND FROM OTHER TUMORS BY A MODIFIED ACID PHOSPHATASE REACTION.
Histochemical evidence of osteoclastic degradation of extracellular matrix in osteolytic metastasis originating from human lung small carcinoma (SBC-5) cells.
Histochemical investigation of nonspecific acid phosphatase in cerebral tumors.
HISTOCHEMICAL STUDIES ON ALKALINE AND ACID PHOSPHATASE IN THE LIVERS OF TWENTY-SEVEN PATIENTS OPERATED ON FOR CANCERS OF THE ABDOMINAL ORGANS.
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Histogenesis of Kaposi's sarcoma associated with AIDS: a histologic, immunohistochemical and enzyme histochemical study.
Histological grading, histochemistry, and electron microscopy of scirrhous carcinoma of the breast.
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.
Hormonal therapy in prostatic carcinoma.
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer.
Human cytokine response to Texas crotaline envenomation before and after antivenom administration.
Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Human hepatocellular carcinoma and putative precancerous disorders: their enzyme histochemical study.
Hydrogen sulfide regulates bone remodeling and promotes orthodontic tooth movement.
Hydrolytic enzymes in meningiomal subtypes.
I?BET151 inhibits osteoclastogenesis via the RANKL signaling pathway in RAW264.7 macrophages.
Identification of diagnostic upper gastrointestinal cancer tissue type-specific urinary biomarkers.
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.
Identification of elicitor-responsive proteins in rice leaves by a proteomic approach.
Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.
Identification of T helper epitopes from prostatic acid phosphatase.
Immunocytochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer.
Immunocytochemical localization of an immunoconjugate (antibody IgG against prostatic acid phosphatase conjugated to 5-fluoro-2'-deoxyuridine) in human prostate tumors.
Immunofluorescent identification of antibodies specific for prostatic acid phosphatase.
Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
Immunohistochemical identification of prostatic acid phosphatase: correlation of tumor grade with acid phosphatase distribution.
Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Immunohistochemistry in diagnostic surgical pathology of the prostate.
Immunohistological localization of prostatic acid phosphatase.
Immunologic testing of patients with genitourinary malignancies.
Immunological and biochemical evidence for identity of tartrate-resistant isoenzymes of acid phosphatases from human serum and tissues.
Immunological classification of acute lymphoblastic leukaemias: evaluation of its clinical significance in a hundred patients.
Immunological studies on the antitumor effect of sporamycin.
Immunoperoxidase staining of acid phosphatase in human prostatic tissue.
Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice.
Improved immunohistochemical detection of prostatic acid phosphatase by a monoclonal antibody.
Incidence of serum acid phosphatase elevation after transurethral prostatectomy.
Increased activity of lysosomal glycohydrolases in glioma tissue and surrounding areas from human brain.
Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection.
Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy.
Increased osteoclast activity is associated with aggressiveness of osteosarcoma.
Increasing Dietary Fish Oil Reduces Adiposity and Mitigates Bone Deterioration in Growing C57BL/6 Mice Fed a High-Fat Diet.
Induction of autoimmune arthritis after direct injection of bone marrow cells from arthritis-prone SKG/Jcl mice into bone cavity of normal mice.
Induction of tumor specific cytotoxic T lymphocytes in prostate cancer using prostatic acid phosphatase derived HLA-A2402 binding peptide.
Infiltration by macrophages and lymphocytes in transplantable mouse sarcoma after irradiation with high-intensity focused ultrasound.
Inflammation with restricted lysosomal proteolysis during early ascites carcinoma invasion of mouse parietal peritoneum. A medium and high-voltage electron microscopic and cytochemical study.
Inflammatory and bone turnover markers in a cross-sectional and prospective study of acute Charcot osteoarthropathy.
Inflammatory fibrous histiocytoma of bone.
Influence of adjuvant therapy with green tea extract in the treatment of experimental periodontitis.
Influence of quercetin on B16 melanotic melanoma growth in C57BL/6 mice and on activity of some acid hydrolases in melanoma tissue.
Influence of tumor grade on survival and on serum acid phosphatase levels in metastatic carcinoma of the prostate.
Inhibition of human prostatic tumour acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustards.
Inhibitory effects of Estracyt on R-3327 rat prostatic carcinoma.
Interaction of tumor and surrounding tissue of mice inoculated B16 melanoma variants in terms of enzyme activity.
Interlaboratory surveys of the determination of tumour markers scatter and repeatability of the results.
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Intermittent therapy with 1,25 vitamin D and calcitonin prevents cyclosporin-induced alveolar bone loss in rats.
Intracellular enzymatic response of lymphocytes and neutrophils in patients with cancer of the larynx.
Intravesical botryoid adenocarcinoma of the prostate: report of an unusual growth pattern of prostatic carcinoma simulating a urinary bladder tumor.
Intrinsic fibroblast-mediated remodeling of damaged collagenous matrices in vivo.
Invasive carcinoma of prostate presenting as rectal carcinoma.
Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice.
Is disease flare a problem?
Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.
KLF2 (kruppel like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
Kockdown of ACP5 inhibits hepatocellular carcinoma progression.
Label-free capacitive diagnostics: exploiting local redox probe state occupancy.
Laparoscopic pelvic lymph node dissection.
Levels of enzymes in leukaemic mice treated withAeromonas L-asparaginase.
Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts.
LH-RH analogue treatment for advanced prostate cancer.
Lipin-1 determines lung cancer cell survival and chemotherapy sensitivity by regulation of endoplasmic reticulum homeostasis and autophagy.
LNCaP model of human prostatic carcinoma.
Localization of parathyroid hormone-related protein in osteoclasts by in situ hybridization and immunohistochemistry.
Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer.
Low or excess levels of dietary cholesterol impaired immunity and aggravated inflammation response in young grass carp (Ctenopharyngodon idella).
Lymphangiography and fine-needle aspiration biopsy: ineffective for staging early prostate cancer.
Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells.
Lymphocyte lysosomal acid phosphatase in patients with carcinoma of the larynx.
Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis.
LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor ? Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.
Lysosomal acid phosphatase: activity and isoenzymes in separated normal human blood cells.
Lysosomal enzymes in macrophages of colonic tumors induced in rats by 1,2-dimethylhydrazine dihydrochloride.
Lysosomal enzymes in peripheral blood lymphocytes of patients with gastric cancer.
Macrophage-induced enhancement of endogenous tumor lysosome activity.
Macrophages in human tumours: an immunohistochemical study.
Magnolol prevents ovariectomy?induced bone loss by suppressing osteoclastogenesis via inhibition of the nuclear factor??B and mitogen?activated protein kinase pathways.
Malignant giant cell tumor of bone. Fine structure and localization of acid phosphatase.
Malignant histiocytosis (true histiocytic lymphoma) clinicopathological study of 25 cases.
Malignant histiocytosis and related tumors. A clinicopathologic study of 42 cases using cytological, histochemical and ultrastructural parameters.
Malignant histiocytosis. Immunohistochemical characterization on paraffin embedded tissue.
Malignant lymphoma of true histiocytic origin: histiocytic sarcoma. A morphological, ultrastructural, immunological, cytochemical and clinical study of 10 cases.
Malignant lymphoma simulating leukemic reticuloendotheliosis: a clinicopathologic study of ten cases.
Malignant neuroendocrine tumor of the jejunum with osteoclast-like giant cells. Enzyme histochemistry distinguishes tumor cells from giant cells.
Management of high risk metastatic prostate cancer: the case for novel therapies.
Manganese deficiency or excess caused the depression of intestinal immunity, induction of inflammation and dysfunction of the intestinal physical barrier, as regulated by NF-?B, TOR and Nrf2 signalling, in grass carp (Ctenopharyngodon idella).
MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis.
Markedly raised serum prostate specific antigen levels. Prostatic infarction rather than malignancy?
Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid.
Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Measurement of eicosanoid release in keratinocyte cultures to investigate skin irritation and tumour promoting activity.
Measurement of prostate-specific antigen and prostatic acid phosphatase concentrations in serum before and 1-42 days after transurethral resection of the prostate and orchidectomy.
Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature.
Metabolomics analysis of the therapeutic effects of Qiwei Tongbi oral liquid on rheumatoid arthritis in rats.
Metastatic prostatic adenocarcinoma of male breast.
Microphotometric quantitation of enzyme activities in giant cell tumor of bone. A case study.
MiR-377 inhibits wear particle-induced osteolysis via targeting RANKL.
Modification of the effects of hyperthermia and neutron radiation on the activity of acid phosphatase in CaNT tumors.
Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis.
Molecular cloning of two alternatively spliced forms of human phosphatidic acid phosphatase cDNAs that are differentially expressed in normal and tumor cells.
Monitoring and treatment of minimal residual cancer of the prostate.
Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas.
Morphometric and ultrastructure features of the ventral prostate of rats (Rattus norvegicus) submitted to long-term nicotine treatment.
Mucinous adenocarcinoma of the prostate gland.
Mucinous adenocarcinoma of urinary bladder type arising from the prostatic urethra. Distinction from mucinous adenocarcinoma of the prostate.
Multienzymatic analyses of human malignant lymphomas. Correlation of enzymatic data with pathologic and ultrastructural findings in Burkitt's and lymphoblastic lymphomas.
Multiple cutaneous metastases in the chest from prostatic carcinoma.
Multiple granular-cell tumors of the ascending colon: microscopic study.
Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres.
Multivariate analysis of factors predicting local relapse after radical prostatectomy--possible indications for postoperative radiotherapy.
Multivariate analysis of plasma hormones in patients with metastatic prostate cancer receiving combined LHRH-analog and antiandrogen therapy.
Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.
Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells.
Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasis.
Neuroendocrine tumors of the liver and pancreas associated with elevated serum prostatic acid phosphatase.
New hypotheses on the function of the avian shell gland derived from microarray analysis comparing tissue from juvenile and sexually mature hens.
New model for bone resorption study in vitro: human osteoclast-like cells from giant cell tumors of bone.
Nonsurgical management of patients with stage D1 adenocarcinoma of prostate: risks vs benefits.
Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatments.
Novel insights into the intestinal immune regulatory effects of (2-Carboxyethyl) dimethylsulfonium Bromide (Br-DMPT) in on-growing grass carp (Ctenopharyngodon idella).
Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice.
Nuclear binding of androgens and acid phosphatase activity in prostatic tumors of Nb rats.
Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells.
On low acid phosphatase values of patients with known metastatic cancer of the prostate.
Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.
Optimal ?-lipoic acid strengthen immunity of young grass carp (Ctenopharyngodon idella) by enhancing immune function of head kidney, spleen and skin.
Orbital metastasis as presenting symptom from a prostatic adenocarcinoma.
Origin of the increased activity of beta-glucuronidase in the soluble fraction of rat mammary tumors during ovariectomy-induced regression.
Osteoclast origin of giant cells in giant cell tumors of bone: ultrastructural and cytochemical study of six cases.
Osteopenic effects of high-fat diet-induced obesity on mechanically induced alveolar bone remodeling.
Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.
Overexpressed ACP5 has prognostic value in colorectal cancer and promotes cell proliferation and tumorigenesis via FAK/PI3K/AKT signaling pathway.
p90/CIP2A mediates breast cancer cell proliferation and apoptosis.
Papillary adenocarcinoma of the male urethra. Case report and review of the literature.
Papillary adenocarcinomas of the prostate. An immunohistochemical study.
Papillary carcinoma of the prostate, location, morphology, and immunohistochemistry: the histogenesis and entity of so-called endometrioid carcinoma.
Papillary eccrine adenoma. A tubulopapillary hidradenoma with eccrine differentiation.
Paraganglioma of the prostatic urethra. A report of three cases and a review of the literature.
Pathological changes on human breast cancer specimens ablated in vitro with high-intensity focused ultrasound.
Patient derived mutation W257G of PPP2R1A enhances cancer cell migration through SRC-JNK-c-Jun pathway.
Pelvic lymphadenectomy for staging prostatic carcinoma: is it always necessary?
Phagocytosis of candida albicans by lymphatic tumour cells in vitro.
Phase change enzyme immunoassay.
Phenotypic heterogeneity of human T-cell malignancies: demonstration by monoclonal antibodies and cytochemical markers.
Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease.
Phyllodes tumor of the prostate: long-term followup study of 23 cases.
Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells.
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma.
Pleomorphic giant cell carcinoma of the prostate.
Porous titanium granules promote bone healing and growth in rabbit tibia peri-implant osseous defects.
Postoperative expressions of TRACP5b and CA125 in patients with breast cancer and their values for monitoring bone metastasis.
Potential therapeutic effect of adriamycin-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
Predication of the effect of carcinostatic agents on tumor-bearing host by the sensitivity test using acid phosphatase activity in vitro.
Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
Prediction of prognosis in untreated stage A2 prostatic carcinoma.
Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study.
Prelinimary report on combination therapy for advanced prostatic cancer.
Prevalence of intratubular germ cell neoplasia in cryptorchid testes of infertile men.
Primary carcinoid tumor in a polycystic kidney.
Primary carcinoid tumor of the kidney with special reference to its histogenesis.
Primary carcinoid tumor of the prostate with concurrent adenocarcinoma: a case report.
Primary malignant fibrous histiocytoma of skin.
Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen.
Primary prostatic endodermal sinus tumor (yolk sac tumor) combined with a small focal seminoma.
Primary signet ring cell carcinoma of the prostate: report and review of 42 cases.
Primary signet-ring stromal tumor of the testis.
Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine.
Prognostic factors in carcinoma of the prostate--analysis of RTOG study 75-06.
Prognostic factors in patients with advanced stage prostate cancer.
Prognostic factors in progression-free survival and corrected survival in patients with advanced prostatic cancer: results from a randomized study comprising 150 patients treated with orchiectomy or estrogens.
Prognostic Significance of ACP5 in Human Gastric Cancer.
Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
Prostate antigen: a new potential marker for prostatic cancer.
Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood.
Prostate cancer. Promising advances that may alter survival rates.
Prostate cancer: a model of cancer in the elderly.
Prostate cancer: Experience at King Abdulaziz University Hospital, Jeddah.
Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
Prostate specific antigen progression rates after radical prostatectomy or radiation therapy for localized prostate cancer.
Prostate specific antigen: clinical use in the diagnosis and management of prostate cancer.
Prostate-specific acid phosphatase in carcinoid tumors.
Prostate-specific antigen as a marker of adenocarcinoma of prostate.
Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer.
Prostate-specific antigen in management of prostatic carcinoma.
Prostate-specific antigen in the follow-up of prostatic adenocarcinoma treated with external beam radiation.
Prostatic acid phosphatase by radioimmunoassay tumor marker in bone marrow.
Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
Prostatic acid phosphatase in carcinoid and islet cell tumors.
Prostatic acid phosphatase in strumal carcinoids of the ovary. An immunohistochemical study.
Prostatic acid phosphatase in the serially transplantable human prostatic tumor lines PC-82 and PC-EW.
Prostatic acid phosphatase is a possible tumor marker for intravascular large B-cell lymphoma.
Prostatic adenocarcinoma PC EW, a new human tumor line transplantable in nude mice.
Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings.
Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase.
Prostatic cancer. VII. Serum acid phosphatase response to cholinergic stimulation in prostatic cancer patients.
Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
Prostatic carcinoma with endocrine features. A report of a neoplasm containing multiple immunoreactive hormonal substances.
Prostatic cystic epithelial-stromal tumors: a report of 2 new cases.
Prostatic origin of fucosyl transferase in human seminal plasma--a study on healthy controls and on men with infertility or with prostatic cancer.
Prostatic origin of tumors. An immunohistochemical study.
Prostatic serum acid phosphatase level in cancer of the prostate; diagnostic and clinical significance as illustrated by thirteen case histories.
Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Prostatic specific antigen as an indicator of response to radiotherapy in prostate cancer.
Prostatic tumor acid phosphatase production. Influence of antineoplastic agents.
Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs.
Protective Effect of Origanum Oil on Alterations of Some Trace Elements and Antioxidant Levels Induced by Mercuric Chloride in Male Rats.
Protective effect of the effective part of Andrographis paniculata (Burm.f.) Nees on PM2.5-induced lung injury in rats by modulating the NF-?B pathway.
Protective effect of zinc on N-methyl-N-nitrosourea and testosterone-induced prostatic intraepithelial neoplasia in the dorsolateral prostate of Sprague Dawley rats.
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA Approved Therapeutic Cancer Vaccine.
Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
Putrescine enhances intestinal immune function and regulates intestinal bacteria in weaning piglets.
Quantitation of prostate-specific acid phosphatase in prostate cancer: reproducibility and correlation with subjective grade.
Quantitative peroxidase-antiperoxidase complex-substrate mass determination in tissue sections by a dual wavelength method.
R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostate cancer.
R3327 prostate adenocarcinoma clonogenic cells: epithelial properties and hormone response.
Radiation therapy in the management of localized carcinoma of the prostate: a preliminary report.
Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results.
Radical prostatectomy or radiotherapy in carcinoma of prostate. The dilemma continues.
Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging.
Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer.
Receiver operator characteristic (ROC) curves and non-normal data: an empirical study.
Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens.
Rectal and colonic carcinoids. A clinicopathologic study of 84 cases.
Redox inhibition of protein phosphatase PP2A: Potential implications in oncogenesis and its progression.
Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?
Relationship of prostatic acid phosphatase localization in human prostate by a monoclonal antibody with the Gleason grading system.
RENAL ORIGIN OF URINARY ACID PHOSPHATASE IN NORMAL AND IN PATIENTS WITH CANCER OF THE PROSTATE.
Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer.
ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia.
Resolution of bony metastases after bilateral orchiectomy for carcinoma of prostate.
Response patterns of hairy cell leukemia to B-cell mitogens and growth factors.
Responses to Cytokine Inhibitors Associated with Cellular Composition in Models of Immune-Mediated Inflammatory Arthritis.
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.
Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer.
Retinoic acid binding protein in normal and neopolastic rat prostate.
Review of acid phosphatase in the diagnosis and prognosis of prostatic cancers.
Reviving the acid phosphatase test for prostate cancer.
Role of lymphography in carcinoma of the prostate.
Role of nerve-sparing radical prostatectomy for clinical stage B2 prostate cancer.
Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.
Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
Salivary duct carcinoma secreting prostate-specific antigen.
Sarcoma arising from interdigitating cells. Cytology and cytochemistry.
Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection.
Screening for occult nodal metastasis in localized carcinoma of the prostate.
Serum acid phosphatase as a tumour marker in giant cell tumour of bone.
Serum acid phosphatase can be a useful tumour marker for giant cell tumour of bone.
Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
Serum and seminal markers in the diagnosis of disorders of the genital tract of the dog: a mini-review.
Serum ceruloplasmin as a marker in prostate cancer.
Serum chromogranin-A in advanced prostate cancer.
Serum Levels of NTx and TRACP5b in Giant Cell Tumor of Bone and its Clinical Implications.
Serum levels of procollagen type I carboxyterminal extension peptide in cancer patients with bone metastases.
Serum prostatic acid phosphatase activity and prostate specific antigen when the prostate gland is enlarged.
Serum prostatic acid phosphatase and cancer of the prostate.
Serum prostatic acid phosphatase in cancer of the prostate.
Serum PSA and PAP measurements discriminating patients with prostate carcinoma from patients with nodular hyperplasia.
Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.
Serum total acid phosphatase for monitoring the clinical course of giant cell tumors of bone--26 patients with 5 local recurrences.
Signet-ring carcinoma of the prostate.
Significance of "high" acid phosphatase activity in the serum of normal children.
Similarities between giant cell tumor of bone, giant cell tumor of tendon sheath, and pigmented villonodular synovitis concerning ultrastructural cytochemical features of multinucleated giant cells and mononuclear stromal cells.
Single-step purification of prostatic acid phosphatase: immunoaffinity chromatography with a monoclonal antibody.
Sipuleucel-T: Prototype for development of anti-tumor vaccines.
Size dependent enzyme activities of multinucleated (osteoclastic) giant cells in bone tumors.
Skene's gland adenocarcinoma with intestinal differentiation: A case report and literature review.
Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients.
Sodium butyrate improved intestinal immune function associated with NF-?B and p38MAPK signalling pathways in young grass carp (Ctenopharyngodon idella).
Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts.
Some biochemical characteristics of hormone-secreting pituitary tumors and of the host's anterior pituitary gland.
Some factors other than neoplasms altering the prostatic fraction of acid phosphatase in the serum.
Specific tumor markers in diagnostic cytology. Immunoperoxidase studies of carcinoembryonic antigen, lysozyme and other tissue antigens in effusions, washes and aspirates.
Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases.
Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-?B pathways.
Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion.
Structural Characterization and Immunostimulatory Activity of a Homogeneous Polysaccharide from Sinonovacula constricta.
Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model.
Studies of estrogen induced renal tumours in male Syrian hamsters. I. Cytochemical studies of lysosomal enzymes acid phosphatase and beta-glucuronidase.
STUDIES OF FIBRINOLYSIS AND ACID PHOSPHATASE IN CANCER OF THE PROSTATE.
Studies on acid phosphatase isoenzymes in tumors of bone and soft parts (author's transl)]
Studies on glycolytic enzymes in relation to cancer. 3. Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase.
Successful resection of a solitary metastatic liver tumor from prostate cancer 15 years after radical prostatectomy: a case report.
Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Surface engineering of titanium substrates with chitosan-atorvastatin conjugate for reduced inflammation responses and improved cytocompatibility.
Surgical treatment of carcinoma of the prostate.
Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers.
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation.
Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female rats.
Targeted therapy for prostate cancer: the Memorial Sloan-Kettering Cancer Center approach.
Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGF?2/T?R and CD44 in MDA-MB-231 breast cancer cells.
Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma.
Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear ?B ligand.
Tartrate-Resistant Acid Phosphatase 5b is a Useful Serum Marker for Diagnosis and Recurrence Detection of Giant Cell Tumor of Bone.
Tartrate-resistant acid phosphatase in serum of cancer patients.
Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
Teriparatide rapidly improves pain-like behavior in ovariectomized mice in association with the downregulation of inflammatory cytokine expression.
Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study.
Tetrandrine Attenuates Cartilage Degeneration, Osteoclast Proliferation, and Macrophage Transformation through Inhibiting P65 Phosphorylation in Ovariectomy-induced Osteoporosis.
The activation state of macrophage subpopulations from a murine fibrosarcoma.
The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.
The application of prostate specific membrane antigen in CART?cell therapy for treatment of prostate carcinoma (Review).
The assessment of disease aggressivity in stage D2 prostate cancer patients (review).
The chemotherapy of prostatic adenocarcinoma.
The correlation between a chronic inflammatory marker Tartrate-resistant acid phosphatase 5a with cancer cachexia.
The effect of human cytomegalovirus on selected functions of peripheral blood monocytes.
The effect of treatment with 4-hydroxyandrostenedione or medroxyprogesterone acetate on human breast tumour regression.
The effects of dietary omega-3 fatty acids on the DU-145 transplantable human prostatic tumor.
The effects of some tumor markers on human erythrocyte (HCA-I and HCA-II), bovine erythrocyte (BCA) and bovine lung (CA-IV) carbonic anhydrase enzyme activities in vitro.
The efficacy of serum prostate specific antigen as a tumour marker in prostatic carcinoma: a comparison with serum acid phosphatase.
The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.
The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor.
The histogenesis of small cell carcinoma of the prostate. An immunohistochemical study.
The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site.
The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry.
The impaired intestinal mucosal immune system by valine deficiency for young grass carp (Ctenopharyngodon idella) is associated with decreasing immune status and regulating tight junction proteins transcript abundance in the intestine.
The improved growth performance and enhanced immune function by DL-methionyl-DL-methionine are associated with NF-?B and TOR signalling in intestine of juvenile grass carp (Ctenopharyngodon idella).
The Influence of Bone Type on the Gene Expression in Normal Bone and at the Bone-Implant Interface: Experiments in Animal Model.
The interaction of monocytes with rheumatoid synovial cells is a key step in LIGHT-mediated inflammatory bone destruction.
The laboratory diagnosis of prostatic adenocarcinoma.
The loss of NDRG2 expression improves depressive behavior through increased phosphorylation of GSK3?.
The mechanism of hepatic graft protection against reperfusion injury by prostaglandin E1.
The natural course of low grade, non-metastatic prostatic carcinoma.
The Nb rat prostatic adenocarcinoma model system.
The Nb rat: prostatic adenocarcinoma model.
The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localized human prostatic adenocarcinoma.
The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer.
The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study.
The role of ?-zearalanol in reversing bone loss induced by ovarian hormone deficiency in rats.
The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling.
The role of new modalities in the early detection and diagnosis of prostate cancer.
The role of serum prostatic acid phosphatase as a tumor marker in men with advanced adenocarcinoma of the prostate.
The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
The salubrious effect of tamoxifen [correction of Tamaxifen] on serum marker enzymes, glycoproteins, and lysosomal enzymes level in breast cancer woman.
The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
The small chemical enzyme inhibitor 5-phenylnicotinic acid/CD13 inhibits cell migration and invasion of tartrate-resistant acid phosphatase/ACP5-overexpressing MDA-MB-231 breast cancer cells.
The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.
The treatment of metastatic prostatic cancer with a potent luteinizing hormone releasing hormone analogue.
The ultrastructural localization of secretory acid phosphatase in giant cell tumor of bone.
The use of leukocyte acid phosphatase in the diagnosis of malignant disease. Case report and review of literature.
The use of serum isoenzymes of alkaline and acid phosphatase as possible quantitative markers of tumor load in prostate cancer.
The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.
The value of acid phosphatase measurements in predicting extraprostatic cancer growth before radical prostatectomy.
Therapeutic cancer vaccines.
Thiamin deficiency induces impaired fish gill immune responses, tight junction protein expression and antioxidant capacity: Roles of the NF-?B, TOR, p38 MAPK and Nrf2 signaling molecules.
Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma.
Topical Treatment with Xiaozheng Zhitong Paste (XZP) Alleviates Bone Destruction and Bone Cancer Pain in a Rat Model of Prostate Cancer-Induced Bone Pain by Modulating the RANKL/RANK/OPG Signaling.
Transitional cell carcinoma of the prostate.
Treatment of advanced prostatic carcinoma with D-Trp-6-LH-RH.
Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model.
Treatment response criteria for prostatic cancer.
Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons.
Triple drug chemotherapy in treatment of prostate adenocarcinoma Nb Pr A.I.-III.
Tubulocystic clear cell adenocarcinoma arising within the prostate.
Tumor antigen and acid phosphatase isoenzyme in prostatic cancer.
Tumor marker doubling time in patients with prostate cancer: determination of prostate-specific antigen and prostatic acid phosphatase doubling time.
Tumor markers in chronic renal failure and hemodialysis patients.
Tumor markers in patients with chronic renal failure.
Tumor markers in prostate cancer.
Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis.
Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone.
Tumour lines from a spontaneous rat endometrial stromal sarcoma, showing dendritic cell-like and myofibroblastic cell-like phenotypes.
Tumour markers in prostatic cancer.
Tumour markers in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase.
Tumour of female paraurethral duct. Immunohistochemical similarity with prostatic carcinoma.
Ultrastructural changes in human prepubertal prostatic epithelium grown in vitro.
Ultrastructural localization of acid phosphatase in human laryngeal carcinoma.
Ultrastructure of tumor cell interaction with alveolar macrophages stimulated by vitamin A.
Unusual behaviour of the LNCaP prostate tumour xenografted in nude mice.
Unusual prostatic adenocarcinoma with endocrine basophilic FSH-immunoreactive cells.
Urothelial and prostate carcinoma metastasizing to the same lymph node: a case report and review of the literature.
Urothelial carcinoma of the urinary bladder with a component of acinar/tubular type differentiation simulating prostatic adenocarcinoma.
Use of enzyme histochemistry in the diagnosis of pancreatoblastoma.
Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears.
Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer.
Validation of commonly used immunostains on cell-transferred cytologic specimens.
Variants in ACPP are associated with cerebrospinal fluid Prostatic Acid Phosphatase levels.
VEGF165 promotes the osteolytic bone destruction of ewing's sarcoma tumors by upregulating RANKL.
Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens.
Well-differentiated endocrine tumours of the middle ear and of the hindgut have immunocytochemical and ultrastructural features in common.
Wild-type p53 gene transfer resulted in cell cycle arrest, but not apoptosis of newly established human malignant fibrous histiocytoma cell line.
Yap1 Acts Downstream of ?-Catenin to Control Epidermal Proliferation.
[A case of clear cell adenocarcinoma of the female urethra]
[A case of effective urgent irradiation therapy for metastatic spine tumor]
[A case of giant prostate cancer]
[A case of prostate cancer with multiple pulmonary metastases]
[A case of prostatic adenocarcinoma with pulmonary metastases--diagnosis by transbronchial lung biopsy and immunohistochemistry]
[A case of prostatic carcinoma presenting as a metastatic orbital tumor]
[A primary adenocarcinoma of the seminal vesicles. Case report of a rare malignancy]
[Acid phosphatase as tumor marker of prostatic cancer]
[Acid phosphatase in the blood serum of male patients with tumors of the urinary and genital organs.]
[Acid phosphatase isoenzyme composition of the lysosomes of normal and tumor cells]
[Acid phosphatase of prostatic origin and its value in the diagnosis of cancer of the prostate.]
[Action of some effectors and of Triton X-100 on the acid phosphatase in cerebral tumors studied histochemically]
[Adenomatous polyps with prostatic type epithelium: a report of two cases]
[Antitumor effects of aromatic retinoids (Ro 10-1670, Ro 10-9359) on the chemically-induced epithelial tumors]
[Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies]
[Blood acid phosphatase in apparently healthy subjects and in those with prostatic adenoma and cancer.]
[Cancer of the prostate: the markers other than prostatic acid phosphatase]
[Changes in tumor markers following cryosurgery of prostate carcinoma]
[Chronic T-cell lymphoid leukemia with helper cell phenotype]
[Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma]
[Clinical significance of prostatic acid phosphatase assay as a tumor marker]
[Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein]
[Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein]
[Clinical study of tumor markers in prostatic cancer]
[Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)]
[Clinicopathological features of primary seminal vesicle adenocarcinoma: A report of 4 cases and review of the literature].
[Clinicopathological study of nonpalpable and nonvisible (stage T1c) prostate cancer]
[Comparative study in man of acid phosphatase levels in the colonic mucosa and corresponding tumor tissue]
[Comparison of tumor markers versus their relative values to prostatic volume in detecting prostate cancer]
[Correlation of gastroscopic, pathohistologic, cytologic and cytochemical analysis of ulcer lesions and other pathologic changes in the gastric mucosa. Preliminary study]
[Correlation of vessel invasion and bone metastasis in prostatic adenocarcinoma. A clinico-pathological and immunohistochemical study of 33 cases of total prostatectomy]
[Creatine phosphotransferase, B subunit, as a tumor marker. Preliminary results]
[Cytochemical analysis of acid phosphatase and beta glucuronidase in B-cell non-Hodgkin's lymphoma of low-grade malignancy]
[Demonstration of osteoclastic acid phosphatase in the serum of patients with giant cell tumors. Preliminary study]
[Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate]
[Determination of tumor marker doubling time in the patients with prostate cancer relapsed from endocrine therapy]
[Early diagnosis of proststic cancer by determination of proststic acid phosphatase in the plasma.]
[Effect of oxidative stress on periprosthetic osteolysis induced by TCP wear particles in mouse calvaria and its mechanism].
[Effect of pulsed laser radiation on the lysosomes of Ehrlich ascitic tumor cells]
[Electron-microscopic histochemistry of phosphohydrolases in the normal mucosa and in the cells of human gastric adenocarcinoma]
[Enzyme and isoenzyme activity in patients with malignant tumors of the oral mucosa]
[Enzyme cytochemical studies of malignant cutaneous lymphomas using simple smear preparations]
[Enzyme cytochemistry and morphometric study of the effects of macrophages on A549 pulmonary alveolar cell carcinoma cell line]
[Enzyme study in cancer of the prostate. Action of ionized calcium on acid phosphatase.]
[Enzymological study of prostatic cancer. I. Changes of serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase, glutamic pyruvic transaminase, glutamic oxalacetic transaminase activity and lactic dehydrogenase isoenzymes in prostatic cancer under anti-androgenic treatment, with special reference to prognosis]
[Enzymological study of prostatic cancer. II. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase activity and lactic dehydrogenase isoenzymes in prostatic cancer, with special reference to relation with stage and histological malignancy]
[Evaluation of two serum isoenzyme phosphatases as bone metastasis markers]
[Experience with transrectal ultrasonic studies in patients with prostatic tumors]
[Expression of endocrine-paracrine cells in prostatic carcinoma]
[Histochemical and ultrastructural investigations on organ culture of malignant tumors (author's transl)]
[HISTOCHEMICAL STUDIES ON ALKALINE AND ACID PHOSPHATASE IN THE LIVER OF PATIENTS OPERATED ON FOR CANCER OF THE ABDOMINAL ORGANS.]
[Histochemical study of acid phosphatase in tumor cells of stomach cancer]
[Immunochemical analysis of prostatic acid phosphatase. 3. Evaluation of patients with prostatic cancers and cancer of other organs and a comparison with conventional method]
[Immunochemical tests in the diagnosis of diseases of the male reproductive system]
[Indices of proteolysis in evaluation of resorption in bone tumors]
[Lymphatic involvement predominating and revealing prostatic carcinoma]
[Lysosomal acid phosphatase of lymphocytes in patients with cancer of the larynx (authors transl)]
[Lysosomal enzymes in the neoplastic pathology of the uterine cervix. Study of acid phosphatase in the diagnostic test of vaginal secretions in patients with pre-invasive and invasive cancer of the uterine cervix. I. Methods and preliminary experiences]
[Malignant histiocytosis in children (pathologicoanatomic study of 16 cases)]
[Microanalysis in oncological diagnosis]
[Molecular forms of acid phosphatase in malignant lung tumors]
[Monoclonal anti-prostatic acid phosphatase antibodies (production and characterization)]
[Morphohistochemical and electron microscopic characteristics of malignant tumors of the upper respiratory tract after combined local hyperthermia and radiotherapy]
[Mucinous adenocarcinoma of the prostatic gland. Histochemical and immunohistochemical studies]
[On the classification of experimental brain tumours (author's transl)]
[On the enzymo-histologic characteristic of cancers of the liver. I. Studies of the activity of alkaline phosphatase, acid phosphatase, lipase and nonspecific esterase]
[Ophthalmoplegia in a patient with prostate cancer and bone metastases]
[PPP2R2A binds and dephosphorylates GFPT2 in breast cancer cells].
[PREVENTION OF THE BONES METASTASES OCCURRENCE IN THE PATIENTS WITH RENAL-CELL CANCER].
[Prognosis of prostate cancer with elevated prostatic acid phosphatase]
[Prostatic acid phosphatase measured by amplified enzyme linked immunoassay. Its application to mass screening for prostatic tumor and monitoring the clinical course of prostatic cancer patients]
[Prostatic carcinoid and neuroendocrine tumors--a case report]
[Prostatic carcinoma in a young adult: a case report]
[Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen]
[PSAP expression in a primary presacral neuroendocrine tumor : Potential for confusion with prostate cancer.]
[Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB]
[Quantitative study of osteoclastic related factors in the process of bone reconstruction]
[Radioimmunoassays in oncology]
[Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer]
[Role of the markers PAP-PSA in the diagnosis of cancer of the prostate]
[Sense and nonsense of tumor markers in practice]
[Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract]
[Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach]
[Studies on acid phosphatase in prostatic cancer. II. Investigation of acid phosphatase isoenzymes by ion-exchange column chromatography in serum and bone marrow of the patient with prostatic cancer (author's transl)]
[Studies on prognosis of prostate cancer with bone metastasis by using pretreatment bone scintigraphy]
[Tartrate-resistant acid phosphatase in the detection of bone metastasis in patients with cancer]
[The influence of tumor growth on natural cytotoxicity and activity of some lysosomal enzymes of human effector cells and the C3HA mouse splenocytes]
[The morphogenesis and histogenesis of an experimental malignant fibrous histiocytoma]
[The significance of acid phosphatase activity in the cytologic diagnosis of thyroid malignancy (author's transl)]
[The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer]
[The ultrastructure and histochemical characteristics of the cells of malignant fibrous histiocytoma in rats]
[Therapeutic effect and mechanism of silver needle heat conduction therapy combined with loxoprofen sodium patch in patients with knee osteoarthritis].
[Urological neoplasms and enzyme. IV. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, and total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with dimethylnitrosamine]
[Urological neoplasms and enzymes. V. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with lead acetate]
[Value of prostate acid phosphatase determination and cytologic examination in the early diagnosis of cancer.]
[Value of prostatic acid phosphatase and its relation to bone gammagraphy in the diagnosis of cancer of the prostate]
[Various immunohistochemical markers of precancer and variants of prostate cancer]
Nephritis
Pharmacological studies on experimental nephritic rats (9). Changes in activities of urinary enzymes in the modified type of Masugi's nephritis and their sources.
[Pathogenetic significance of lipid peroxidation in damage of the proximal segment of the nephron in acute Masugi's nephritis]
Nephrotic Syndrome
Changes in the Dickkopf-1 and tartrate-resistant acid phosphatase 5b serum levels in preschool children with nephrotic syndrome.
Neuroblastoma
Electrophoretic patterns of glucose metabolizing enzymes and acid phosphatase in mouse and human neuroblastoma cells.
FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells.
In 'undifferentiated' PC12 cells, GERL is not segregated from the Golgi apparatus.
Modification of opioid receptor activity by acid phosphatase in neuroblastoma x glioma NG108-15 hybrid cells.
Neurodegenerative Diseases
Downregulation of adenosine and adenosine A1 receptor contributes to neuropathic pain in resiniferatoxin neuropathy.
Neuroendocrine Tumors
Neuroendocrine tumors of the liver and pancreas associated with elevated serum prostatic acid phosphatase.
Renal neuroendocrine tumour and synchronous pancreas metastasis: histopathological diagnosis using prostatic acid phosphatase.
Neurologic Manifestations
Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis.
Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
Neutropenia
Clinical differential diagnosis of hairy-cell leukaemia.
Niemann-Pick Diseases
Determination of serum acid phosphatase in Gaucher's disease using 4-methylumbelliferyl phosphate.
Studies on pyrophosphate diesterase activity in cultured human fibroblasts: a deficiency in Niemann-Pick disease.
Obesity
A possible genetic component of obesity in childhood. Observations on acid phosphatase polymorphism.
ACP1 genotype, glutathione reductase activity, and riboflavin uptake affect cardiovascular risk in the obese.
Apparent lack of effect of obesity on the soluble phosphatidic acid phosphatase activity in human adipose tissue.
Body mass index and acid phosphatase locus 1 in diabetic disorders.
Caveolae-mediated endocytosis of the glucosaminoglycan-interacting adipokine tartrate resistant acid phosphatase 5a in adipocyte progenitor lineage cells.
Expression and secretion of the novel adipokine tartrate-resistant acid phosphatase from adipose tissues of obese and lean women.
Lipin1 regulation by estrogen in uterus and liver: implications for diabetes and fertility.
Low-molecular-weight acid phosphatase (ACP1), obesity, and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus.
Monomeric tartrate resistant Acid phosphatase induces insulin sensitive obesity.
Tartrate-resistant acid phosphatase type 5/ACP5 promotes cell cycle entry of 3T3-L1 preadipocytes by increasing IGF-1/Akt signaling.
The adipokine tartrate-resistant acid phosphatase 5a in serum correlates to adipose tissue expansion in obesity.
Time-course microarray analysis for identifying candidate genes involved in obesity-associated pathological changes in the mouse colon.
Obesity, Morbid
A study of acid phosphatase locus 1 in women with high fat content and normal body mass index.
Odontogenic Cysts
Enzyme histochemical studies on the formation of hyalin bodies in the epithelium of odontogenic cysts.
Identification of RANKL in osteolytic lesions of the facial skeleton.
In vitro growth characteristics of human odontogenic keratocysts and dentigerous cysts.
Odontogenic keratocysts: a clinical and histological study with special reference to enzyme histochemistry.
Odontogenic Tumors
[Histochemical and immunohistochemical double staining for osteolytic related factors in keratocystic odontogenic tumor]
Oligospermia
[Zinc in the seminal plasma in infertile men]
Optic Atrophy
Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis.
Osteitis Deformans
Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
Tartrate-resistant acid phosphatase 5b, but not periostin, is useful for assessing Paget's disease of bone.
Osteoarthritis
Biochemical and histological changes in osteoarthritic synovial membrane.
Biomarkers for identifying the early phases of osteoarthritis secondary to medial patellar luxation in dogs.
[Relation between serum enzymes and articular radionuclide tests in the diagnosis of osteoarthrosis and rheumatoid arthritis]
[The diagnostic information value of determining the cytochemical properties of the neutrophils from the blood and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis deformans]
[The effect of intra-articular treatment with corticosteroids, polyvinylpyrrolidone and dimethyl sulfoxide on the composition of the synovial fluid in patients with rheumatoid arthritis]
[Therapeutic effect and mechanism of silver needle heat conduction therapy combined with loxoprofen sodium patch in patients with knee osteoarthritis].
Osteoarthritis, Hip
[Morphometric and molecular biological features of femoral head tissue in different nosological entities of coxarthrosis].
Osteoarthritis, Knee
Lysosomal enzymes in serum and synovial fluid in patients with osteoarthritis.
Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA.
Osteoblastoma
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Osteochondrodysplasias
Acid phosphatase activity of chondroclasts from Fusarium-induced tibial dyschondroplastic cartilage.
Osteochondrosis
Cytology of polychrome-stained equine synovial fluid smears. Comparison with clinical findings, histologic specimens, Wright-Giemsa-stained smears and outcome.
Osteogenesis Imperfecta
Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta.
Normal serum acid phosphatase levels in osteogenesis imperfecta.
Reduced serum levels of carboxy-terminal propeptide of human type I procollagen in a family with type I-A osteogenesis imperfecta.
Serum acid phosphatase in osteogenesis imperfecta.
Total body bone mineral and tartrate-resistant acid phosphatase levels in type I and III osteogenesis imperfecta.
Osteolysis
A novel murine model of orthopaedic wear-debris associated osteolysis.
Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
Characterization of Normal Murine Carpal Bone Development Prompts Re-Evaluation of Pathologic Osteolysis as the Cause of Human Carpal-Tarsal Osteolysis Disorders.
Clinical and biological aspects of acid phosphatase.
Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.
Early detection and treatment of wear particle-induced inflammation and bone loss in a mouse calvarial osteolysis model using HPMA copolymer conjugates.
Effect of cytosolic phospholipase A2 on proinflammatory cytokine-induced bone resorptive genes including receptor activator of nuclear factor kappa B ligand in human dental pulp cells.
Excessive dietary intake of vitamin A reduces skull bone thickness in mice.
Induction of osteoclast-like cell formation by leptin-induced soluble intercellular adhesion molecule secreted from cancer cells.
Joint fluid from patients with failed total hip arthroplasty stimulates pit formation by mouse osteoclasts on dentin slices.
Lymphocyte-activation gene 3(+) (LAG3(+)) forkhead box protein 3(-) (FOXP3(-)) regulatory T cells induced by B cells alleviates joint inflammation in collagen-induced arthritis.
Nasal inverted papilloma expresses the muscle segment homeobox gene Msx2: possible prognostic implications.
Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: A cohort study.
tBHQ Suppresses Osteoclastic Resorption in Xenogeneic-Treated Dentin Matrix-Based Scaffolds.
[Effect of oxidative stress on periprosthetic osteolysis induced by TCP wear particles in mouse calvaria and its mechanism].
[The effect of procyanidin on periprosthetic osteolysis caused by TCP wear particles in the mouse calvaria and its mechanism].
Osteomalacia
Anticonvulsant drugs and bone disease in the elderly.
Biochemical markers of bone turnover.
Osteomyelitis
Functional dissociation of the basolateral transcytotic compartment from the apical phago-lysosomal compartment in human osteoclasts.
[Biochemical markers of the osteomyelitis development]
Osteonecrosis
Risk factors for osteonecrosis in patients with type 1 Gaucher's disease.
Osteopetrosis
A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts.
Bone morphogenetic protein-induced heterotopic bone in osteopetrosis.
Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation.
High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice.
Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers.
Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis.
Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
Serum creatine kinase isoenzyme BB in mammalian osteopetrosis.
Tartrate-resistant acid phosphatase activity in tibial osteoclasts and cells elicited by ectopic bone and suture implants in normal and osteopetrotic rats.
Osteophyte
Ectopic mineralization of cartilage and collagen-rich tendons and ligaments in Enpp1asj-2J mice.
Osteoporosis
A novel immunoassay for the determination of tartrate-resistant acid phosphatase 5b from rat serum.
Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
Application of bone transgenic zebrafish in anti-osteoporosis chemical screening.
Beta-2-microglobulin in diseases with high bone remodeling.
Biological sources of variations of tartrate-resistant acid phosphatase 5b in a healthy Japanese population.
Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Chitooligosaccharides prevent osteopenia by promoting bone formation and suppressing bone resorption in ovariectomised rats: possible involvement of COX-2.
Chronic obstructive pulmonary disease severity in middle-aged and older men with osteoporosis associates with decreased bone formation.
Consumption of Vitamin D-and Calcium-Fortified Soft White Cheese Lowers the Biochemical Marker of Bone Resorption TRAP 5b in Postmenopausal Women at Moderate Risk of Osteoporosis Fracture.
Edgeworthia papyrifera Regulates Osteoblast and Osteoclast Differentiation In Vitro and Exhibits Anti-osteoporosis Activity in Animal Models of Osteoporosis.
Effects of garlic oil on postmenopausal osteoporosis using ovariectomized rats: comparison with the effects of lovastatin and 17beta-estradiol.
Effects of GLP-1 receptor analogue liraglutide and DPP-4 inhibitor vildagliptin on the bone metabolism in ApoE-/- mice.
Effects of the drug (BSZGC)-containing serum on proliferation of rat's osteoclasts and TRACP activity in vitro.
Grapefruit juice exerts anti-osteoporotic activities in a prednisolone-induced osteoporosis rat femoral fracture model, possibly via the RANKL/OPG axis.
Increased tartrate-resistant Acid phosphatase expression in osteoblasts and osteocytes in experimental osteoporosis in rats.
Limited utility of tartrate-resistant acid phosphatase isoform 5b in assessing response to therapy in osteoporosis.
Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression.
Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Postmenopausal Iron Overload Exacerbated Bone Loss by Promoting the Degradation of Type I Collagen.
Relevance of parathyroid hormone (PTH), vitamin 25(OH)D3, calcitonin (CT), bone metabolic markers, and bone mass density (BMD) in 860 female cases.
Roles of TNF-?, GSK-3? and RANKL in the occurrence and development of diabetic osteoporosis.
Rutin Isolated from Chrozophora tinctoria Enhances Bone Cell Proliferation and Ossification Markers.
Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study.
Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure.
Structure of Acid phosphatases.
Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes.
Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
U.S. Montmorency Tart Cherry Juice Decreases Bone Resorption in Women Aged 65-80 Years.
Uteroferrin: a progesterone-induced hematopoietic growth factor of uterine origin.
[Age related changes of serum sex hormone levels and tartrate-resistant acid phosphatase activity in healthy women]
[Application of analyses of acid phosphatase 5b bone isoenzyme in patients with osteopenia and osteoporosis (pilot study)]
[Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies]
[Early, noninvasive diagnostic of osteoporosis in men]
[Organic gallium improves tretinoin-induced osteoporosis in rats]
[Research progress of Rehmanniae Radix in prevention and treatment of osteoporosis].
[Study on the theraputic effect of plants of Camellia genus on osteoporosis]
[The mechanism of TRACP 5b maturation]
Osteoporosis, Postmenopausal
17 beta-estradiol suppresses gene expression of tartrate-resistant acid phosphatase and carbonic anhydrase II in ovariectomized rats.
Beta 2-microglobulin in postmenopausal osteoporosis.
New evidence that serum beta(2)-microglobulin behaves as a biological marker of bone remodelling in women.
Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis.
Zinc, biochemical markers of nutrition, and type I osteoporosis.
[Assessment of the alkaline (ALP) and acid phosphatase (ACP) in the blood serum of rats during experimental postmenopausal osteoporosis]
Osteosarcoma
A novel assessment method of serum alkaline phosphatase for the diagnosis of osteosarcoma in children and adolescents.
Characterizations of recombinant human tartrate-resistant acid phosphatase from osteosarcoma: comparison study between recombinant and placental proteins.
Enzyme histochemical investigations on bone and soft tissue tumours.
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.
Human osteogenic sarcoma. Study of the ultrastructure, with special notes on the localization of alkaline and acid phosphatase.
Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
Osteosarcoma-derived exosomal miR-501-3p promotes osteoclastogenesis and aggravates bone loss.
Significance of "high" acid phosphatase activity in the serum of normal children.
Size dependent enzyme activities of multinucleated (osteoclastic) giant cells in bone tumors.
[Acid phosphatase indices during irradiation, UHF hyperthermia and chemotherapy of osteogenic sarcoma in children and adolescents]
[Malignant fibrous histiocytoma of the bone]
Otitis
Alteration of adenoid tissue alkaline and acid phosphatase in children with secretory otitis media.
Otitis Media
Bone resorption in chronic otitis media.
Bone resorption in chronic otitis media. A light-microscopical and histochemical investigation of acid phosphatase activity.
Ultrastructural evaluation of biochemical events of bone resorption in human chronic otitis media.
Otitis Media with Effusion
Alteration of adenoid tissue alkaline and acid phosphatase in children with secretory otitis media.
Certain oxidative and hydrolytic enzymes in the middle ear effusion in serous otitis media.
Ovarian Neoplasms
Translocation of lysophosphatidic acid phosphatase in response to gonadotropin-releasing hormone to the plasma membrane in ovarian cancer cell.
Pancreatic Neoplasms
A spheroid-based 3-D culture model for pancreatic cancer drug testing, using the acid phosphatase assay.
[OCCURRENCE OF RAISED SERUM ACID PHOSPHATASE LEVELS IN PANCREATIC CANCER AND HEPATOBILIARY DISEASES.]
Pancreatitis
Acid phosphatase activity in different organs as a marker of acute pancreatitis.
Hormonal and cholinergic effects on amylase and lysosomal enzyme activities in pancreatic tissue and ascites of rats with acute experimental pancreatitis.
Lysosomal-mitochondrial interrelationships in damage to the liver in acute experimental pancreatitis in dogs. Treatment with prostacyclin (PGI2).
PENTOXIFYLLINE PREVENTS LOSS OF PP2A PHOSPHATASE ACTIVITY AND RECRUITMENT OF HISTONE ACETYLTRANSFERASES TO PRO-INFLAMMATORY GENES IN ACUTE PANCREATITIS.
The effect of heparin on lysosomes of the dog pancreas during acute experimental pancreatitis.
[Activity and subcellular distribution of lysosomal enzymes in acute pancreatitis induced by CDE diet in mice]
[Diagnosis of membrane disorders in acute pancreatitis]
[Morphofunctional elements of the pathogenesis of acute pancreatitis]
[Protective effect of fructus gardeniae on pancreatic subcellular organs of the acute pancreatitis in rats]
Pancytopenia
Ultrastruct and tartrate-resistant acid phosphatase localization in a T-cell hairy-cell leukemia cell line.
Update on hairy cell leukemia.
[Leukemic infiltration of gastrointestinal system: unusual complication of hairy cell leukemia]
[Role of alpha-interferon in the treatment of hairy cell leukemia]
Papilloma
Deficiency of beta-glucuronidase in neutrophils from patients with precancerous states of the larynx.
Lymphocytes, neutrophils and serum immunoglobulins in patients with precancerous states of the larynx.
The lymphocyte cytochemical equipment and serum immunoglobulins in patients with precancerous states of the larynx.
[Papillomas of the mucous membranes of the larynx and pharynx. Relations between enzyme histochemistry and histological classification (author's transl)]
Paraproteinemias
Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling index.
Plasma cell acid phosphatase and prognosis in multiple myeloma.
Plasma cell acid phosphatase, a discriminative test for benign and malignant monoclonal gammopathies.
[Plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies]
[Usefulness of plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies]
Parathyroid Neoplasms
Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.
Paratuberculosis
Relationship of acid phosphatase activity to ultrastructural features in mice inoculated with Mycobacterium paratuberculosis.
Parkinson Disease
Bioinformatics analysis on the differentiation of bone mesenchymal stem cells into osteoblasts and adipocytes.
Pediatric Obesity
A possible genetic component of obesity in childhood. Observations on acid phosphatase polymorphism.
Periodontal Diseases
Effect of gingival application of melatonin on alkaline and acid phosphatase, osteopontin and osteocalcin in patients with diabetes and periodontal disease.
Evaluating the levels of salivary alkaline and acid phosphatase activities as biochemical markers for periodontal disease: A case series.
Evaluation of salivary biomarkers of periodontitis among smokers and nonsmokers: A novel study.
Isolation, cloning, and expression of an acid phosphatase containing phosphotyrosyl phosphatase activity from Prevotella intermedia.
Topical H2 antagonist prevents periodontitis in a rabbit model.
[Beta-glucuronidase, beta-acetylgalactosaminidase and acid phosphatase activities in whole saliva of the patients with periodontal disease (author's transl)]
Periodontitis
Alkaline phosphatase and acid phosphatase levels in saliva and serum of patients with healthy periodontium, gingivitis, and periodontitis before and after scaling with root planing: A clinico-biochemical study.
Calcitriol suppresses lipopolysaccharide-induced alveolar bone damage in rats by regulating T helper cell subset polarization.
Chloroquine and 3-Methyladenine Attenuates Periodontal Inflammation and Bone Loss in Experimental Periodontitis.
Effect of locally administered novel biodegradable chitosan based risedronate/zinc-hydroxyapatite intra-pocket dental film on alveolar bone density in rat model of periodontitis.
Evaluation of Biochemical Parameters Present in the Saliva of Patients with Chronic Periodontitis: Results from a Meta-Analysis.
Evaluation of salivary biomarkers of periodontitis among smokers and nonsmokers: A novel study.
High acid phosphatase level in the gingival tissues of periodontitis subjects.
Proinflammatory M1 Macrophages Inhibit RANKL-Induced Osteoclastogenesis.
Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis.
Role of enhancer of zeste homolog 2 in osteoclast formation and periodontitis development by downregulating microRNA-101-regulated VCAM-1.
Sclerostin antibody treatment causes greater alveolar crest height and bone mass in an ovariectomized rat model of localized periodontitis.
Therapeutic Effects of Systemic Vitamin K2 and Vitamin D3 on Gingival Inflammation and Alveolar Bone in Rats With Experimentally Induced Periodontitis.
TLR-4 targeting contributes to the recovery of osteoimmunology in periodontitis.
[Comparative studies on lactate, proteins and enzymes in saliva of healthy and periodontitis sick juveniles]
[The behavior of unspecific acid phosphatase in the human gingiva before and after the effect of aminofluorides]
Peripheral Nerve Injuries
Deceased expression of prostatic acid phosphatase in primary sensory neurons after peripheral nerve injury.
Mapping and plasticity of acid phosphatase afferents in the rat dorsal horn.
Persistent Infection
Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas.
Photosensitivity Disorders
Photosensitization effects on the solubility of acid phosphatase in nervous tissue.
Phyllodes Tumor
Giant cystosarcoma phyllodes of the prostate associated with adenocarcinoma.
Piebaldism
Tyrosinase and acid phosphatase activities in melanocytes from avian albinos.
Placenta, Retained
Reduced phagocytotic activity of macrophages in the bovine retained placenta.
Plague
[Activation of proteinases and acid phosphatase in swine leukocytes infected with the swine classical plague virus]
Plasmacytoma
Activity and isoenzymes of acid phosphatase in human B-cell lymphomas of low-grade malignancy: a novel aid in the classification of malignant lymphoma.
[Unspecific esterases and acid phosphatase in plasmacytomas]
Platelet Storage Pool Deficiency
Acquired storage pool deficiency with increased platelet-associated IgG. Report of five cases.
Pleural Effusion
Accumulation of 99m Tc-Sn-pyrophosphate in pleural effusions.
Carcinoma of the prostate presenting with massive pleural effusion and elevated pleural acid phosphatase.
[Tuberculous pleural effusion and pleural effusion secondary to non-specific bacterial infection: biochemical differential diagnosis (author's transl)]
Pneumonia
Two-week inhalation toxicity of polymeric diphenylmethane-4, 4'-diisocyanate (PMDI) in rats: analysis of biochemical and morphological markers of early pulmonary response.
[Immunological indices and the acid phosphatase activity of the blood serum in patients with suppurative and destructive complications of acute pneumonia during the treatment/process]
[Importance of the cytochemical study of blood leukocyte enzyme activity in acute pneumonias]
Polycystic Kidney, Autosomal Dominant
A distinct bone phenotype in ADPKD patients with end-stage renal disease.
Polycythemia
Early diagnostic and prognostic criteria for health disorders in chemical workers.
Polycythemia Vera
Activity and intracellular localization of lysosomal acid phosphatase in lymphocytes from patients with Hodgkin's disease, plasma cell myeloma and primary polycythemia.
Presence of "prostatic" acid phosphatase in human neutrophils.
Polymyalgia Rheumatica
Polymyalgia rheumatica and giant cell arteritis--rational diagnosis and treatment predicated and disordered prostaglandin metabolism.
Porcine Reproductive and Respiratory Syndrome
PP2A Facilitates Porcine Reproductive and Respiratory Syndrome Virus Replication by Deactivating irf3 and Limiting Type I Interferon Production.
Porphyria, Acute Intermittent
Absence of close linkage between acute intermittent porphyria and the ABO, Rh, P, acid phosphatase, Pr, orosmucoid and pepsinogen loci.
Porphyrias
Absence of close linkage between acute intermittent porphyria and the ABO, Rh, P, acid phosphatase, Pr, orosmucoid and pepsinogen loci.
Pre-Eclampsia
[Acid phosphatase of the neutrophils and lymphocytes in pregnancy toxemias]
[Activity of acid phosphatase in the blood serum and placenta and cathepsin in the placenta in patients with late pregnancy toxemias]
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acid phosphatase positivity in childhood acute lymphocytic leukemia.
Acid phosphatase staining pattern as an indicator of T-cell acute leukemia.
Acute lymphocytic leukemia with prominent azurophilic granulation and punctate acidic nonspecific esterase and phosphatase activity.
Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias".
Lymphoblastic lymphoma of convoluted or acid phosphatase type-a tumor of T precursor cells.
Non-T, non-B childhood acute lymphoblastic leukemia. Correlation between cytochemical markers and first complete remission.
Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells.
Prognostic significance of acid alpha-naphthyl acetate esterase and acid phosphatase in childhood acute lymphoblastic leukemia.
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias.
Significance of enzyme markers as a part of multiple marker analysis in leukemia research.
Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma: a study of 15 cases.
[Activity of acid phosphatase and the surface receptors of the lymphoblasts in the subclassification of lymphoblastic leukemia in children]
[Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)]
[The importance of studying the acid phosphatase of the blood serum and bone marrow lymphoblasts and polymorphonuclear neutrophils in the prognosis of the course of acute lymphoblastic leukemia]
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Acid phosphatase positivity in childhood acute lymphocytic leukemia.
Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies.
Cytochemical comparison of immunologically characterized human leukaemia/lymphoma cell lines representing different levels of maturation.
Relation of some enzyme activities and argyrophilic proteins in childhood acute lymphoblastic leukemia.
[Cytochemical characteristics of blast cells forming autologous rosettes in acute lymphoblastic leukemia in children]
[Immunological aspects of acute lymphoblastic leukemia (ALL) in children (author's transl)]
Pregnancy, Prolonged
An ultrahistochemical study of the distribution of acid and alkaline phosphatases in placentae from normal and complicated pregnancies.
Premature Ejaculation
[Semen biochemical markers and their significance in the patients with premature ejaculation]
Prostatic Diseases
A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
A radioimmune assay for human prostatic acid phosphatase-levels in prostatic disease.
Acid phosphatase and zinc in semen of subjects with no clinical evidence of prostatic disease.
Acute and chronic retention of urine: relevance of raised serum prostatic acid phosphatase levels. A prospective study.
Case report. Two contrasting radiological presentations of prostatic adenocarcinoma in the jaws.
Characterization of secretion pattern of human prostatic acid phosphatase: a reassessment.
Clinical application of prostatic markers. II. Circulating tumour markers in diagnosis and treatment.
Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease.
Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation.
Diurnal variation of prostatic acid phosphatase (PAP) in urologic patients with nonprostatic disease.
Elevation of the acid phosphatase in benign prostatic disease.
Expression of prostate specific antigen in male breast cancer.
Gamma-seminoprotein--a new tumour marker in prostatic cancer? Results of a pilot study.
Perspectives on serum acid phosphatase in prostatic disease. An evaluation of two methods.
Prostate-specific acid phosphatase: re-evaluation of radioimmunoassay in diagnosing prostatic disease.
Serum prostatic acid phosphatase determination in prostatic diseases: a critical comparison of an enzymatic and a radioimmunologic assay.
The effect of rectal examination on serum acid phosphatase levels in benign and malignant prostatic disease.
[Determination of activity of acid phosphatase in serum in prostatic diseases]
[Immunological colorimetric determination of serum prostatic acid phosphatase activity in patients with prostatic diseases comparing with RIA and Kind-King modified methods]
[Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases]
[Value of the determination of acid phosphatase of the blood in the diagnosis and prognosis of prostatic diseases. Comparisons of the results obtained with the technic of King and Jegatheesan and the technic of Babson and Read]
Prostatic Hyperplasia
A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
A radioimmune assay for human prostatic acid phosphatase-levels in prostatic disease.
Acid phosphatase and 5-nucleotidase activities of human nodular prostatic hyperplasia as revealed by electron microscopy.
Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma.
Amyloidosis presented with whitening and loss of hair which improved after dimethylsulfoxide (DMSO) treatment.
An objective look at acid phosphatase determinations: a comparison of biochemical and immunological methods.
An unusual alkaline phosphatase isoenzyme in a patient with concomitant marked elevation of acid phosphatase without clinical evidence of prostatic carcinoma.
Atrophy and apoptosis in ventral prostate of rats induced by 5alpha-reductase inhibitor, epristeride.
Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus.
Changes in prostate-specific antigen and prostatic acid phosphatase concentration following prostatic examination in benign prostatic hypertrophy and prostate cancer patients.
Circadian and day-to-day variation of prostatic acid phosphatase.
Circadian variation of different fractions of serum acid phosphatase.
Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
Clinical significance of serum acid phosphatase as measured by ELISA after treatment of benign prostatic hyperplasia.
Clinical study on estramustine binding protein (EMBP) in human prostate.
Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications.
Comparison of prostatic acid phosphatase assays.
Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation.
Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques.
Differential suppression of serum prostatic acid phosphatase and prostate-specific antigen by 5-alpha-reductase inhibitor.
Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH).
Elevation of serum prostatic acid phosphatase levels after prostatic massage.
Enzyme immunoassay for the prostate-specific acid phosphatase (E. C. 3.1.3.2).
Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.
Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disorders.
Evaluation of serum arginase activity in benign prostatic hypertrophy and prostatic cancer.
Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypertrophy or prostate cancer.
Experience with prostate-specific antigen in prostatic carcinoma.
Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
Expression of prostatic acid phosphatase in human prostate cancer.
Immunocytochemistry of epithelial markers in citral-induced prostate hyperplasia in rats.
Inhibition effects of chlorogenic acid on benign prostatic hyperplasia in mice.
Lack of association between prostate-specific acid phosphatase RFLP genotypes and prostatic cancer or benign prostatic hyperplasia.
Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.
Measurement of prostate-specific antigen and prostatic acid phosphatase concentrations in serum before and 1-42 days after transurethral resection of the prostate and orchidectomy.
Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.
Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
Prostate-specific antigen as a marker of adenocarcinoma of prostate.
Prostatic acid phosphatase by radioimmunoassay tumor marker in bone marrow.
Prostatic acid phosphatase, purification and iodination using Iodogen.
Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study.
Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
Ratio of serum tartrate-inhibitable acid phosphatase to total serum protein in benign prostatic hypertrophy and prostatic carcinoma.
Secretion into and elimination from blood circulation of prostate specific acid phosphatase, measured by radioimmunoassay.
Serial lectin affinity chromatography with concavalin A and wheat germ agglutinin demonstrates altered asparagine-linked sugar-chain structures of prostatic acid phosphatase in human prostate carcinoma.
Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
Significance of PSA and PAP in patients with or without prostatic cancer.
TARTRATE-INHIBITED ACID PHOSPHATASE IN BENIGN PROSTATIC HYPERTROPHY AND IN PROSTATIC CANCER.
The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
The distribution of S-100 protein in hyperplastic and neoplastic prostatic epithelium.
The effect of prostatic massage on acid phosphatase in patients with and without benign prostatic hypertrophy.
The histochemical behaviour, electrophoretic mobility and distribution in cell fractions of acid phosphatase isozymes in prostatic cancer and benign prostate hyperplasia.
The histochemical demonstration of human prostatic acid phosphatase with phosphorylcholine.
The role of prostatic specific antigen in monitoring prostatic cancer and its prognostic importance.
The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice.
Transient high serum prostate-specific acid phosphatase measured by radioimmunoassay in prostatic infarction.
[A case of endometrioid carcinoma of the prostate]
[A pelvic tumor unusual in terms of its volume and clinical expression]
[An experimental study(I) on the inhibition of prostatic hyperplasia with extract of seeds of Brassica alba]
[Blood acid phosphatase in apparently healthy subjects and in those with prostatic adenoma and cancer.]
[Citrate and acid phosphatase in the ejaculate in prostatic carcinoma and adenoma]
[Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer]
[Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer]
[Clinical study of tumor markers in prostatic cancer]
[Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue]
[Immunochemical analysis of prostatic acid phosphatase. 2. Evaluation of normal individuals and patients with prostatic hypertrophy and a comparison with conventional methods]
[Immunochemical tests in the diagnosis of diseases of the male reproductive system]
[Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer]
[Role of prostatic acid phosphatases in the treatment of adenocarcinoma of the prostate]
[Serum acid phosphatase levels following prostatic massage (author's transl)]
[Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases]
[Significance of various examination methods in the management of prostatic cancer]
[The diagnostic value of the radioimmunological estimation of prostatic acid phosphatase. Comparative value of the measurement of enzyme activity (author's transl)]
[The significance of free-type PSA and complex-type PSA in patients with prostatic carcinoma--the characteristics of ACS-PSA method compared with that of Delfia- and Eiken-PSA method]
[The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers]
[Two cases of mucinous adenocarcinoma of the prostate]
Prostatic Intraepithelial Neoplasia
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Morphometric and ultrastructure features of the ventral prostate of rats (Rattus norvegicus) submitted to long-term nicotine treatment.
The role of new modalities in the early detection and diagnosis of prostate cancer.
[Various immunohistochemical markers of precancer and variants of prostate cancer]
Prostatic Neoplasms
A case of Sister Mary Joseph's nodule from prostatic cancer.
A clinical assay for prostatic acid phosphatase using choline phosphate as a substrate: comparison with thymolphthalein phosphate.
A new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer (SPIF).
A new method for estimating serum acid phosphatase of prostatic origin applied to the clinical investigation of cancer of the prostate.
A phase I study of a DNA vaccine targeting prostatic Acid phosphatase in patients with stage D0 prostate cancer.
A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma.
A reappraisal of serial isotope bone scans in prostate cancer.
A solid-phase radioimmunoassay for human prostatic acid phosphatase.
Acid phosphatase and prostate cancer: historical overview.
Acid Phosphatase and Prostatic Cancer.
Acid phosphatase for monitoring prostatic carcinoma. Comparison of radioimmunoassay and enzymatic techniques.
Acid phosphatase isozymes in cancer of the prostate.
Acid phosphatase.
Acid phosphatase: defining a role in androgen-independent prostate cancer.
Acid phosphatase: new developments.
Acute gastrointestinal bleeding as the presenting manifestation of prostate cancer.
Advanced prostate cancer follow-up with prostate-specific antigen, prostatic acid phosphatase, osteocalcin and bone isoenzyme of alkaline phosphatase.
Alteration of acid phosphatase isoenzyme in a human prostatic cancer cell line.
An assessment of serum acid and alkaline phosphatase determinations in prostatic cancer with a clinical validation of an acid phosphatase assay utilizing adenosine 3'-monophosphate as substrate.
An enzyme-amplified monoclonal immunoenzymometric assay for prostatic acid phosphatase.
An evaluation of a kinetic acid phosphatase method.
An evaluation of five tests to diagnose prostate cancer.
An LH-RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections.
An unusual increase in prostatic acid phosphatase not associated with prostatic cancer.
Anti-thyroid and antifungal activities, BSA interaction and acid phosphatase inhibition of methimazole copper(II) complexes.
Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer.
Antigen-presenting cells 8015 (Provenge) in patients with androgen-dependent, biochemically relapsed prostate cancer.
Antinociceptive effect of prostatic acid phosphatase in a rat model of cancer-induced bone pain.
Aspects on reference values for tumor markers in human prostatic carcinoma.
Autologous dendritic cells pulsed with prostatic acid phosphatase (APC8015) for patients with hormone-refractory prostate cancer with a Gleason score
Avian prostatic acid phosphatase: estrogen regulation in the oviduct and epithelial cell-derived ovarian carcinomas.
Based on biomedical index data: Risk prediction model for prostate cancer.
BCG adjuvant immunotherapy in carcinoma of the prostate: an interim report.
Biochemical and immunologic techniques for acid phosphatase measurement in the diagnosis of prostate cancer.
Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer.
Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex).
Biologic markers in cancer diagnosis and treatment.
Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus.
Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods.
Bone marrow acid phosphatase in staging of prostatic cancer: how reliable is it?
Bone marrow and acid phosphatase by counterimmune electrophoresis: pre-treatment and post-treatment correlations.
Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: are they helpful in staging prostatic cancer?
Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
Calcification in human osteoblasts cultured in medium conditioned by the prostatic cancer cell line PC-3 and prostatic acid phosphatase.
Cancer of prostate metastatic to the skin diagnosed by immunoperoxidase staining.
Cancer serum index and prostatic acid phosphatase for detection of progressive prostatic cancer.
Carcinoembryonic antigen and carbohydrate antigen 19-9-producing adenocarcinoma of the prostate: report of an autopsy case.
Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression.
Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer.
Changes in prostate-specific antigen and prostatic acid phosphatase concentration following prostatic examination in benign prostatic hypertrophy and prostate cancer patients.
Changes in serum levels of prostatic acid phosphatase and prostate specific antigen after luteinizing hormone-releasing hormone analogue administration in patients with metastatic prostatic cancer in relation to glandular differentiation.
Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells.
Characterization of secretion pattern of human prostatic acid phosphatase: a reassessment.
Chromosomal structural variations during progression of a prostate epithelial cell line to a malignant metastatic state inactivate the NF2, NIPSNAP1, UGT2B17 and LPIN2 genes.
Circadian and day-to-day variation of prostatic acid phosphatase.
Circadian rhythm in prostatic acid phosphatase (PAP): a potential tumor marker rhythm in prostatic cancer (PCa).
Circadian variation of different fractions of serum acid phosphatase.
CIRCADIAN VARIATION OF SERUM ACID PHOSPHATASE IN PROSTATIC CANCER.
Clinical and biological aspects of acid phosphatase.
Clinical applicability of acid phosphatase isoenzyme assay.
Clinical application of prostatic markers. II. Circulating tumour markers in diagnosis and treatment.
Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study.
Clinical evaluation of gamma-seminoprotein in prostate cancer.
Clinical significance of serum acid phosphatase levels in advanced prostatic carcinoma.
Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase.
Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
Clinical utility of prostatic specific antigen and prostatic acid phosphatase serum levels in monitoring prostate cancer.
Clinical utility of serum prostatic acid phosphatase measurements for detection (screening), diagnosis, and therapeutic monitoring of prostatic carcinoma; assessment of monoclonal and polyclonal enzymes and radioimmunoassays.
Clinical value of different methods for determination of acid phosphatase in prostatic cancer.
Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy.
Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro.
Combined serum and bone marrow radioimmunoassays for prostatic acid phosphatase.
Comparative evaluation of bone marrow acid phosphatase and bone scanning in staging of prostatic cancer.
Comparative evaluation of serum acid phosphatase, urinary cholesterol, and androgens in diagnosis of prostatic cancer.
Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
Comparison of countercurrent immunoelectrophoretic assay with commercial radioimmunoassay kits for measuring prostatic acid phosphatase.
Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.
Comparison of immunologic and enzymatic assay of prostatic acid phosphatase for follow-up and assessment of clinical status of stage D prostate cancer.
Comparison of prostate-specific antigen and prostatic acid phosphatase in the management of prostatic cancer.
Comparison of radioimmunological and conventional acid phosphatase assays in the serum of prostatic cancer patients.
Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors.
Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer.
Correlation between bone scans and serum levels of osteocalcin, prostate-specific antigen, and prostatic acid phosphatase in monitoring patients with disseminated cancer of the prostate.
Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase in serum with Eiken PAP RIA kit.
Correlation between tissular levels of prostatic acid phosphatase and prostate-specific antigen and hormonal response of metastatic prostatic cancer.
Counterimmunoelectrophoresis in determination of prostatic acid phosphatase in human serum.
Creatine kinase BB and other markers of prostatic carcinoma.
Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer.
Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
Current experience with radioimmunoassay techniques for prostatic acid phosphatase.
Current status of immunological therapies for prostate cancer.
Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation.
Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells.
Dendritic cell gene therapy.
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma.
Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.
Determination of prostate cancer biomarker acid phosphatase at a copper phthalocyanine-modified screen printed gold transducer.
Development of Parallel Reaction Monitoring Assays for the Detection of Aggressive Prostate Cancer Using Urinary Glycoproteins.
Development of the VCaP androgen-independent model of prostate cancer.
Diagnostic and prognostic use of bone turnover markers.
Diagnostic and therapeutic utility of monoclonal antibodies in urologic oncology.
Diagnostic efficiency of biological markers in blood serum on prostate cancer: a comparison of four different markers and 12 different methods.
Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells.
DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer.
Early detection of prostate cancer by routine screening.
Early detection of prostate cancer.
Early detection of prostatic cancer by radioimmunoassay for prostatic acid phosphatase.
Early stage prostatic cancer investigated by pelvic lymph node biopsy and bone marrow acid phosphatase.
Effectiveness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy in prostatic carcinoma.
Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostate.
Emerging Roles of Human Prostatic Acid Phosphatase.
Emerging vaccine therapy approaches for prostate cancer.
Enzymatic prostatic acid phosphatase in the clinical staging of patients diagnosed with prostate cancer.
Enzyme markers in human prostatic carcinoma.
ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.
Evaluation of a new tumor marker for localized prostate cancer.
Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation.
Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.
Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the prostate.
Evaluation of serum arginase activity in benign prostatic hypertrophy and prostatic cancer.
Expression of a Human Prostatic Acid Phosphatase (PAP)-IgM Fc Fusion Protein in Plants Using
Expression of androgen receptor and prostate-specific antigen in male breast carcinoma.
Expression of E-cadherin in primary prostate cancer: correlation with clinical features.
Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines.
Expression of prostatic acid phosphatase in human prostate cancer.
Extremely high concentration of serum prostate-specific acid phosphatase in an untreated prostatic cancer patient.
False positive values of PAP and PSA in complicated and non-complicated benign prostatic hypertrophy.
Fibrils of Prostatic Acid Phosphatase Fragments Boost Infections by XMRV, a Human Retrovirus Associated with Prostate Cancer.
Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonist.
From gene to protein: Prostatic acid phosphatase: Structure and expression of gene and protein*.
Gene expression and prostate specificity of human prostatic acid phosphatase (PAP): evaluation by RNA blot analyses.
Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.
Growth and characterization of LNCaP prostate cancer cell spheroids.
Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.
Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Listeria vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming.
High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
High-dose medroxyprogesterone acetate versus prednisolone in hormone-resistant prostatic cancer. A pilot study.
Histochemical study of R1881-binding protein, prostatic acid phosphatase, prostate-specific antigen, and r-seminoprotein in prostatic cancer.
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer.
Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients.
Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade.
Human prostatic acid phosphatase and prostate specific antigen: protein structure, gene organization, and expression in neoplastic and benign tissues.
Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.
HUMORAL IMMUNE RESPONSE AGAINST NON-TARGETED TUMOR ANTIGENS AFTER TREATMENT WITH SIPULEUCEL-T AND ITS ASSOCIATION WITH IMPROVED CLINICAL OUTCOME.
Identification and Validation of Potential New Biomarkers for Prostate Cancer Diagnosis and Prognosis Using 2D-DIGE and MS.
Identification of cultured, human, malignant, prostatic epithelial cells.
Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.
Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.
Immune response to sipuleucel-T in prostate cancer.
Immunodiagnosis by prostatic acid phosphatase to differentiate primary male breast cancer from metastatic prostate cancer.
Immunofluorescent identification of antibodies specific for prostatic acid phosphatase.
Immunohistochemical Staining of Precursor Forms of Prostate-specific Antigen (proPSA) in Metastatic Prostate Cancer.
Immunohistochemistry of prostatic acid phosphatase.
Immunohistological localization of prostatic acid phosphatase.
Immunologically measured serum markers and their role in the management of prostate cancer.
Immunoreactive prostate-specific acid phosphatase in prostatic cancer.
Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients.
Immunoreactive prostatic specific antigen in male periurethral glands.
Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: relation to progression following radical prostatectomy.
Immunoscintigraphic evaluation of lymph node involvement in prostatic carcinoma.
Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.
Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells.
Immunotherapy for prostate cancer.
Importance of acid phosphatase in response criteria for prostate cancer.
In vivo behavior of 111In-labeled monoclonal anti-prostatic acid phosphatase antibody after intraprostatic and intravenous injections.
Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.
Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer.
Induction of tumor specific cytotoxic T lymphocytes in prostate cancer using prostatic acid phosphatase derived HLA-A2402 binding peptide.
Influence of luteinizing hormone-releasing hormone analogues on serum levels of prostatic acid phosphatase and prostatic specific antigen in patients with metastatic carcinoma of the prostate.
Inhibition of cancer cell mitosis by reducing the availability of phosphate.
Inhibition of growth and increase of acid phosphatase by testosterone on androgen-independent murine prostatic cancer cells transfected with androgen receptor cDNA.
Instructed-Assembly of Small Peptides Inhibits Drug-Resistant Prostate Cancer Cells.
Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells.
Intracerebroventricular injection of human prostatic acid phosphatase has potent neuroprotective effects against transient focal cerebral ischemia in rats.
Investigation of specific antigens in prostatic cancer.
Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Is the determination of prostatic acid phosphatase still worthwhile in prostate cancer patients?
Isoenzymes of human prostate acid phosphatase.
Laboratory studies for the detection of carcinoma of the prostate.
Lack of association between prostate-specific acid phosphatase RFLP genotypes and prostatic cancer or benign prostatic hyperplasia.
Lack of usefulness of bone marrow enzymes and calcium in staging patients with prostatic cancer.
Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.
Laparoscopic pelvic lymph node dissection.
Levels of prostate specific antigen that predict skeletal spread in prostate cancer.
Loss of prostatic acid phosphatase and ?-synuclein cause motor circuit degeneration without altering cerebellar patterning.
Luteinizing hormone-releasing hormone downstaging of clinical stage C prostate cancer.
Markedly raised serum prostate specific antigen levels. Prostatic infarction rather than malignancy?
Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Measurements of serum gamma-seminoprotein and prostate specific antigen evaluated for monitoring carcinoma of the prostate.
Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase.
Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
Mice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations.
Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis.
Monitoring of prostatic cancer by an enzyme-linked immunosorbent assay of serum prostatic acid phosphatase.
Multiple cutaneous metastases in the chest from prostatic carcinoma.
Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
Multiple marker evaluation in prostatic cancer using prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase.
Multiple marker evaluation in prostatic cancer with prostatic acid phosphatase, gamma-seminoprotein and prostate-specific antigen.
Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer.
Near-infrared fluorescence probe for the determination of acid phosphatase and imaging of prostate cancer cells.
New agents for prostatic cancer activated specifically by prostatic acid phosphatase.
New diagnostic use of bone marrow acid and alkaline phosphatase.
NKX3.1 as a marker of prostatic origin in metastatic tumors.
On low acid phosphatase values of patients with known metastatic cancer of the prostate.
Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.
Parotid saliva acid phosphatase in prostatic cancer.
PC-3-Derived Exosomes Inhibit Osteoclast Differentiation by Downregulating miR-214 and Blocking NF-?B Signaling Pathway.
Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL.
Pharmacokinetics and dosimetry of [111In] F(ab')2 fragments against prostatic acid phosphatase after intraprostatic injection for immunoscintigraphy in prostate cancer.
Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer.
Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells.
Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers.
Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer.
Preparation of F(ab')2 fragments from monoclonal mouse IgG1 suitable for use in radioimaging.
Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination.
Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide).
Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine.
Production of specific antibody to purified prostatic acid phosphatase.
Prognostic factors in patients with advanced prostate cancer.
Prognostic factors in patients with prostate cancer refractory to endocrine therapy: univariate and multivariate analyses including doubling times of prostate-specific antigen and prostatic acid phosphatase.
Prognostic factors in survival free of progression after androgen deprivation therapy for treatment of prostate cancer.
Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer.
Prognostic value of bone marrow acid phosphatase in prostatic carcinoma.
Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer.
Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
Prostate antigen: a new potential marker for prostatic cancer.
Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.
Prostate cancer vaccines in clinical trials.
Prostate cancer vaccines: current status and future potential.
Prostate cancer. Promising advances that may alter survival rates.
Prostate inhibin peptide (PIP) in prostate cancer: a comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP).
Prostate specific antigen (PSA) and prostate specific acid phosphatase (PSAP) immunoreactivity in benign seminal vesicle\ejaculatory duct epithelium: a potential pitfall in the diagnosis of prostate cancer in needle biopsy specimens.
Prostate specific antigen and prostate acid phosphatase declines after estramustine phosphate withdrawal: a case report.
Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.
Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer.
Prostate specific antigen: clinical use in the diagnosis and management of prostate cancer.
Prostate-related antigen-derived new peptides having the capacity of inducing prostate cancer-reactive CTLs in HLA-A2+ prostate cancer patients.
Prostate-specific acid phosphatase versus acid phosphatase in monitoring patients with prostate cancer.
Prostate-specific antigen and prostate acid phosphatase in the detection of early prostate cancer and the prediction of regional lymph node metastases.
Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer.
Prostate-specific antigen and prostatic acid phosphatase in the detection of early prostate cancer and in the prediction of regional lymph node metastases.
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase.
Prostate-specific antigen in mass screening for carcinoma of the prostate.
Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer.
Prostate-specific antigen: biochemistry, analytical methods, and clinical application.
Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?
Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy.
Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.
Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
Prostatic acid phosphatase and prostatic cancer.
Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with nonprostate adenocarcinoma.
Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma.
Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
Prostatic acid phosphatase in serum of patients with prostatic cancer is a specific phosphotyrosine acid phosphatase.
Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.
Prostatic acid phosphatase is not a prostate specific target.
Prostatic acid phosphatase measurement: its role in detection and management of prostatic cancer.
Prostatic acid phosphatase, a neglected ectonucleotidase.
Prostatic acid phosphatase. Biomolecular features and assays for serum determination.
Prostatic acid phosphatase: a possible diagnostic marker of intravascular large B-cell lymphoma.
Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin. Immunodiagnosis by prostatic acid phosphatase.
Prostatic cancer with bone metastases: serum alkaline phosphatase (SAP) as a predictor of response and the significance of the SAP "flare".
Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study.
Prostatic cancer. XII. Extremely elevated serum acid phosphatase associated with altered liver function.
Prostatic cancer. Immunochemical detection of prostatic acid phosphatase in serum and bone marrow.
Prostatic cancer. VII. Serum acid phosphatase response to cholinergic stimulation in prostatic cancer patients.
Prostatic serum acid phosphatase in patients with localized prostatic cancer.
Prostatic serum acid phosphatase level in cancer of the prostate; diagnostic and clinical significance as illustrated by thirteen case histories.
Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Protection of prostatic acid phosphatase activity in human serum samples by plasmin inhibitors.
Protein kinase C pathway is involved in regulating the secretion of prostatic acid phosphatase in human prostate cancer cells.
Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3? signaling and inhibition of cellular prostatic acid phosphatase.
PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer.
Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma.
Purification of monoclonal antibodies raised against prostate-specific acid phosphatase for use in vivo in radioimaging of prostatic cancer.
Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T.
Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
Quantitation of prostate-specific acid phosphatase in prostate cancer: reproducibility and correlation with subjective grade.
Radiation therapy for localized prostate cancer. Justification by long-term follow-up.
Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen-year follow-up.
Radical surgery versus radiation therapy in early prostatic carcinoma.
Radioimaging of lymph node involvement in prostatic carcinoma.
Radioimmunoassay for prostatic acid phosphatase helps discriminate patients with prostatic cancer.
Radioimmunoassay of serum prostatic acid phosphatase in prostatic cancer.
Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
Radioimmunodetection of lymph node invasion in prostatic cancer. The use of iodine 123 (123I)-labeled monoclonal anti-prostatic acid phosphatase (PAP) 227 A F(ab')2 antibody fragments in vivo.
Radioimmunodetection of prostate cancer by 111In-labeled monoclonal antibody against prostatic acid phosphatase.
Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging.
Radioimmunological imaging of metastatic prostatic cancer with 111indium-labeled monoclonal antibody PAY 276.
Real-time immune monitoring to guide plasmid DNA vaccination schedule targeting prostatic acid phosphatase in patients with castration-resistant prostate cancer.
Receiver operator characteristic (ROC) curves and non-normal data: an empirical study.
Recent advances in immunotherapy for the treatment of prostate cancer.
Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP.
Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphatase.
Reliability of bone marrow acid phosphatase as a parameter of metastatic prostatic cancer.
RENAL ORIGIN OF URINARY ACID PHOSPHATASE IN NORMAL AND IN PATIENTS WITH CANCER OF THE PROSTATE.
Review of acid phosphatase in the diagnosis and prognosis of prostatic cancers.
Reviving the acid phosphatase test for prostate cancer.
Role of acid phosphatase measurement in management of prostate cancer.
Routine acid phosphatase testing for screening and monitoring prostate cancer no longer justified.
Routine screening for prostatic cancer by assay of serum acid phosphatase: a modest proposal.
Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.
Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection.
Screening and characterization of a novel RNA aptamer that specifically binds to human prostatic Acid phosphatase and human prostate cancer cells.
Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared.
Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening.
Sensitivity and specificity of acid phosphatase to detect prostate cancer using data from a hospital information system.
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
Serum acid phosphatase in the assessment of response to systemic therapy in metastatic prostate cancer: comparison of radioimmune and enzymatic assays.
Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer.
Serum acid phosphatase of prostatic origin in the diagnosis of prostatic cancer: clinical evaluation of 2408 tests by the Fishman-Lerner method.
Serum acid phosphohydrolase (phosphatase) and ribonuclease in diagnosis of prostatic cancer.
Serum and bone marrow radioimmunoassay of acid phosphatase in prostatic cancer.
Serum ceruloplasmin as a marker in prostate cancer.
Serum chromogranin-A in advanced prostate cancer.
Serum gamma-seminoprotein determination in prostatic cancer.
Serum osteocalcin concentration in patients with prostatic cancer.
Serum prostatic acid phosphatase and cancer of the prostate.
Serum prostatic acid phosphatase in cancer of the prostate.
Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
Serum tissue polypeptide antigen (TPA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
Serum TPS, PSA, and PAP values in relapsing stage D2 adenocarcinoma of the prostate.
Significance of a new stratification of alkaline phosphatase and extent of disease in patients with prostate carcinoma with bone metastasis.
Significance of serum protein and lipid-bound sialic acid as a marker for genitourinary malignancies.
Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer.
Sipuleucel-T (Provenge): active cellular immunotherapy for advanced prostate cancer.
Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer.
Sipuleucel-T: a therapeutic cancer vaccine for the treatment of castration- or hormone-refractory prostate cancer.
Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.
Sonographic and pathological staging of patients with clinically localized prostate cancer.
Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer.
Steroid hormone regulation of prostatic acid phosphatase expression in cultured human prostatic carcinoma cells.
Structure of Acid phosphatases.
STUDIES OF FIBRINOLYSIS AND ACID PHOSPHATASE IN CANCER OF THE PROSTATE.
Studies on falsely negative serum acid phosphatase tests in disseminated prostatic cancer.
Studies on glycolytic enzymes in relation to cancer. 3. Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase.
Successful resection of a solitary metastatic liver tumor from prostate cancer 15 years after radical prostatectomy: a case report.
Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Surveillance of patients with prostate cancer after treatment: the roles of serologic and imaging studies.
Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers.
Survival markers related to bone metastases in prostate cancer.
Systematic association of PAP and PSA determinations to bone scintigraphy in prostatic cancer.
Systemic treatment of advanced prostatic cancer: development of a new system for defining response.
Targeting the spectrum of immune checkpoints in prostate cancer.
TARTRATE-INHIBITED ACID PHOSPHATASE IN BENIGN PROSTATIC HYPERTROPHY AND IN PROSTATIC CANCER.
Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer.
Technology evaluation: APC-8015, Dendreon.
The 1993 ISOBM Abbott Award Lecture. Isozymes, tumor markers and oncodevelopmental biology.
The application of prostate specific membrane antigen in CART?cell therapy for treatment of prostate carcinoma (Review).
The contribution of prostatic acid phosphatase and prostatic specific antigen in the diagnosis of prostatic cancer.
The current role of prostatic acid phosphatase and prostate-specific antigen in the management of prostate cancer.
The diagnostic significance of serum creatine kinase-BB isoenzyme in adenocarcinoma of prostate.
The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
The discovery of prostate specific antigen as a biomarker for the early detection of adenocarcinoma of the prostate.
The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells.
The histochemical behaviour, electrophoretic mobility and distribution in cell fractions of acid phosphatase isozymes in prostatic cancer and benign prostate hyperplasia.
The predictive value of prostatic acid phosphatase as a screening test for prostatic cancer.
The prognostic value of acid phosphatase and beta-glucuronidase activity in biopsy specimens from patients with reactivated prostatic cancer.
The prognostic value of prostate-specific antigen and prostatic acid phosphatase in serum of patients with prostate cancer after orchidectomy.
The prostatic acid phosphatase (ACPP) gene is localized to human chromosome 3q21-q23.
The role of prostatic specific antigen in monitoring prostatic cancer and its prognostic importance.
The role of sipuleucel-T in therapy for castration-resistant prostate cancer: a critical analysis of the literature.
The staging of M1 disease: the role of bone scan, Xray and other imaging techniques.
The use of serum isoenzymes of alkaline and acid phosphatase as possible quantitative markers of tumor load in prostate cancer.
The value of acid phosphatase measurements in predicting extraprostatic cancer growth before radical prostatectomy.
The value of serum carboxyterminal propeptide of type 1 procollagen in predicting bone metastases in prostate cancer.
The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer.
Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.
Tissue polypeptide antigen (TPA) and prostatic acid phosphatase in serum of prostatic cancer patients.
Transmembrane Prostatic Acid Phosphatase (TMPAP) Interacts with Snapin and Deficient Mice Develop Prostate Adenocarcinoma.
Treatment of advanced hormone-refractory prostate carcinoma with a combination of etoposide, pirarubicin and cisplatin.
Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable hormone-refractory disease.
Tumor antigen and acid phosphatase isoenzyme in prostatic cancer.
Tumor marker doubling time in patients with prostate cancer: determination of prostate-specific antigen and prostatic acid phosphatase doubling time.
Tumour markers in prostatic cancer.
Two new, direct, and specific methods of acid phosphatase determination. National field trial.
Two prostate-specific antigens, gamma-seminoprotein and beta-microseminoprotein.
Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells.
Undetectable serum prostate-specific antigen associated with metastatic prostate cancer: a case report and review of the literature.
Unpredictable fluctuations in serum acid phosphatase activity in prostatic cancer.
URI Regulates KAP1 Phosphorylation and Transcriptional Repression via PP2A Phosphatase in Prostate Cancer Cells.
Urinary hydroxyproline excretion as a marker of bone metastasis in prostatic cancer.
Urology-Important Advances in Clinical Medicine: Prostatic Acid Phosphatase Is Not a Screening Test for Early Prostatic Cancer.
Use of CT to reduce understaging in prostatic cancer: comparison with conventional staging techniques.
Value of biochemical markers in the management of disseminated prostatic cancer.
Value of new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer.
Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens.
Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells.
What is the 'normal range' for prostate-specific antigen? Use of a receiver operating characteristic curve to evaluate a serum marker.
XB130 is overexpressed in prostate cancer and involved in cell growth and invasion.
[ACID PHOSPHATASE AND DIAGNOSIS OF PROSTATIC CANCER.]
[Acid phosphatase and prostatic cancer. Survey of present assay methods]
[Acid phosphatase as tumor marker of prostatic cancer]
[Acid phosphatase of prostatic origin and its value in the diagnosis of cancer of the prostate.]
[Acid phosphatases]
[Aldolase, acid phosphatase and prostatic phosphatase in the blood of patients with prostatic cancer]
[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer].
[Cancer of the prostate: the markers other than prostatic acid phosphatase]
[Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer]
[Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer]
[Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer]
[Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma]
[Clinical evaluation of serum basic fetoprotein for prostatic cancer--comparative study with PAP, gamma-Sm and PSA]
[Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer]
[Clinical significance of acid phosphatase in the blood serum in prostatic cancer.]
[Clinical significance of prostate-specific antigen]
[Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein]
[Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein]
[Clinical study of tumor markers in prostatic cancer]
[Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase (PAP) in blood by PAP RIA kit "EIKEN" (author's transl)]
[Current assessment of radioimmunological determination (RIA) of prostate acid phosphatase in the diagnosis of prostatic cancer]
[Current status and problems of a screening for prostatic cancer in the health facilities in Fukuoka Prefecture]
[Determination of acid phosphatase in prostatic carcinoma]
[Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate]
[Determination of tumor marker doubling time in the patients with prostate cancer relapsed from endocrine therapy]
[Diagnosis and follow-up of prostatic cancer using an enzyme immunoassay for prostate-specific acid phosphatase]
[Diagnostic significance of immunologically determined serum acid phosphatase in prostatic cancer]
[Diagnostic value of prostatic specific antigen (PSA) in comparison to prostatic acid phosphatase (PAP) in prostatic cancer and adenoma]
[Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue]
[Enzyme study in cancer of the prostate. Action of ionized calcium on acid phosphatase.]
[Enzymological study of prostatic cancer VIII. Comparison of acid phosphatase by measurement of enzymatic level and radioimmunoassay in diagnosis of patients with prostatic carcinoma (author's transl)]
[Enzymological study of prostatic cancer. I. Changes of serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase, glutamic pyruvic transaminase, glutamic oxalacetic transaminase activity and lactic dehydrogenase isoenzymes in prostatic cancer under anti-androgenic treatment, with special reference to prognosis]
[Enzymological study of prostatic cancer. II. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase activity and lactic dehydrogenase isoenzymes in prostatic cancer, with special reference to relation with stage and histological malignancy]
[Enzymological study of prostatic cancer. VI. Serum acid phosphatase level and prognosis of patients with prostatic carcinoma (author's transl)]
[Evaluation of immunosuppressive acid protein in genitourinary malignant diseases]
[Immunochemical analysis of prostatic acid phosphatase. 3. Evaluation of patients with prostatic cancers and cancer of other organs and a comparison with conventional method]
[Immunochemical tests in the diagnosis of diseases of the male reproductive system]
[Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer]
[Immunohistochemical detection of prostate carcinoma]
[Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase]
[Isoenzyme as tumor marker]
[Mass screening for prostatic cancer in Hisayama town, Fukuoka]
[Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer]
[Measurement of serum PSA by DELFIA PSA kit and its application for mass screening. The Gunma Urological Oncology Study Group]
[Metastasis and markers]
[Prognosis of prostate cancer with elevated prostatic acid phosphatase]
[Prognostic value of prostatic acid phosphatase in stage B and C prostatic cancer. Apropos of 84 cases]
[Prostate cancer test and medical reimbursement]
[Prostate cancer with an unusual course]
[Prostate-specific antigen, acid phosphatases and rectal exploration in the diagnosis of prostatic cancer]
[Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma]
[Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer]
[Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay]
[Prostatic acid phosphatase measured by amplified enzyme linked immunoassay. Its application to mass screening for prostatic tumor and monitoring the clinical course of prostatic cancer patients]
[Prostatic acid phosphatase measured by immunoenzyme assay]
[Prostatic cancer and acid phosphatase]
[Prostatic carcinoma: immunoperoxidase study with antisera against prostatic acid phosphatase and the prostate-specific antigen]
[Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB]
[Purification of prostatic acid phosphatase and prostate specific antigen from human seminal plasma]
[Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer]
[Serum acid phosphatase determined by the radioimmunochemical method (P.A.P.-RIA): its diagnostic value in prostatic cancer]
[Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract]
[Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt]
[Significance of prostatic specific antigen in the mass screening for prostate cancer]
[Significance of tumor markers in the treatment of urological malignancies]
[Significance of various examination methods in the management of prostatic cancer]
[Studies on acid phosphatase in prostatic cancer. I. Acid phosphatase isoenzymes of various tissue extracts (author's transl)]
[Studies on acid phosphatase in prostatic cancer. II. Investigation of acid phosphatase isoenzymes by ion-exchange column chromatography in serum and bone marrow of the patient with prostatic cancer (author's transl)]
[Studies on acid phosphatase in prostatic cancer. III. Production of specific antibody against human prostatic acid phosphatase (author's transl)]
[Studies on acid phosphatase in prostatic cancer. IV. Immunochemical assay of prostatic acid phosphatase (author's transl)]
[Studies on human prostatic carcinoma cell lines: evaluation of acid phosphatase productivity and effects of sex hormones on the cells]
[The evaluation of chemotherapy of relapse in prostatic cancer with new response criteria]
[THE EVOLUTION OF MARKERS OF PROSTATE CANCER].
[The histochemistry of complex carbohydrates in the prostatic tumor]
[The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer]
[The significance of serum gamma-seminoprotein in prostatic cancer]
[The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers]
[Tumor marker in urology]
[Urogenital cancer]
[Usefulness of bone gammagraphy versus tumor markers (PSA/PAP) in monitoring cancer of the prostate]
[Value of prostatic acid phosphatase and its relation to bone gammagraphy in the diagnosis of cancer of the prostate]
[VALUE OF THE DETERMINATION OF SERUM ACID PHOSPHATASE IN PROSTATIC CANCER. APROPOS OF 100 CASES.]
Prostatitis
An immunohistological study of granulomatous prostatitis.
Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus.
Creatine phosphokinase relative to acid phosphatase, lactate dehydrogenase, zinc and fructose in human semen with special reference to chronic prostatitis.
Enzyme immunoassay for the prostate-specific acid phosphatase (E. C. 3.1.3.2).
Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.
Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disorders.
Granulomatous prostatitis and poorly differentiated prostate carcinoma. Their distinction with the use of immunohistochemical methods.
Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer.
Paradoxical increase of sperm motility and seminal carnitine associated with moderate leukocytospermia in infertile patients.
Prostate-specific antigen (protein and mRNA) analysis in the differential diagnosis and staging of prostate cancer.
Proteolytic enzymes and acid phosphatase in the prostatic fluid in chronic prostatitis.
The characterization of nonbacterial prostatitis: search for an etiology.
The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.
The response of seven prostatic fluid components to prostatic disease.
[The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer]
[The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers]
Protein Deficiency
Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.
Protein-Energy Malnutrition
Changes in serum lysosomal hydrolases in marasmus.
Metabolism of lysosomal enzymes in the protein-deficient weanling rat.
Proteinuria
Associations between polymorphic variety and disease susceptibility in two New Guinea populations.
Changes in lysosome populations in the rat kidney cortex induced by passive Heymann glomerulonephritis.
[A study of urine acid phosphatase in students with proteinuria and patients with renal diseases (author's transl)]
[Experimental studies on the ketogenic effect of high doses of proteins in dairy cows]
[Study of the enzymatic activity of the blood leukocytes in experimental nephrotoxic nephritis in rats]
Pseudohypoparathyroidism
Skeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism.
Psoriasis
Acid phosphatase of neutrophils in peripheral blood of patients with psoriasis.
Lack of association between psoriasis vulgaris and red cell acid phosphatase polymorphism.
[Acid phosphatase distribution in the epidermis in psoriasis (an electron microscopy-histochemical study)]
[Acid phosphatase in peripheral blood leukocytes of patients with psoriasis]
[Acid phosphatase in peripheral blood lymphocytes of patients with psoriasis]
[Acid phosphatase in scale in psoriasis.]
[Acid phosphatase of peripheral blood neutrophils in patients with psoriasis]
[Activity of beta-glucuronidase and acid phosphatase in fractions of granulocytes isolated from PMNL in peripheral blood of patients with psoriasis]
[Comparative enzyme histochemical studies using four different slide making methods. II. Demonstration of acid phosphatase and non-specific esterase in psoriasis and the farmer's skin]
Pulmonary Disease, Chronic Obstructive
Activity of ?1-antitrypsin and some lysosomal enzymes in the blood serum of patients with chronic obstructive pulmonary disease after smoking cessation.
Purpura, Thrombocytopenic, Idiopathic
The activity of serum acid phosphatase in bone marrow aspirates predicts response to steroids/splenectomy in acute/chronic immune thrombocytopenic purpura.
Pyelonephritis
Bacterial antigen and acid phosphatase in macrophages in experimental pyelonephritis.
[Renal acid phosphatase activities in experimental and human chronic pyelonephritis (author's transl)]
Radiation Pneumonitis
Enzyme histochemical observations of diffuse pulmonary fibrosis of rats experimentally induced by ionizing irradiation.
Radicular Cyst
Identification of RANKL in osteolytic lesions of the facial skeleton.
Rectal Neoplasms
Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
Relative Energy Deficiency in Sport
Biomolecule from Trigonella stellata from Saudi Flora to Suppress Osteoporosis via Osteostromal Regulations.
OCY454 Osteocytes as an in Vitro Cell Model for Bone Remodeling Under Mechanical Loading.
Phelligridin D-loaded oral nanotube titanium implant enhances osseointegration and prevents osteolysis in rat mandible.
Processing and Sectioning Undecalcified Murine Bone Specimens.
Water extract of Rumex crispus prevents bone loss by inhibiting osteoclastogenesis and inducing osteoblast mineralization.
Renal Insufficiency
Acid phosphatase, beta-glucuronidase and N-acetyl-beta-D-glucosaminidase activity of peritoneal neutrophils in patients with terminal renal failure treated by intermittent peritoneal dialysis.
Activity of some lysosomal enzymes in peritoneal lymphocytes from patients with terminal renal failure treated by intermittent peritoneal dialysis.
Clinical and experimental studies of acid phosphatase in renal failure.
Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.
Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis.
When is it an osteoclast?
[Cytomorphological, cytochemical and functional characteristics of cells from peritoneal dialysate of patients with terminal renal failure treated by intermittent peritoneal dialysis. IV. Cytochemical studies of acid phosphatase, beta-glucuronidase and N-acetyl-beta-D-glucosaminidase activity]
[Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies]
Renal Insufficiency, Chronic
Effects of Yishenjiangzhuo granules on immunity and bone metabolism in patients with stage 3-4 chronic kidney disease.
Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.
Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
[Effects of Yishen Jiangzhuo Granule on the bone metabolism of patients with stage 3-4 chronic kidney disease and its correlation with the immune indices].
Retinal Detachment
Lysosomal enzymes in tear fluids from patients with ocular diseases.
Lysosomal enzymes in the serum of patients with with Behçet's disease.
Progressive cone dystrophy associated with low alpha-L-fucosidase activity in serum and leukocytes.
Retinal Dystrophies
Acid phosphatase localization in normal and dystrophic retinal pigment epithelium.
Lysosomal enzymes in tear fluids from patients with ocular diseases.
Retinitis Pigmentosa
The distribution of extra-cellular acid phosphatase in the retinas of retinitis pigmentosa rats.
Retinoblastoma
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.
Retroviridae Infections
Fibrils of Prostatic Acid Phosphatase Fragments Boost Infections by XMRV, a Human Retrovirus Associated with Prostate Cancer.
Rhabdomyolysis
Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.
Lipin-1 regulates Bnip3-mediated mitophagy in glycolytic muscle.
Rhabdomyosarcoma
Acid phosphatase response in murine rhabdomyosarcoma for various tumour volumes and after different doses of neutron irradiation, alone or combined with exogenous ATP.
Rheumatic Diseases
Paradoxical elevation of serum TRACP5b levels despite increase in lumbar spine bone mineral density during anti-TNF? therapy in patients with inflammatory rheumatic disease: a 2-year prospective assessment of bone mass, bone metabolism, and the trabecular bone score.
[Acid phosphatase of the blood serum in rheumatism]
[Cyclic nucleotides and enzymes of the synovial fluid in various rheumatic diseases]
[Study of blood acid phosphatase levels in patients with rheumatism (several perspectives in the clinical study of lysosomal permeability)]
Rheumatic Fever
[Zinc and enzymes in the synovial fluid and blood in various types of rheumatism]
Rheumatoid Nodule
A combined immunohistological and histochemical analysis of lymphocyte and macrophage subpopulations in the rheumatoid nodule.
Rhinitis, Allergic
The histological and histochemical effects of ketotifen in allergic rhinitis.
Riboflavin Deficiency
Dietary riboflavin deficiency decreases immunity and antioxidant capacity, and changes tight junction proteins and related signaling molecules mRNA expression in the gills of young grass carp (Ctenopharyngodon idella).
Intestinal immune function, antioxidant status and tight junction proteins mRNA expression in young grass carp (Ctenopharyngodon idella) fed riboflavin deficient diet.
[Influence of riboflavin deficiency on the activity of acid phosphatase in maternal and fetal organs of rats]
Rickets
Polarization and secretion of cathepsin K precede tartrate-resistant acid phosphatase secretion to the ruffled border area during the activation of matrix-resorbing clasts.
[Acid phosphatase and alpha-glycerolphosphate dehydrogenase activity of the lymphocytes in rickets in children (a cytochemical study)]
[Structure and function of hepatocyte lysosomes and peroxisomes of rachitic rats]
Root Resorption
Cellular events at the onset of physiological root resorption in rabbit deciduous teeth.
Cystathionine gamma lyase aggravates orthodontic root resorption in mice.
Dynamic Evaluation of Orthodontically-Induced Tooth Movement, Root Resorption, and Alveolar Bone Remodeling in Rats by in Vivo Micro-Computed Tomography.
Effect of appliance reactivation after decay of initial activation on osteoclasts, tooth movement, and root resorption.
Effects of calcitonin on orthodontic tooth movement and associated root resorption in rats.
Effects of continuous force application for extrusive tipping movement on periapical root resorption in the rat mandibular first molar.
Effects of Histamine Receptor Antagonist Cetirizine on Orthodontic Tooth Movement.
Expressions of RANKL/RANK and M-CSF/c-fms in root resorption lacunae in rat molar by heavy orthodontic force.
Histological and histochemical quantification of root resorption incident to the application of intrusive force to rat molars.
Histomorphometric and biochemical study of osteoclasts at orthodontic compression sites in the rat during indomethacin inhibition.
Inhibitory effects of IL-12 on experimental tooth movement and root resorption in mice.
Non-clast cells start orthodontic root resorption in the periphery of hyalinized zones.
Orthodontically induced root and alveolar bone resorption: inhibitory effect of systemic doxycycline administration in rats.
Periodontal regeneration of transplanted rat molars after cryopreservation.
Proinflammatory mediators related to orthodontically induced periapical root resorption in rat mandibular molars.
Root resorption on torqued human premolars shown by tartrate-resistant acid phosphatase histochemistry and transmission electron microscopy.
TGF-? and Physiological Root Resorption of Deciduous Teeth.
Tissue responses resulting from tooth movement surgically assisted by corticotomy and corticision in rats.
Sacroiliitis
Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateral sacroiliitis.
Sarcoidosis
Acid phosphatase (EC 3.1.3.2) activity in alveolar macrophages from patients with active sarcoidosis.
Diminished activity of tartrate resistant acid phosphatase in alveolar macrophages from patients with active sarcoidosis.
Hydrolytic enzyme of the alveolar macrophage in diffuse pulmonary interstitial disease.
Polymorphism of acid hydrolases in human epitheliod cells indicates cellular origin and defined differentiation stages.
Tartrate-resistant acid phosphatase 5a in sarcoidosis: further evidence for a novel macrophage biomarker in chronic inflammation.
[Acid phosphatase and beta-glucuronidase activities of lymphocytes in patients with sarcoidosis (author's transl)]
[Functional and morphological characterization of alveolar macrophages from patients with pulmonary sarcoidosis]
[Serum enzyme tests in the diagnosis and follow-up of the evolution of sarcoidosis]
Sarcoidosis, Pulmonary
Circulating levels of tartrate-resistant acid phosphatase in macrophage-activated lung disease.
Sarcoma
An enzyme histochemical study of non-Hodgkin's lymphoma and allied disease.
Characterization of a cell line derived from a human giant cell tumor that stimulates osteoclastic bone resorption.
The results of some cytochemical reactions in metastatic malignant tumor cells in pleural and peritoneal effusions.
[Metabolic study of sarcoma 45 and Walker carcinosarcoma cells during the process of growth and exposure to anticoagulants (an enzyme cytochemical analysis)]
Sarcoma, Ewing
Enzyme histochemical investigations on bone and soft tissue tumours.
Sarcoma, Myeloid
Differential characterization of the "reticulum cell" in lymphoreticular neoplasms.
Sarcoma, Synovial
Size dependent enzyme activities of multinucleated (osteoclastic) giant cells in bone tumors.
Schistosomiasis
Histochemistry of acid phosphatase in murine hepatic bilharziasis.
Schistosomiasis mansoni
An isoenzyme marker possibly associated with the susceptibility of Biomphalaria glabrata populations to Schistosoma mansoni.
Scoliosis
Association of glycosaminoglycan depletion and degradative enzyme activity in scoliosis.
[Association between tartrate-resistant acid phosphatase 5 gene polymorphism and adolescent idiopathic scoliosis].
Scrapie
Intraneuronal enzymic inclusions in the histological diagnosis of scrapie.
Scurvy
Alkaline and acid phosphatase activities in the gingiva and alveolar bone in scurvy.
Seizures
Picrotoxin-induced convulsions and lysosomal function in the rat brain.
Severe Dengue
Characterization of serum acid phosphatase associated with dengue hemorrhagic fever.
Sexually Transmitted Diseases
[In vivo neutralization of physiological cervicovaginal acidity by sperm nitrogen bases]
Shock, Septic
Production of toxic shock syndrome toxin 1 by Staphylococcus aureus under aerobic and anaerobic conditions and the effect of magnesium ion limitation.
Sickle Cell Trait
Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
Sjogren's Syndrome
Circulating prostatic acid phosphatase-immunoglobulin complexes in Sjogren's syndrome.
Skin Diseases
Psoriasis vulgaris and genetic markers.
Spinal Cord Compression
Hormone stimulation and chemotherapy in advanced prostate cancer: preliminary results of a prospective controlled clinical trial.
Spinal Cord Injuries
Lysosomal activity in experimental spinal cord trauma: an ultrastructural cytochemical evaluation.
[Electro-acupuncture effects on experimental spinal cord injury of the cat as evaluated by acid phosphatase detection]
Spondylarthritis
In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes.
Spondylitis, Ankylosing
Increased tartrate-resistant acid phosphatase serum levels in ankylosing spondylitis and relationship with the inflammatory process.
Squamous Cell Carcinoma of Head and Neck
Acid phosphatase in squamous cell carcinoma.
Starvation
A major root-associated acid phosphatase in Arabidopsis, AtPAP10, is regulated by both local and systemic signals under phosphate starvation.
A type 5 acid phosphatase gene from Arabidopsis thaliana is induced by phosphate starvation and by some other types of phosphate mobilising/oxidative stress conditions.
Activity alterations of metabolic enzymes in the anterior pituitary of female rats during acute and chronic starvation, as well as after refeeding.
An Arabidopsis mutant missing one acid phosphatase isoform.
Arabidopsis PHL2 and PHR1 Act Redundantly as the Key Components of the Central Regulatory System Controlling Transcriptional Responses to Phosphate Starvation.
Attenuation of phosphate starvation responses by phosphite in Arabidopsis.
Biochemical and molecular characterization of AtPAP26, a vacuolar purple acid phosphatase up-regulated in phosphate-deprived Arabidopsis suspension cells and seedlings.
Characterization of low phosphorus insensitive mutants reveals a crosstalk between low phosphorus-induced determinate root development and the activation of genes involved in the adaptation of Arabidopsis to phosphorus deficiency.
Conditional identification of phosphate-starvation-response mutants in Arabidopsis thaliana.
Corrigendum to "Identification and characterization of an Arabidopsis phosphate starvation induced secreted acid phosphatase as a vegetative storage protein" [Plant Sci. 277 (2018) 278-284].
Cytochemical investigation of the digestive gland of two strombidae species (Strombus gigas and Strombus pugilis) in relation to the nutrition.
Differential increase in activity of acid phosphatase induced by phosphate starvation in Tetrahymena.
Effect of starvation and 6-methylprednisolone (Medrol) on the acid phosphatase of rat liver and muscle.
Examination of the endosomal and lysosomal pathways in Dictyostelium discoideum myosin I mutants.
Feeding hungry plants: The role of purple acid phosphatases in phosphate nutrition
Function of hybrid human-yeast cyclin-dependent kinases in Saccharomyces cerevisiae.
Genome-wide characterization of the phosphate starvation response in Schizosaccharomyces pombe.
Glycogen and glycogen-hydrolysing lysosomal enzyme activity in mouse liver: effects of fasting, adrenoceptor antagonism and insulin-induced hypoglycaemia.
GmPAP12 Is Required for Nodule Development and Nitrogen Fixation Under Phosphorus Starvation in Soybean.
High level of zinc triggers phosphorus starvation by inhibiting root-to-shoot translocation and preferential distribution of phosphorus in rice plants.
High-level expression of endogenous acid phosphatase inhibits growth and vectorial secretion in Saccharomyces cerevisiae.
Histochemical findings in the rat gastric mucosa during starvation.
Identification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans.
Identification of rice purple acid phosphatases related to phosphate starvation signalling.
Involvement of OsSPX1 in phosphate homeostasis in rice.
Lysosomal abnormalities in hadacidin-treated Dictyostelium discoideum amoebae.
Lysosomal hydrolase secretion by Tetrahymena: a comparison of several intralysosomal enzymes with the isoenzymes released into the medium.
Mathematical model of cell growth and phosphatase biosynthesis in Saccharomyces carlsbergensis under phosphate limitation.
Metabolic and compositional changes in Escherichia coli cells starved in seawater.
Metabolic priorities during starvation: enzyme sparing in liver and white muscle of Atlantic cod, Gadus morhua L.
Modulation of a cell surface glycoprotein in yeast: acid phosphatase.
On the mitochondria, ribonucleic acid, acid phosphatase and polysaccharide of liver cells of a fish (Oryzias latipes) during starvation. II. On acid phosphatase.
On the mitochondria, ribonucleic acid, acid phosphatase and polysaccharide of liver cells of a fish (Oryzias latipes) during starvation. III. On polysaccharide.
On the mitochondria, ribonucleic acid, acid phosphatase and polysaccharide of liver cells of a fish (Oryzias latipes) during starvation. I. On the mitochondria and ribonucleic acid.
Overexpression of OsPAP10a, A Root-Associated Acid Phosphatase, Increased Extracellular Organic Phosphorus Utilization in Rice.
Pho5p and newly identified nucleotide pyrophosphatases/ phosphodiesterases regulate extracellular nucleotide phosphate metabolism in Saccharomyces cerevisiae.
Phosphate Starvation Inducible Metabolism in Lycopersicon esculentum: I. Excretion of Acid Phosphatase by Tomato Plants and Suspension-Cultured Cells.
Phosphate Starvation Inducible Metabolism in Lycopersicon esculentum: II. Characterization of the Phosphate Starvation Inducible-Excreted Acid Phosphatase.
PRD, an Arabidopsis AINTEGUMENTA-like gene, is involved in root architectural changes in response to phosphate starvation.
Regulation of two phosphatases and a cyclic phosphodiesterase of Salmonella typhimurium.
RNA polymerase II CTD phospho-sites Ser5 and Ser7 govern phosphate homeostasis in fission yeast.
Serum acid phosphatase response to starvation and cortisone administration in rats.
Strigolactone regulates anthocyanin accumulation, acid phosphatases production and plant growth under low phosphate condition in Arabidopsis.
The Arabidopsis gene hypersensitive to phosphate starvation 3 encodes ethylene overproduction 1.
The Dual-targeted Purple Acid Phosphatase Isozyme AtPAP26 is Essential for Efficient Acclimation of Arabidopsis thaliana to Nutritional Phosphate Deprivation.
The effect of myo-inositol deficiency on phosphatases of yeast.
TORC1 and TORC2 converge to regulate the SAGA co-activator in response to nutrient availability.
Use of the p-nitrophenyl phosphate method for the demonstration of acid phosphatase during starvation and cell autolysis in the planarian Polycelis tenuis Iijima.
[Genetical effect of different rye chromosomes on the acid phosphatase (Acph) secretion of common wheat roots under phosphorus starvation conditions]
[Interrelationship between metabolic and genetic regulation of alkaline and acid phosphatases in E. coli cells]
Status Epilepticus
Enzyme histochemistry of the rat hippocampus during experimental status epilepticus.
Steatitis
Fish oil-induced yellow fat disease in rats. II. Enzyme histochemistry of adipose tissue.
Stomach Neoplasms
Activity of some lysosomal enzymes in neutrophils from peripheral blood of patients with digestive tract cancer at different clinical stages of the disease. A cytochemical study.
Clinical significance of tartrate-resistant acid phosphatase type-5 expression in human gastric cancer.
Enzymatic deficiencies of the immune system cells in patients with cancer of the larynx and other malignancies.
Identification of diagnostic upper gastrointestinal cancer tissue type-specific urinary biomarkers.
Lysosomal enzymes in peripheral blood lymphocytes of patients with gastric cancer.
Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer.
Ultrastructural cytochemical study of enzymes expressed by signet ring cells in gastric cancer.
Ultrastructural cytochemistry of human gastric cancer: electron microscopic observations of five organellae marker enzymes.
[Histochemical study of acid phosphatase in tumor cells of stomach cancer]
[Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach]
[The phagocytic activity and the alkaline and acid phosphatase indices of the neutrophilic leukocytes in patients with stomach cancer treated with 5-fluorouracil and zymosan]
Stomach Ulcer
[Lipid peroxidation, the enzyme antioxidative system and acid phosphatase content of the gastric mucosa in stomach ulcer]
Synovitis
Associations of symptomatic knee OA with histopathologic features in subchondral bone.
Cruciate ligament degeneration and stifle joint synovitis in 56 dogs with intact cranial cruciate ligaments: Correlation of histological findings and numbers and phenotypes of inflammatory cells with age, body weight and breed.
IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel Fc?RIIB-deficient rheumatoid arthritis mouse model.
[The diagnostic information value of determining the cytochemical properties of the neutrophils from the blood and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis deformans]
Teratoma
Free amino Acid pools and enzymes in teratonia and habituated tobaceo tissue cultures.
Teratozoospermia
Hypothyroidism has an adverse effect on human spermatogenesis: a prospective, controlled study.
Testicular Neoplasms
Acid phosphatases of dog testis and a Leydig cell tumor.
Prevalence of intratubular germ cell neoplasia in cryptorchid testes of infertile men.
[Metastasis and markers]
[Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract]
Thalassemia
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Thrombocytopenia
Advanced cancer of the prostate combined with hypercalcaemia.
Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis.
Plasma acid phosphatase in idiopathic and secondary thrombocytopenias.
[Case report of Gaucher's disease]
[Leucocyte tartrate-resistant acid phosphatase as marker for the transition of monocyte to macrophage]
Thrombocytosis
Platelet-derived acid phosphatase isoenzyme in the serum in thrombocythemia.
Uteroferrin and recombinant bovine GM-CSF modulate the myelosuppressive effects of 5-fluorouracil in young female pigs (Sus scrofa).
Thromboembolism
[Megakaryocytopoiesis in patients with acute infectious destruction of the lungs]
Thrombosis
Treatment with recombinant human macrophage colony-stimulating factor resorbs blood clot and restores osteoclastogenesis in heterotopic bone induced by partially purified native bone morphogenetic protein in osteopetrotic (op/op) mice.
Thyroid Neoplasms
An ultrastructural and cytoenzymological study on the folliculo-papillary thyroid carcinoma.
Biologic markers in cancer diagnosis and treatment.
Lipid-rich residual bodies in the human thyroid gland: ultrastructural, histochemical, and morphometric study.
[Radioimmunoassays in oncology]
Thyrotoxicosis
A crucial role of interleukin-6 in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in mice.
[Acid phosphatase of leukocytes in patients with diffuse toxic goiter in evaluating the stage of the disease]
Tonsillitis
Enzymatic study of tonsil tissue alkaline and acid phosphatase in children with recurrent tonsillitis and tonsil hypertrophy.
Tooth Mobility
Development of Thymol microsponges loaded In situ gel for the treatment of Periodontitis.
Tourette Syndrome
Linkage to Tourette syndrome is excluded for red-cell acid phosphatase (ACP1) and flanking markers on chromosome 2pter-2p23.
Toxoplasmosis
[Cytochemical activity of cells of the lymphocytic-macrophageal system in patients with chronic acquired toxoplasmosis]
Tremor
Sipuleucel-T (Provenge): active cellular immunotherapy for advanced prostate cancer.
Tricuspid Valve Insufficiency
Predictors of osteoclast activity in patients with sickle cell disease.
Tuberculosis
A comparative study on the activation of J-774 macrophage-like cells by gamma-interferon, 1,25-dihydroxyvitamin D3 and lipopeptide RP-56142: ability to kill intracellularly multiplying Mycobacterium tuberculosis and Mycobacterium avium.
Fate of Mycobacterium tuberculosis inside rat peritoneal macrophages in vitro.
Fatty acid-sensitive acid phosphatase activity of tubercle bacilli.
HLA-DR2 phenotype and plasma lysozyme, beta-glucuronidase and acid phosphatase levels in pulmonary tuberculosis.
Secreted acid phosphatase (SapM) of Mycobacterium tuberculosis is indispensable for arresting phagosomal maturation and growth of the pathogen in guinea pig tissues.
Secretion of an acid phosphatase (SapM) by Mycobacterium tuberculosis that is similar to eukaryotic acid phosphatases.
Sinomenine Suppresses Osteoclast Formation and Mycobacterium tuberculosis H37Ra-Induced Bone Loss by Modulating RANKL Signaling Pathways.
[Alteration in activities of NAD-glycohydrolase, acid and alkaline phosphatases in blood cells tuberculosis]
[Histochemical study of alkaline and acid phosphatase in prolonged therapy of tuberculosis]
[SapM-induced fusion blocking of autophagosome-lysosome is depended on interaction with Rab7].
[Secretory acid phosphatase of Mycobacterium tuberculosis inhibits the autophagy of murine macrophages].
Tuberculosis, Osteoarticular
Mycobacterium tuberculosis infection increases the number of osteoclasts and inhibits osteoclast apoptosis by regulating TNF-?-mediated osteoclast autophagy.
Tuberculosis, Pulmonary
Enzyme levels in bronchoalveolar lavage fluid and serum of active pulmonary tuberculosis patients.
HLA-DR2 phenotype and plasma lysozyme, beta-glucuronidase and acid phosphatase levels in pulmonary tuberculosis.
[Acid phosphatase and beta-glucuronidase activities of T and B lymphocytes in patients with pulmonary tuberculosis (author's transl)]
[Alteration in activities of NAD-glycohydrolase, acid and alkaline phosphatases in blood cells tuberculosis]
[Lymphocyte enzymes, activity of lipid peroxidation processes and the antioxidant protection of patients with tuberculosis of the lungs]
Ureteral Neoplasms
[Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies]
Ureteral Obstruction
Prostate cancer: a model of cancer in the elderly.
Rectal obstruction secondary to carcinoma of the prostate.
Urinary Bladder Neck Obstruction
Hormonal therapy in prostatic carcinoma.
Urinary Bladder Neoplasms
Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder.
[Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies]
[Enzymological study of bladder tumor. I. Serum lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase, prostatic acid phosphatase, glutamic pyruvic transaminase, glutamic oxalacetic transaminase activities and LDH isoenzymes: the relations with stage and histological grade]
Urologic Diseases
[Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer]
[Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein]
Urologic Neoplasms
[Urological neoplasms and enzyme. IV. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, and total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with dimethylnitrosamine]
[Urological neoplasms and enzymes. V. Studies on the alteration of lactic dehydrogenase, alkaline phosphatase, leucine aminopeptidase, total acid phosphatase activities and LDH isozymes in experimentally induced renal tumors with lead acetate]
Uterine Cervical Neoplasms
Antitumor activity and DNA-binding investigations of isoeuxanthone and its piperidinyl derivative.
Cytotoxic activity and DNA-binding properties of isoeuxanthone derivatives.
[Lysosomal enzymes in the neoplastic pathology of the uterine cervix. Study of acid phosphatase in the diagnostic test of vaginal secretions in patients with pre-invasive and invasive cancer of the uterine cervix. I. Methods and preliminary experiences]
Uveitis
Lysosomal enzymes in the serum of patients with with Behçet's disease.
[The role of lysosomal enzymes in adjuvant-induced uveitis in rabbits (author's transl)]
Vaccinia
Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.
Varicocele
Fructose, prostatic acid phosphatase and zinc levels in the seminal plasma of varicoceles.
Markers of accessory sex glands function in men with varicocele, relationship with seminal parameters.
Seminal biochemistry and sperm characteristics in infertile men with bacteria in ejaculate.
Varicose Veins
Lysosomal enzymes and superoxide production in polymorphonuclear leukocytes of patients with primary varicose veins.
Vascular Calcification
Biochemical markers of vascular calcification in elderly hemodialysis patients.
The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
Vasculitis
Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?
Virus Diseases
Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG.
CORTISONE ON IN VITRO VIRAL INFECTION. II. EFFECT ON DISTRIBUTION OF CYTOPATHIC EFFECT AND ACID PHOSPHATASE ARRANGEMENT IN HUMAN CELLS INFECTED WITH POLIOVIRUS.
Cytochemical demonstration of acid phosphatase in peripheral blood cells in Rauscher virus infection.
Fibrils of Prostatic Acid Phosphatase Fragments Boost Infections by XMRV, a Human Retrovirus Associated with Prostate Cancer.
Influence of 2,4,6-triamino-pyrimidyl-5-azobenzene on the activities of acid phosphatase, alkaline phosphatase and lactate dehydrogenase in cell cultures infected with herpes simplex virus type 1.
Inhibition of semen-derived enhancer of virus infection (SEVI) fibrillogenesis by zinc and copper.
Inhibitory Effect of Naphthoquinone-Tryptophan Hybrid towards Aggregation of PAP f39 Semen Amyloid.
PP2A Facilitates Porcine Reproductive and Respiratory Syndrome Virus Replication by Deactivating irf3 and Limiting Type I Interferon Production.
Rapid Formation of Peptide/Lipid Coaggregates by the Amyloidogenic Seminal Peptide PAP248-286.
The effect on chick osteoclasts of infection with paramyxoviruses.
The semen enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen.
Vitamin B 6 Deficiency
Intravenous Vitamin B6 Increases Resistance to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: A Randomized Controlled Trial.
Vitamin D Deficiency
Impaired bone marrow-derived macrophage differentiation in vitamin D deficiency.
Vitamin E Deficiency
Vitamin E deficiency depressed fish growth, disease resistance, and the immunity and structural integrity of immune organs in grass carp (Ctenopharyngodon idella): Referring to NF-?B, TOR and Nrf2 signaling.
Waldenstrom Macroglobulinemia
[Cytochemical studies of bone marrow plasma cells in monoclonal gammapathies (author's transl)]
Whooping Cough
Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.
Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes.
Zenker Diverticulum
Morphology of the cricopharyngeal muscle in Zenker and control specimens.